
<html lang="en"     class="pb-page"  data-request-id="32811d8d-ca38-4732-906b-f5203b1e1a1b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00032;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-9;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis" /></meta><meta name="dc.Creator" content="Nicolas  Desroy" /></meta><meta name="dc.Creator" content="Christopher  Housseman" /></meta><meta name="dc.Creator" content="Xavier  Bock" /></meta><meta name="dc.Creator" content="Agnès  Joncour" /></meta><meta name="dc.Creator" content="Natacha  Bienvenu" /></meta><meta name="dc.Creator" content="Laëtitia  Cherel" /></meta><meta name="dc.Creator" content="Virginie  Labeguere" /></meta><meta name="dc.Creator" content="Emilie  Rondet" /></meta><meta name="dc.Creator" content="Christophe  Peixoto" /></meta><meta name="dc.Creator" content="Jean-Marie  Grassot" /></meta><meta name="dc.Creator" content="Olivier  Picolet" /></meta><meta name="dc.Creator" content="Denis  Annoot" /></meta><meta name="dc.Creator" content="Nicolas  Triballeau" /></meta><meta name="dc.Creator" content="Alain  Monjardet" /></meta><meta name="dc.Creator" content="Emanuelle  Wakselman" /></meta><meta name="dc.Creator" content="Veronique  Roncoroni" /></meta><meta name="dc.Creator" content="Sandrine  Le Tallec" /></meta><meta name="dc.Creator" content="Roland  Blanque" /></meta><meta name="dc.Creator" content="Celine  Cottereaux" /></meta><meta name="dc.Creator" content="Nele  Vandervoort" /></meta><meta name="dc.Creator" content="Thierry  Christophe" /></meta><meta name="dc.Creator" content="Patrick  Mollat" /></meta><meta name="dc.Creator" content="Marieke  Lamers" /></meta><meta name="dc.Creator" content="Marielle  Auberval" /></meta><meta name="dc.Creator" content="Boska  Hrvacic" /></meta><meta name="dc.Creator" content="Jovica  Ralic" /></meta><meta name="dc.Creator" content="Line  Oste" /></meta><meta name="dc.Creator" content="Ellen  van der Aar" /></meta><meta name="dc.Creator" content="Reginald  Brys" /></meta><meta name="dc.Creator" content="Bertrand  Heckmann" /></meta><meta name="dc.Description" content="Autotaxin is a circulating enzyme with a major role in the production of lysophosphatic acid (LPA) species in blood. A role for the autotaxin/LPA axis has been suggested in many disease areas inclu..." /></meta><meta name="Description" content="Autotaxin is a circulating enzyme with a major role in the production of lysophosphatic acid (LPA) species in blood. A role for the autotaxin/LPA axis has been suggested in many disease areas inclu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 1, 2017" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00032" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00032" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00032" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00032" /></link>
        
    
    

<title>Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00032" /></meta><meta property="og:title" content="Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0013.jpeg" /></meta><meta property="og:description" content="Autotaxin is a circulating enzyme with a major role in the production of lysophosphatic acid (LPA) species in blood. A role for the autotaxin/LPA axis has been suggested in many disease areas including pulmonary fibrosis. Structural modifications of the known autotaxin inhibitor lead compound 1, to attenuate hERG inhibition, remove CYP3A4 time-dependent inhibition, and improve pharmacokinetic properties, led to the identification of clinical candidate GLPG1690 (11). Compound 11 was able to cause a sustained reduction of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid. Compound 11 is currently being evaluated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00032"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00032">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00032&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00032&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00032&amp;href=/doi/10.1021/acs.jmedchem.7b00032" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3580-3590</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01807" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.7b00423" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Desroy">Nicolas Desroy</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4879-3439" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Housseman">Christopher Housseman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Bock">Xavier Bock</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agn%C3%A8s++Joncour">Agnès Joncour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natacha++Bienvenu">Natacha Bienvenu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=La%C3%ABtitia++Cherel">Laëtitia Cherel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Virginie++Labeguere">Virginie Labeguere</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emilie++Rondet">Emilie Rondet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Peixoto">Christophe Peixoto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Marie++Grassot">Jean-Marie Grassot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++Picolet">Olivier Picolet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denis++Annoot">Denis Annoot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Triballeau">Nicolas Triballeau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alain++Monjardet">Alain Monjardet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emanuelle++Wakselman">Emanuelle Wakselman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Veronique++Roncoroni">Veronique Roncoroni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandrine++Le+Tallec">Sandrine Le Tallec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Blanque">Roland Blanque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celine++Cottereaux">Celine Cottereaux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nele++Vandervoort">Nele Vandervoort</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Christophe">Thierry Christophe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Mollat">Patrick Mollat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marieke++Lamers">Marieke Lamers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marielle++Auberval">Marielle Auberval</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boska++Hrvacic">Boska Hrvacic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jovica++Ralic">Jovica Ralic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Line++Oste">Line Oste</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ellen++van+der+Aar">Ellen van der Aar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reginald++Brys">Reginald Brys</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bertrand++Heckmann">Bertrand Heckmann</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Charles River Laboratories, Chesterford Research Park, CB10 1XL Saffron Walden, United Kingdom</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Fidelta Ltd., Prilaz baruna Filipovića 29, Zagreb, HR-10000, Croatia</span></div><div class="corresp-info"><strong>*</strong>N.D.: phone, +33-1-4942-4820; e-mail, <a href="/cdn-cgi/l/email-protection#eb85828884878a98c58f8e98998492ab8c879b8cc5888486"><span class="__cf_email__" data-cfemail="1c72757f73707d6f3278796f6e73655c7b706c7b327f7371">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>B.H.: phone, +33-1-4942-4700; e-mail, <a href="/cdn-cgi/l/email-protection#c3a1a6b1b7b1a2ada7edaba6a0a8aea2adad83a4afb3a4eda0acae"><span class="__cf_email__" data-cfemail="650700171117040b014b0d00060e08040b0b25020915024b060a08">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00032&amp;href=/doi/10.1021%2Facs.jmedchem.7b00032" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3580–3590</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 17, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 January 2017</li><li><span class="item_label"><b>Published</b> online</span>1 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 May 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00032" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00032</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ec-1612971054143.svg" alt="ACS Editors’ Choice" /></img><span>ACS Editors’ Choice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00032"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">9535</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">64</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00032" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Desroy&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Housseman&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Bock&quot;},{&quot;first_name&quot;:&quot;Agnès&quot;,&quot;last_name&quot;:&quot;Joncour&quot;},{&quot;first_name&quot;:&quot;Natacha&quot;,&quot;last_name&quot;:&quot;Bienvenu&quot;},{&quot;first_name&quot;:&quot;Laëtitia&quot;,&quot;last_name&quot;:&quot;Cherel&quot;},{&quot;first_name&quot;:&quot;Virginie&quot;,&quot;last_name&quot;:&quot;Labeguere&quot;},{&quot;first_name&quot;:&quot;Emilie&quot;,&quot;last_name&quot;:&quot;Rondet&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Peixoto&quot;},{&quot;first_name&quot;:&quot;Jean-Marie&quot;,&quot;last_name&quot;:&quot;Grassot&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Picolet&quot;},{&quot;first_name&quot;:&quot;Denis&quot;,&quot;last_name&quot;:&quot;Annoot&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Triballeau&quot;},{&quot;first_name&quot;:&quot;Alain&quot;,&quot;last_name&quot;:&quot;Monjardet&quot;},{&quot;first_name&quot;:&quot;Emanuelle&quot;,&quot;last_name&quot;:&quot;Wakselman&quot;},{&quot;first_name&quot;:&quot;Veronique&quot;,&quot;last_name&quot;:&quot;Roncoroni&quot;},{&quot;first_name&quot;:&quot;Sandrine&quot;,&quot;last_name&quot;:&quot;Le Tallec&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Blanque&quot;},{&quot;first_name&quot;:&quot;Celine&quot;,&quot;last_name&quot;:&quot;Cottereaux&quot;},{&quot;first_name&quot;:&quot;Nele&quot;,&quot;last_name&quot;:&quot;Vandervoort&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Christophe&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Mollat&quot;},{&quot;first_name&quot;:&quot;Marieke&quot;,&quot;last_name&quot;:&quot;Lamers&quot;},{&quot;first_name&quot;:&quot;Marielle&quot;,&quot;last_name&quot;:&quot;Auberval&quot;},{&quot;first_name&quot;:&quot;Boska&quot;,&quot;last_name&quot;:&quot;Hrvacic&quot;},{&quot;first_name&quot;:&quot;Jovica&quot;,&quot;last_name&quot;:&quot;Ralic&quot;},{&quot;first_name&quot;:&quot;Line&quot;,&quot;last_name&quot;:&quot;Oste&quot;},{&quot;first_name&quot;:&quot;Ellen&quot;,&quot;last_name&quot;:&quot;van der Aar&quot;},{&quot;first_name&quot;:&quot;Reginald&quot;,&quot;last_name&quot;:&quot;Brys&quot;},{&quot;first_name&quot;:&quot;Bertrand&quot;,&quot;last_name&quot;:&quot;Heckmann&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;3580-3590&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00032&quot;},&quot;abstract&quot;:&quot;Autotaxin is a circulating enzyme with a major role in the production of lysophosphatic acid (LPA) species in blood. A role for the autotaxin/LPA axis has been suggested in many disease areas including pulmonary fibrosis. Structural modifications of the known autotaxin inhibitor lead compound 1, to attenuate hERG inhibition, remove CYP3A4 time-dependent inhibition, and improve pharmacokinetic properties, led to the identification of clinical candidate GLPG1690 (11). Compound 11 was able to cause a sustained reduction of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid. Compound 11 is currently being evaluated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00032&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00032" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00032&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00032" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00032&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00032" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00032&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00032&amp;href=/doi/10.1021/acs.jmedchem.7b00032" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00032" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00032" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00032%26sid%3Dliteratum%253Aachs%26pmid%3D28414242%26genre%3Darticle%26aulast%3DDesroy%26date%3D2017%26atitle%3DDiscovery%2Bof%2B2-%255B%255B2-Ethyl-6-%255B4-%255B2-%25283-hydroxyazetidin-1-yl%2529-2-oxoethyl%255Dpiperazin-1-yl%255D-8-methylimidazo%255B1%252C2-a%255Dpyridin-3-yl%255Dmethylamino%255D-4-%25284-fluorophenyl%2529thiazole-5-carbonitrile%2B%2528GLPG1690%2529%252C%2Ba%2BFirst-in-Class%2BAutotaxin%2BInhibitor%2BUndergoing%2BClinical%2BEvaluation%2Bfor%2Bthe%2BTreatment%2Bof%2BIdiopathic%2BPulmonary%2BFibrosis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D9%26spage%3D3580%26epage%3D3590%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/jmcmar.2017.60.issue-9/20170511/jmcmar.2017.60.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Autotaxin is a circulating enzyme with a major role in the production of lysophosphatic acid (LPA) species in blood. A role for the autotaxin/LPA axis has been suggested in many disease areas including pulmonary fibrosis. Structural modifications of the known autotaxin inhibitor lead compound <b>1</b>, to attenuate hERG inhibition, remove CYP3A4 time-dependent inhibition, and improve pharmacokinetic properties, led to the identification of clinical candidate GLPG1690 (<b>11</b>). Compound <b>11</b> was able to cause a sustained reduction of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid. Compound <b>11</b> is currently being evaluated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Autotaxin (ATX) is a secreted lysophophospholipase D (lysoPLD) that converts lysophosphatidyl choline (LPC) into the bioactive phospholipid derivative lysophosphatidic acid (LPA).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> LPA consists of a glycerol backbone, a phosphate group, and a fatty acyl chain of varying length and saturation (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). LPA exerts its biological activities through activation of the LPA receptors: LPA<sub>1–6</sub>.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The ATX/LPA axis has triggered considerable interest in the pharmaceutical industry due to its involvement in numerous physiological and pathophysiological processes.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> A role for LPA and LPA receptors has been claimed in various pathologies such as cancer,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> pain,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and cholestatic pruritus,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> as well as fibrotic,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> inflammatory,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and cardiovascular diseases.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> We focused our research on lung diseases, more particularly on idiopathic pulmonary fibrosis (IPF). Several lines of evidence suggest that by modulating the biology of lung epithelial cells, fibroblasts, and smooth muscle cells, ATX/LPA signaling plays a role in various pulmonary diseases.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Studies related to IPF indicate an increase in LPA levels in the bronchoalveolar lavage fluid (BALF) of patients, as well as increased ATX levels in the lung.<a onclick="showRef(event, 'cit11c cit12c'); return false;" href="javascript:void(0);" class="ref cit11c cit12c">(11c, 12c)</a> Furthermore, LPA<sub>1</sub> knockout and inhibition studies revealed a key role for LPA in fibrotic processes in lung. These studies were then complemented by studies using knockout mice lacking ATX expression specifically in bronchial epithelial cells and macrophages, in which these mice were shown to be less sensitive to experimental models of lung fibrosis.<a onclick="showRef(event, 'cit11c'); return false;" href="javascript:void(0);" class="ref cit11c">(11c)</a> The role of LPA in lung remodeling relates to the effects of LPA on both lung fibroblasts (through LPA<sub>1</sub>) and epithelial cells (through LPA<sub>2</sub>). LPA<sub>2</sub> was shown to play a key role in the activation of TGF-β in epithelial cells under fibrotic conditions,<a onclick="showRef(event, 'cit12c'); return false;" href="javascript:void(0);" class="ref cit12c">(12c)</a> and LPA<sub>2</sub> deficiency confers protection against bleomycin (BLM)-induced lung injury and fibrosis in mice.<a onclick="showRef(event, 'cit12d'); return false;" href="javascript:void(0);" class="ref cit12d">(12d)</a> By inhibition of ATX mediated production of LPA, both LPA<sub>1</sub> and LPA<sub>2</sub> biology would be addressed suggesting an additional benefit compared to the use of LPA<sub>1</sub> or LPA<sub>2</sub> antagonists alone. In this article we will describe the discovery of <b>11</b> (GLPG1690),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> a first-in-class ATX inhibitor currently evaluated in an exploratory phase 2a study in IPF patients.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conversion of LPC into LPA by ATX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">HTS efforts identified 2,3,6 trisubstituted imidazo[1,2-<i>a</i>]pyridine derivatives as ATX inhibitors.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Subsequent structure–activity relationship exploration led to the identification of compound <b>1</b> as a potent ATX inhibitor in biochemical and rat plasma assays, with an IC<sub>50</sub> of 27 nM and 22 nM, respectively (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). However, compound <b>1</b> showed limited oral exposure and unsatisfactory clearance in rodents. In addition compound <b>1</b> inhibited the hERG channel with an IC<sub>50</sub> of 2.9 μM in a hERG automated patch-clamp assay and showed CYP3A4 time-dependent inhibition (TDI) in a human liver microsomes assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>); these properties were not appropriate to initiate clinical development of compound <b>1</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hit series and lead compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. hERG Inhibition and CYP3A4 TDI Profiles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">ring type (A)</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">ATX LPC (IC<sub>50</sub>, nM)</th><th class="colsep0 rowsep0" align="center">hERG inhibition (IC<sub><b>50</b></sub>, μM)</th><th class="colsep0 rowsep0" align="center">CYP3A4 TDI</th><th class="colsep0 rowsep0" align="center">calcd p<i>K</i><sub>a</sub> <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">piperidine (CH)</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">positive</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">piperazine (N)</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">>11</td><td class="colsep0 rowsep0" align="left">positive</td><td class="colsep0 rowsep0" align="left">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">piperidine (CH)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">246</td><td class="colsep0 rowsep0" align="left">5.6<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">positive</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">piperazine (N)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">274</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">positive</td><td class="colsep0 rowsep0" align="left">5.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">p<i>K</i><sub>a</sub> calculation of conjugated acid on basic nitrogen of piperidine and piperazine rings performed with ACD/Labs Percepta Platform (2014).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Data from hERG manual patch clamp assay.</p></div></div></div><div class="NLM_p">We reasoned that hERG inhibition associated with compound <b>1</b> might be due to the presence of the basic piperidine linker (calculated p<i>K</i><sub>a</sub> of 7.8). As seen in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, replacement of the piperidine ring by a less basic piperazine ring at position 6 of the imidazo[1,2-<i>a</i>]pyridine scaffold for compounds <b>2</b> and <b>4</b> resulted in a lowering of hERG inhibition while retaining similar potency on ATX compared to compounds <b>1</b> and <b>3</b>, respectively. However, whereas hERG inhibition could be mitigated by lowering basicity, compounds <b>1</b>–<b>4</b> were positive in the CYP3A4 TDI assay in human liver microsomes. Variation of the substitution in position 6 of the imidazo[1,2-<i>a</i>]pyridine core had no impact on CYP3A4 TDI; therefore scaffold modification was investigated.</div><div class="NLM_p">As seen in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, replacement of the imidazo[1,2-<i>a</i>]pyridine core in <b>2</b> with an imidazo[1,2-<i>b</i>]pyridazine backbone as in compound <b>5</b> led to comparable biochemical potency (27 nM vs 60 nM). In contrast replacement of the thiazole moiety by other heteroaromatic rings in position 3 as in compounds <b>6</b> and <b>7</b> led to 3- to 5-fold loss of potency versus <b>5</b>. Unfortunately exchanging the imidazo[1,2-<i>a</i>]pyridine scaffold for an imidazo[1,2-<i>b</i>]pyridazine ring in compound <b>5</b> had no impact on CYP3A4 TDI. Similarly the replacement of the thiazole ring by either a thiadiazole or a pyridine ring (as shown in compounds <b>6</b> and <b>7</b>, respectively) also resulted in no impact. Remarkably, compound <b>8</b> bearing an imidazo[1,2-<i>a</i>]pyrazine scaffold displayed no CYP3A4 TDI. This marked improvement outweighed the 4-fold loss in activity of compound <b>8</b> versus <b>2</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. CYP3A4 TDI Profile of Analogs of <b>2</b> with Alternative Scaffolds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0011.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center">ATX LPC (IC<sub>50</sub>, nM)</th><th class="colsep0 rowsep0" align="center">CYP3A4 TDI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">imidazo[1,2-<i>b</i>]pyridazine</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">positive</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">imidazo[1,2-<i>b</i>]pyridazine</td><td class="colsep0 rowsep0" align="left">297</td><td class="colsep0 rowsep0" align="left">positive</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">imidazo[1,2-<i>b</i>]pyridazine</td><td class="colsep0 rowsep0" align="left">192</td><td class="colsep0 rowsep0" align="left">positive</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">imidazo[1,2-<i>a</i>]pyrazine</td><td class="colsep0 rowsep0" align="left">102</td><td class="colsep0 rowsep0" align="left">negative</td></tr></tbody></table></div></div><div class="NLM_p">When further derivatives with imidazo[1,2-<i>a</i>]pyrazine scaffold were prepared, it appeared that DMSO solutions of compound <b>8</b> and analogs thereof degraded upon storage. This chemical instability prevented further progression of derivatives with this core. <sup>1</sup>H NMR and LCMS analysis of DMSO stock solutions of <b>8</b> and analogs suggested that oxidation of the imidazo[1,2-<i>a</i>]pyrazine scaffold might occur, although the degradants were not isolated. The absence of CYP3A4 TDI for compound <b>8</b> indicated the C<sub>7</sub>–C<sub>8</sub> double bond of the imidazo[1,2-<i>a</i>]pyridine or imidazo[1,2-<i>b</i>]pyridazine scaffolds might be responsible for the occurrence of CYP3A4 TDI for compounds <b>1</b>–<b>7</b>. As can be seen in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, putative metabolic oxidation of the C<sub>7</sub>–C<sub>8</sub> double bond of the imidazo[1,2-<i>a</i>]pyridine ring leads to a reactive epoxide metabolite that can be trapped by glutathione (GSH) or nucleophilic residues in CYPs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Steric hindrance caused by a methyl group on the C<sub>7</sub> or C<sub>8</sub> position of the imidazo[1,2-<i>a</i>]pyridine scaffold presumably disfavored this oxidative pathway in compounds <b>9</b> and <b>10</b>, which displayed no CYP3A4 TDI liability (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). However, introduction of the methyl substituent led to a 3- to 4-fold loss of potency in the biochemical assay compared to <b>1</b> and <b>3</b>, respectively.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Formation and Trapping of Reactive Metabolite on Imidazo[1,2-<i>a</i>]pyridine Scaffold</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biochemical Activity and CYP3A4 TDI Profile of Compounds <b>1</b>, <b>3</b>, <b>9</b>, <b>10</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0012.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>9</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>10</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> or R<sub>2</sub></td><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = H</td><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = Me</td><td class="colsep0 rowsep0" align="left">R<sub>2</sub> = H</td><td class="colsep0 rowsep0" align="left">R<sub>2</sub> = Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 TDI</td><td class="colsep0 rowsep0" align="left">positive</td><td class="colsep0 rowsep0" align="left">negative</td><td class="colsep0 rowsep0" align="left">positive</td><td class="colsep0 rowsep0" align="left">negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATX LPC (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">103</td><td class="colsep0 rowsep0" align="left">246</td><td class="colsep0 rowsep0" align="left">811</td></tr></tbody></table></div></div><div class="NLM_p">Introduction of the methyl group on C<sub>8</sub> of the imidazo[1,2-<i>a</i>]pyridine was combined with the piperazine linker at C<sub>6</sub> to yield compound <b>11</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Compound <b>11</b> represented the optimum combination of structural features to achieve desired ADMET properties and ATX inhibitory activity. Several synthetic routes were envisaged for the preparation of compound <b>11</b>, in particular for the construction of the imidazo[1,2-<i>a</i>]pyridine core, which was usually prepared by three-component Groebke–Blackburn–Bienaymé reaction using costly Walborsky’s reagent. In order to prepare larger amounts of material and avoid limitations on reagent availability, an alternative synthesis was developed from commercially available 5-bromo-3-methylpyridin-2-amine (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Multicomponent reaction with potassium cyanide, benzotriazole, and propanal afforded the 3-aminoimidazo[1,2-<i>a</i>]pyridine scaffold<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> that was formylated to give compound <b>12</b>. Methylation of <b>12</b> followed by deformylation led to intermediate <b>13</b>. The preformed anion of <b>13</b> reacted via nucleophilic aromatic substitution with <b>17</b>, which was synthesized by oxidative cyclization of 4-fluorobenzoylacetonitrile with thiourea<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> followed by Sandmeyer reaction. The brominated derivative <b>14</b> obtained underwent Buchwald coupling reaction with boc-piperazine with subsequent removal of the protecting group to give intermediate <b>15</b>. Finally alkylation of <b>15</b> with the chloroacetamide derivative <b>18</b> yielded compound <b>11</b> in eight linear steps from 5-bromo-3-methylpyridin-2-amine.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural modifications from <b>1</b> to <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) EtCHO, benzotriazole, toluene, rt, then KCN, EtOH, rt to 80 °C, (2) AcCl, EtOH, rt, 29%; (b) HCO<sub>2</sub>H, 80 °C, 95%; (c) K<sub>2</sub>CO<sub>3</sub>, MeI, acetone, 80 °C, 93%; (d) HCl, MeOH, 80 °C, 98%; (e) (1) NaH, THF, reflux, (2) <b>17</b>, 40 °C to reflux, 73%; (f) boc-piperazine, <sup><i>t</i></sup>BuONa, Pd<sub>2</sub>dba<sub>3</sub>, JohnPhos, toluene, 115 °C, 82%; (g) HCl, MeOH, rt, 90%; (h) <b>18</b>, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, 81%; (i) pyridine, thiourea, iodine, EtOH, 70 °C to rt, 65%; (j) CuCl<sub>2</sub>, <sup><i>t</i></sup>BuONO, MeCN, rt, 62%; (k) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DCM, rt, 70%.</p></p></figure><div class="NLM_p">Compound <b>11</b> was cocrystallized with human ATX. Cocrystals diffracted with a maximum resolution of 2.4 Å, enabling the construction of an experimental model of reasonably good quality (<i>R</i><sub>free</sub> = 24.5%). Apart from a slight rotation of the core moiety of about 10°, compound <b>11</b> adopts the same binding mode as previously observed for the imidazo[1,2-<i>a</i>]pyridine derivative <b>19</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Introduction of the methyl group in position 8 of the imidazo[1,2-<i>a</i>]pyridine core is deemed responsible for the positional shift which allows for a better fit in a locally constrained region of the protein. The three major substituents on the imidazo[1,2-<i>a</i>]pyridine core can be projected toward each of the three pockets of the T-shaped groove (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). The short ethyl chain in position 2 of the imidazo[1,2-<i>a</i>]pyridine core points toward the catalytic site but remains remote from the reactive Thr210 (more than 5.7 Å for compound <b>11</b>, distance measured from the terminal methyl to the nucleophilic alcohol of Thr210). The 4-fluorophenylthiazole substituent in position 3 of the imidazo[1,2-<i>a</i>]pyridine core occupies the hydrophobic pocket and is positioned almost perpendicular to the imidazo[1,2-<i>a</i>]pyridine core via the <i>N</i>-methyl linker. The 4-fluorophenyl moiety makes an aromatic interaction (T-shape) with the side chain of Phe274. The nitrile group on the thiazole displaces a high energy water molecule leading to potency gain.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Finally, the substituted piperazine in position 6 of the imidazo[1,2-<i>a</i>]pyridine core lies in the hydrophobic channel. Some notable interactions in that region include a cation−π interaction between the basic nitrogen of the piperazine and the indole side chain of Trp255 and a hydrogen bond between the carbonyl group of the acetyl chain on the piperazine and the indole NH of Trp261 possibly via a water molecule. Consequently the cocrystal structure of compound <b>11</b> in ATX shows the molecule occupies both the hydrophobic pocket, which otherwise accommodates the fatty acyl chain of LPA, and the hydrophobic channel, which is proposed to play a key role for the transport and delivery of LPA to its target receptors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This particular binding mode could provide a significant advantage over other ATX inhibitors as it could prevent not only LPA formation but also ATX-mediated LPA delivery to its target receptors. As is highlighted in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, introduction of a methyl on the imidazo[1,2-<i>a</i>]pyridine core induces a scaffold rotation in order to fit within the protein. The requirement for this positional shift possibly explains the slight activity loss observed for compound <b>11</b> versus the parent, nonmethylated, analog <b>2</b> in the biochemical assay (IC<sub>50</sub> of 131 nM versus 26 nM).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Overlay of binding modes of compounds <b>11</b> (carbon atoms in light green) and <b>19</b> (carbon atoms in gray). The binding site carbon atoms and local backbone structures of ATX are depicted in dark green or gray. The two zinc atoms of the catalytic site are depicted in magenta in CPK mode. For clarity, the binding site surface has been clipped vertically. (B) Binding mode of compound <b>11</b> cocrystallized with human ATX. Protein–ligand interactions are represented by dashed lines (hydrogen bond in green, cation−π interaction in orange, and hydrophobic contacts in pink). The surface is colored by residue hydrophobicity (from brown for hydrophobic to blue for hydrophilic). For clarity, the surface has been clipped vertically.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>11</b> was shown to inhibit ATX in a competitive manner versus the substrate (LPC) with a <i>K</i><sub>i</sub> of 15 nM (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Since ATX and LPC species are naturally present in plasma, the ability of compound <b>11</b> to inhibit the production of LPA in plasma from mice, rats, or healthy donors was evaluated by incubating plasma at 37 °C for 2 h in the presence of a dose range of the compound. LPA 18:2 is one of the major LPA species present in plasma and was chosen as a representative species to monitor the reduction of LPA associated with ATX inhibition. The formation of LPA 18:2 was measured by LC–MS/MS using LPA 17:0 as a standard. Compound <b>11</b> inhibited ATX-induced LPA 18:2 production in mouse, rat, and healthy donor plasma in a concentration-dependent manner, with IC<sub>50</sub> values of 418 nM, 542 nM, and 242 nM, respectively. In view of the comparable high binding of compound <b>11</b> to plasma proteins in human and rodents (plasma protein binding higher than 99% was measured in human, dog, rat, and mouse plasma), the observed interspecies difference in potency was considered as not significant. The high binding of compound <b>11</b> to plasma proteins does not seem to hamper the inhibition of ATX.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activity Properties of Compound <b>11</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>11</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATX LPC (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">131</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATX LPC (<i>K</i><sub>i</sub>, nM)</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma assay (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">418</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat plasma assay (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">542</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human plasma assay (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">242</td></tr></tbody></table></div></div><div class="NLM_p">With respect to ADMET properties compound <b>11</b> showed no CYP3A4 TDI and decreased hERG inhibitory activity (IC<sub>50</sub> = 15 μM in manual patch clamp assay) compared to the lead compound <b>1</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). In addition, compound <b>11</b> displayed improved pharmacokinetic properties, with a lower plasma clearance and higher bioavailability than compound <b>1</b> in mouse and rat. The good pharmacokinetic profile was further confirmed in dog, with compound <b>11</b> showing low plasma clearance (0.12 L·h<sup>–1</sup>·kg<sup>–1</sup>) and a high bioavailability (63%).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Properties and in Vivo Pharmacokinetic Parameters for <b>1</b> and <b>11</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>11</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG inhibition (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.9 (APC)</td><td class="colsep0 rowsep0" align="left">15 (MPC)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 TDI</td><td class="colsep0 rowsep0" align="left">positive</td><td class="colsep0 rowsep0" align="left">negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse iv Cl (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse po <i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat iv Cl (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat po <i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog iv Cl (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog po <i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">63</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Mouse and rat oral bioavailability determined from 5 mg/kg po (po = per os) and 1 mg/kg iv (iv = intravenous) doses. Dog oral bioavailability determined from 1 mg/kg po and iv doses.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">APC: automated patch clamp assay. MPC: manual patch clamp assay.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">nd: not determined.</p></div></div></div><div class="NLM_p">In order to evaluate the PK/PD relationship for compound <b>11</b>, in vivo reduction of plasma LPA upon administration of compound <b>11</b> was monitored. Conversion of LPC into LPA by ATX is the major source of circulating LPA in blood.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In vivo inhibition of this process can be evaluated by quantification of LPA levels in plasma. Mice received a single dose of compound <b>11</b> (3, 10, or 30 mg/kg) under fasted conditions. Blood was sampled predose and 1, 3, 6, and 24 h postdosing for the determination of the levels of both compound <b>11</b> and LPA 18:2 (the biomarker) in plasma using LC–MS/MS. Mean plasma concentrations of <b>11</b> and mean percentage of LPA reduction are displayed in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Mean pharmacokinetic parameters of <b>11</b> and the maximum reduction of LPA production are shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. Following oral administration of compound <b>11</b> at 3, 10, and 30 mg/kg, prolonged absorption was seen, and a roughly dose-proportional increase of <i>C</i><sub>max</sub> and AUC<sub>(0–24h)</sub> was observed. As seen in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, the decrease in plasma LPA levels at 3, 10, and 30 mg/kg was concomitant with the increasing plasma concentration of compound <b>11</b>, thus demonstrating target engagement in vivo from a dose of 3 mg/kg onward. At 3 mg/kg, compound <b>11</b> exposure in plasma covered the IC<sub>50</sub> level, determined in the mouse plasma assay, for approximately 6 h which resulted in at least 50% reduction of LPA levels for more than 6 h. The higher compound exposure levels at 10 and 30 mg/kg led to a stronger and more sustained reduction of LPA levels. The peak of compound activity was detected at 3 h postdosing whatever the dose, whereas <i>t</i><sub>max</sub> for compound <b>11</b> in plasma was reached between 1 and 3 h postdosing depending on the dose. A maximal reduction in plasma LPA levels of 84%, 91%, and 95% was achieved at 3, 10, and 30 mg/kg, respectively.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mean (±SEM) plasma exposure of <b>11</b> and LPA 18:2 reduction after single oral doses of 3, 10, and 30 mg/kg in mice (<i>n</i> = 3). Plasma exposure of <b>11</b> and LPA 18:2 reduction levels are represented by dashed lines and solid lines, respectively. The horizontal black line corresponds to the IC<sub>50</sub> (ng/mL) of <b>11</b> determined in the mouse plasma assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Parameters of <b>11</b> and in Vivo LPA Reduction<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">3 mg/kg po</th><th class="colsep0 rowsep0" align="center">10 mg/kg po</th><th class="colsep0 rowsep0" align="center">30 mg/kg po</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1075</td><td class="colsep0 rowsep0" align="left">4363</td><td class="colsep0 rowsep0" align="left">21 367</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub>/dose (ng/mL per mg/kg)</td><td class="colsep0 rowsep0" align="left">358</td><td class="colsep0 rowsep0" align="left">436</td><td class="colsep0 rowsep0" align="left">712</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–24h)</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">5553</td><td class="colsep0 rowsep0" align="left">20 786</td><td class="colsep0 rowsep0" align="left">101 225</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–24h)</sub>/dose (ng·h/mL per mg/kg)</td><td class="colsep0 rowsep0" align="left">1851</td><td class="colsep0 rowsep0" align="left">2079</td><td class="colsep0 rowsep0" align="left">3374</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>24h</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">295</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.21</td><td class="colsep0 rowsep0" align="left">2.22</td><td class="colsep0 rowsep0" align="left">3.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">max of LPA reduction (%)</td><td class="colsep0 rowsep0" align="left">83.6</td><td class="colsep0 rowsep0" align="left">90.9</td><td class="colsep0 rowsep0" align="left">95.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">time at maximum reduction (h)</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Mean pharmacokinetic parameters and mean percentage of LPA 18:2 reduction in mouse plasma following a single oral administration of <b>11</b> in mice at 3, 10, and 30 mg/kg (<i>n</i> = 3).</p></div></div></div><div class="NLM_p">As the BLM-induced pulmonary fibrosis model in rodents is the most commonly used animal model to investigate the potential of compounds as novel therapies for IPF,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> the next step was the evaluation of the efficacy of compound <b>11</b> in a 21-day model of BLM-induced pulmonary fibrosis in mice. Compound <b>11</b> was evaluated in a prophylactic setting in comparison with the reference substance pirfenidone, an approved treatment for IPF patients with antifibrotic and anti-inflammatory effects.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> An intranasal challenge of BLM was administered to mice, and oral treatment with pirfenidone (50 mg/kg) or compound <b>11</b> (10 or 30 mg/kg), twice a day, started simultaneously for 21 days. The efficacy of compound <b>11</b> and pirfenidone was evaluated based on the assessment of histopathological changes in lung architecture using Matsuse’s modification of the Ashcroft score.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Intranasal application of BLM induced diffuse epithelial damage, pulmonary inflammation, fibrosis, and occasionally severe focal distortion of the pulmonary structure, as observed in the vehicle control group. Within 21 days, the reference substance pirfenidone significantly reduced the Ashcroft score as compared to the vehicle-treated group (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Treatment with compound <b>11</b> at a dose of 10 mg/kg or 30 mg/kg twice a day resulted in a significant reduction of the Ashcroft score. These effects were also reflected by lung weight measurements (data not shown). In addition, the efficacy of compound <b>11</b> given at 30 mg/kg twice a day was significantly better than that of pirfenidone based on the Ashcroft score.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Activity of compounds in mouse BLM model: Ashcroft score (Matsuse’s modification) at day 21. The efficacy of pirfenidone and compound <b>11</b> was compared to that of PBS-challenged and BLM-challenged groups that received vehicle as treatment. Total score for each animal was calculated as mean of the score obtained for 10 low-power fields selected from the whole pulmonary area. Data are represented as group median: (∗) <i>p</i> < 0.05 vs BLM-vehicle control; (+) <i>p</i> < 0.05 vs BLM-pirfenidone; nonparametric Mann–Whitney test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The impact of compound <b>11</b> on LPA production in BALF was evaluated in the same BLM-induced pulmonary fibrosis mouse model. After 21 days, LPA 18:2 content in the BALF of mice challenged with PBS or BLM and treated with vehicle or compound <b>11</b> (30 mg/kg) was quantified by LC–MS/MS analysis. As can be seen in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, LPA 18:2 levels were significantly increased in the BLM group versus PBS-challenged animals and administration of compound <b>11</b> twice daily at 30 mg/kg resulted in a significant reduction of the LPA 18:2 BALF content in comparison to the diseased vehicle-treated group.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This result clearly demonstrated the ability of compound <b>11</b> to inhibit ATX mediated production of LPA 18:2 in BALF.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Analysis of LPA 18:2 in BALF of PBS-challenged mice (<i>n</i> = 9) or BLM-challenged mice treated either with vehicle (<i>n</i> = 6) or compound <b>11</b> (30 mg/kg twice daily, <i>n</i> = 7) for 21 days. BALF was collected 2 h after administration of either vehicle or compound <b>11</b>: mean ± SEM, (∗∗∗) <i>p</i> < 0.001 versus BLM-vehicle by one-way ANOVA followed by Dunnett’s multiple comparisons test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The evolution of the potent autotaxin inhibitor lead compound <b>1</b> into clinical candidate <b>11</b> was achieved by appropriate structural modifications to improve ADMET (hERG and CYP3A4 TDI) and PK properties (bioavailability and clearance). Compound <b>11</b> was able to decrease LPA levels in a sustainable manner, in mouse plasma, from a dose of 3 mg/kg onward. In addition, compound <b>11</b> demonstrated significant activity in the mouse BLM-induced fibrosis model at doses of 10 and 30 mg/kg twice a day, with an efficacy comparable or superior to that of the reference compound pirfenidone. Compound <b>11</b> is currently being evaluated in an exploratory phase 2a study in IPF patients. Additional safety, pharmacological, pharmacokinetic, and clinical data will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents were of commercial grade and were used as received without further purification unless otherwise stated. Commercially available anhydrous solvents were used for reactions conducted under inert atmosphere. Reagent grade solvents were used in all other cases, unless otherwise specified. Column chromatography was performed on silica gel 60 (35–70 μm). Thin layer chromatography was carried out using precoated silica gel F-254 plates (thickness 0.25 mm). Microwave heating was performed with a Biotage Initiator apparatus. Celpure P65 is a filtration aid, commercial product (CAS number 61790-53-2). <sup>1</sup>H NMR spectra were recorded on a Bruker DPX 400 NMR spectrometer (400 MHz) or a Bruker Advance 300 NMR spectrometer (300 MHz). Chemical shifts (δ) for <sup>1</sup>H NMR spectra are reported in parts per million (ppm) relative to tetramethylsilane (δ 0.00) or the appropriate residual solvent peak, i.e., CHCl<sub>3</sub> (δ 7.27), as internal reference. Multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), quintuplet (quin), multiplet (m), and broad (br). Waters Acquity UPLC with Waters Acquity PDA detector and SQD mass spectrometer were used to generate UV and MS chromatograms as well as MS spectra. Columns used were the following: UPLC BEH C18 1.7 μm, 2.1 mm × 5 mm, VanGuard Pre-column with Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 30 mm column or Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm column. LC–MS analyses were conducted using the following two methods. Method 1: solvent A, H<sub>2</sub>O–0.05% NH<sub>4</sub>OH; solvent B, MeCN–0.05% NH<sub>4</sub>OH; flow rate, 0.8 mL/min; start 5% B, final 95% B in 1.55 min, linear gradient. Method 2: solvent A, H<sub>2</sub>O–0.1% HCO<sub>2</sub>H; solvent B, MeCN–0.1% HCO<sub>2</sub>H; flow rate, 0.8 mL/min; start 5% B, final 95% B in 1.55 min, linear gradient. All final compounds reported were analyzed using one of these analytical methods and were at least 95% pure. Autopurification system from Waters was used for LC–MS purification. LC–MS columns used: Waters XBridge Prep OBD C18 5 μm, 30 mm × 100 mm (preparative column) and Waters XBridge BEH C18 5 μm, 4.6 mm × 100 mm (analytical column). All the methods used MeCN/H<sub>2</sub>O gradients. MeCN and H<sub>2</sub>O contained either 0.1% formic acid or 0.1% diethylamine. API5500 QTRAP mass spectrometer from ABSciex was used for the detection and quantification of compound and LPA in plasma. The hERG automated and manual patch clamp assays were performed at BioFocus (now Charles River Laboratories). The CYP3A4 TDI assay in human liver microsomes was performed at Fidelta and BioFocus; compounds were evaluated using testosterone and midazolam as probe substrates. A compound was considered positive in the CYP3A4 TDI assay when the IC<sub>50</sub> shift between with and without preincubation conditions was higher than 2-fold. When IC<sub>50</sub> could not be determined for both conditions, the compound was considered positive when sigmoidal curves would show misalignment. The BLM-induced pulmonary fibrosis model in mice was performed at Fidelta. Biochemical and plasma assays, preparation of compound <b>18</b>, and protein production and purification will be described separately.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>11</b>)</h3><div class="NLM_p last">To a solution of 2-[(2-ethyl-8-methyl-6-piperazin-1-yl-imidazo[1,2-<i>a</i>]pyridin-3-yl)methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>15</b>) (18.05 g, 38 mmol) in MeCN (126 mL) were added potassium carbonate (10.49 g, 75.9 mmol) and 2-chloro-1-(3-hydroxyazetidin-1-yl)ethanone (<b>18</b>) (7.38 g, 49.3 mmol). The reaction mixture was refluxed for 3.5 h and then filtered, and the solid was washed with MTBE and MeCN. The collected precipitate was then suspended in 300 mL of water, stirred for 1 h, filtered, and finally washed with water. The solid obtained was dried in vacuo to afford 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>11</b>) (18.0 g, 81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.20–8.12 (m, 2 H), 7.22–7.13 (m, 2 H), 6.99 (s, 2 H), 4.75–4.66 (m, 1 H), 4.51–4.43 (m, 1 H), 4.34–4.26 (m, 1 H), 4.14–4.05 (m, 1 H), 3.88 (dd, <i>J</i> = 10.9, 4.4 Hz, 1 H), 3.61 (s, 3 H), 3.14–3.02 (m, 6 H), 2.74 (q, <i>J</i> = 7.7 Hz, 2 H), 2.70–2.62 (m, 4 H), 2.59 (s, 3 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 589.6 [M + H].</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>N</i>-(6-Bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)formamide (<b>12</b>)</h3><div class="NLM_p">(a) To a suspension of 2-amino-5-bromo-3-methylpyridine (420 g, 2.24 mol, washed before use with an aqueous saturated NaHCO<sub>3</sub> solution) in toluene (1.5 L) under nitrogen atmosphere were added propanal (248 mL, 3.36 mol) and benzotriazole (281 g, 2.36 mol). The resulting mixture was stirred for 4 h at room temperature. Then ethanol (3.5 L) and potassium cyanide (175 g, 2.70 mol) were added. <i><b>CAUTION!</b> Potassium cyanide is highly toxic.</i> The reaction mixture was further stirred overnight at room temperature and refluxed for 2 h. After cooling to room temperature, the mixture was quenched by addition of a 2.5 M NaOH aqueous solution (3 L). This experiment was performed in four batches with the same quantities of reagents, and the crude mixtures were then pooled together and concentrated in vacuo to low volume. The remaining oil was diluted with EtOAc (15 L) and washed with a 2 M NaOH aqueous solution (2 × 2 L). The aqueous layer was extracted twice with EtOAc (2 × 1 L). The combined organic layers were then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude mixture was dissolved in ethanol (2 L) and carefully added to a solution of acetyl chloride (1 L, 14.0 mol, 1.6 equiv) in ethanol (6 L). The resulting reaction mixture was stirred at room temperature overnight and then concentrated to dryness. The residue was triturated in DCM (7 L) for 3 days, the precipitate formed was collected, washed with DCM (2 × 500 mL), and dried to afford 6-bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-amine as a hydrochloride salt (791g, 29%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 8.70 (s, 1 H), 7.75 (s, 1 H), 4.86 (br s, 3 H), 2.81 (q, <i>J</i> = 7.6 Hz, 2 H), 2.56 (s, 3 H), 1.25 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 254.0/256.0 [M + H].</div><div class="NLM_p last">(b) A suspension of 6-bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-amine as a hydrochloride salt (785 g, 2.70 mol) in formic acid (713 mL) was heated at 80 °C for 2 h. The crude mixture was concentrated in vacuo to low volume (about 400 mL). The residue was brought up in water (1 L) and a 3 M solution of NaOH (2 L), then further basified with a saturated NaHCO<sub>3</sub> solution until foaming ceased and pH reached 8–9. After homogenization for 1 h, the precipitate was filtered, washed with water (2 × 300 mL), then dissolved in a mixture of toluene and MeOH 3:1 (4 L) followed by concentration in vacuo. Trituration of the residue in a mixture of 200 mL of MeOH and 5 L of diisopropyl ether, decantation, and filtration of the resulting suspension afforded <i>N</i>-(6-bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)formamide (<b>12</b>) (724 g, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>), presence of 2 rotamers, δ (ppm) 10.2 (br s, 1 H), 8.51 (s, 1 H, one rotamer), 8.36 (s, 1 H, one rotamer), 8.23 (s, 1 H, one rotamer), 8.11 (s, 1 H), 7.23 (s, 1 H, one rotamer), 7.21 (s, 1 H, one rotamer), 2.63–2.60 (m, 2 H), 2.58 (s, 3 H, one rotamer), 2.56 (s, 3 H, one rotamer), 1.24–1.17 (m, 3 H). LC–MS: <i>m</i>/<i>z</i> = 282.0/284.0 [M + H].</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 6-Bromo-2-ethyl-<i>N</i>,8-dimethylimidazo[1,2-<i>a</i>]pyridin-3-amine (<b>13</b>)</h3><div class="NLM_p">(a) To a suspension of <i>N</i>-(6-bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)formamide (78.2 g, 277 mmol) and potassium carbonate (114.8 g, 831 mmol) in acetone (923 mL), iodomethane (25.9 mL, 416 mmol) was added at room temperature, and the reaction mixture was stirred at 80 °C overnight. The solids were filtered off and rinsed with acetone and DCM. The filtrate was concentrated, and the obtained solid was triturated in Et<sub>2</sub>O, filtered, and rinsed with Et<sub>2</sub>O and water. The solid was collected and dried under vacuum to afford <i>N</i>-(6-bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-methylformamide as a white solid (75.9 g, 93%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), presence of 2 rotamers, δ (ppm) 8.49 (s, 1H, minor rotamer), 8.19 (s, 1 H, major rotamer), 7.78 (s, 1 H, major rotamer), 7.65 (s, 1 H, minor rotamer), 7.15 (s, 1 H, major rotamer), 7.08 (s, 1 H, minor rotamer), 3.36 (s, 3 H, minor rotamer), 3.24 (s, 3 H, major rotamer), 2.73–2.70 (m, 2 H), 2.59 (s, 3 H), 1.31 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 296.0/298.0 [M + H].</div><div class="NLM_p last">(b) A solution of HCl 1.25 M in methanol (35 mL, 43.8 mmol) was added to <i>N</i>-(6-bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-methylformamide (5.0 g, 16.9 mmol), and the reaction mixture was stirred for 4 h at 80 °C (oil bath temperature). Another addition of HCl 1.25 M in methanol (14 mL, 17.5 mmol) was performed, and the reaction mixture was stirred at 80 °C for 1 h and then at 100 °C overnight. Solvent was evaporated, and the crude product was partitioned between water and DCM. The aqueous layer was basified with NaHCO<sub>3</sub> and extracted with DCM. Combined organic layers were washed with brine, dried over sodium sulfate, filtered, and evaporated to give 6-bromo-2-ethyl-<i>N</i>,8-dimethylimidazo[1,2-<i>a</i>]pyridin-3-amine (<b>13</b>) (4.44 g, 98%) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.05 (s, 1 H), 7.04 (s, 1 H), 2.84–2.78 (m, 5 H), 2.60 (s, 3 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 268.2/270.3 [M + H].</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-[(6-Bromo-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl)methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>14</b>)</h3><div class="NLM_p last">To a solution compound <b>13</b> (4.4 g, 16.6 mmol) in THF (44 mL) under argon was slowly added NaH (60% in oil suspension, 2.0 g, 50.0 mmol). The reaction mixture was heated at 90 °C (oil bath temperature) for 30 min and then cooled to 40 °C before adding 2-chloro-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>17</b>) (4.74 g, 19.9 mmol). The reaction mixture was stirred at 90 °C overnight. After cooling to room temperature, the mixture was slowly quenched by addition of water and then diluted with EtOAc. The organic layer was separated and the aqueous layer extracted with EtOAc. The combined organic layers were then washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was triturated in Et<sub>2</sub>O, filtered, and washed with Et<sub>2</sub>O and MeCN. Recrystallization was performed in MeCN (180 mL) to afford compound <b>14</b> as an orange solid (5.7 g, 73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 8.21–8.15 (m, 2 H), 7.82 (s, 1 H), 7.25–7.18 (m, 3 H), 3.66 (s, 3 H), 2.85–2.76 (m, 2 H), 2.68 (s, 3 H), 1.38 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 470.3/472.3 [M + H].</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-[(2-Ethyl-8-methyl-6-piperazin-1-ylimidazo[1,2-<i>a</i>]pyridin-3-yl)methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>15</b>)</h3><div class="NLM_p">(a) To a solution of compound <b>14</b> (24.2 g, 51.5 mmol) in toluene under argon were successively added <i>N</i>-boc-piperazine (14.4 g, 77.3 mmol), sodium <i>tert</i>-butoxide (9.9 g, 103 mmol), JohnPhos (1.54 g, 5.15 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (2.36 g, 2.58 mmol). The reaction mixture was heated at 115 °C for 1 h. After cooling to room temperature, the reaction was filtered on Celpure P65 and the filtrate was evaporated. The residue was dissolved in EtOAc and washed with water. The organic layer was further washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude product was purified by chromatography on silica gel to afford <i>tert</i>-butyl 4-[3-[[5-cyano-4-(4-fluorophenyl)thiazol-2-yl]methylamino]-2-ethyl-8-methylimidazo[1,2-<i>a</i>]pyridin-6-yl]piperazine-1-carboxylate (24.4 g, 82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 8.18–8.14 (m, 2 H), 7.21–7.16 (m, 2 H), 7.08–7.02 (m, 2 H), 3.62 (s, 3 H), 3.61–3.57 (m, 4H), 3.07–2.96 (m, 4H), 2.80 (q, <i>J</i> = 7.6 Hz, 2 H), 2.66 (s, 3 H), 1.47 (s, 9 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 576.6 [M + H].</div><div class="NLM_p last">(b) To a solution of the latter compound (24.4 g, 42.4 mmol) in MeOH (100 mL) was added a 2 M HCl solution in Et<sub>2</sub>O (127 mL, 254 mmol). The reaction mixture was stirred at room temperature for 3.5 h and then concentrated in vacuo. The residue was partitioned between EtOAc and water. The aqueous layer was extracted twice with EtOAc. A 2 M NaOH solution was added to the aqueous layer until pH 8–9 was reached, and further extraction with EtOAc was performed. The combined organic layers were then washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The solid was stirred in heptane (100 mL) at room temperature overnight, filtered off, washed with heptane and Et<sub>2</sub>O, and dried to afford 2-[(2-ethyl-8-methyl-6-piperazin-1-ylimidazo[1,2-<i>a</i>]pyridin-3-yl)methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>15</b>) (18.06 g, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 8.23–8.16 (m, 2 H), 7.24–7.16 (m, 2 H), 7.06–7.00 (m, 2 H), 3.61 (s, 3 H), 3.09–2.98 (m, 8 H), 2.75 (q, <i>J</i> = 7.6 Hz, 2 H), 2.61 (s, 3 H), 1.34 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 476.5 [M + H].</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Amino-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>16</b>)</h3><div class="NLM_p last">To a solution of 4-fluorobenzoylacetonitrile (50 g, 306 mmol) in EtOH (600 mL) was added pyridine (24.7 mL, 306 mmol). The resulting mixture was stirred at 70 °C for 15 min and then cooled to room temperature. A previously stirred suspension of thiourea (46.7 g, 613 mmol) and iodine (77.8 g, 306 mmol) in EtOH (300 mL) was then slowly added. After 1 h at room temperature a cold 1 M Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (360 mL) was added under stirring. The resulting precipitate was filtered, washed with water, and finally dried in vacuo to afford 2-amino-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>16</b>) as a white solid (22 g, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 8.26 (s, 2 H), 7.99–7.94 (m, 2 H), 7.36 (t, <i>J</i> = 9.0 Hz, 2 H). LC–MS: <i>m</i>/<i>z</i> = 220.2 [M + H].</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Chloro-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>17</b>)</h3><div class="NLM_p last">To a solution of copper(II) chloride (36.8 g, 273 mmol) in MeCN (500 mL) was added dropwise <i>tert</i>-butyl nitrite (40.7 mL, 342 mmol). After stirring at room temperature for 30 min, 2-amino-4-(4-fluorophenyl)thiazole-5-carbonitrile (50 g, 228 mmol) was introduced portionwise and stirring was continued for 1 h. The reaction mixture was then carefully quenched by addition of a 1 N HCl solution (750 mL). After 15 min of stirring, the organic phase was separated; the aqueous phase was further extracted with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude product was filtered on a silica plug (250 g) and eluted with DCM. Solvents were evaporated and the residue was finally triturated in heptane, filtered, and dried to afford compound <b>17</b> (33.95 g, 62%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 8.10–8.03 (m, 2 H), 7.50–7.42 (m, 2 H). LC–MS: <i>m</i>/<i>z</i> = 239.2/241.3 [M + H].</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Mouse PK/PD with Compound <b>11</b></h3><div class="NLM_p">Female C57BL/6Rj mice, 4–5 weeks old (Janvier, Le Genest St. Isle, France), were maintained in a controlled environment and dosed with compound <b>11</b> formulated in PEG 200/MC 0.5% (25/75; v/v) as a single oral gavage with a dose level of 3, 10, or 30 mg/kg (0.3, 1, or 3 mg/mL of <b>11</b>, respectively). A control group received vehicle only. Blood samples were collected by intracardiac sampling under gaseous anesthesia with isoflurane according to protocols approved by the GALAPAGOS Ethical Committee for animals welfare with the agreement of the Ministère de l’Enseignement Supérieur et de la Recherche and the Direction Départementale de la Protection des Populations, at the following time points 1, 3, 6, 24 h after dosing and placed into tubes containing Li-heparin as anticoagulant. LPA 18:2 plasma peak areas and compound <b>11</b> plasma concentrations were assayed by LC–MS/MS. Plasma concentrations of compound <b>11</b> were measured against a calibration curve consisting of eight levels with a 3 log amplitude. Back-calculated values of the QCs (three levels prepared in duplicate) were used for accepting or rejecting the whole batch. The lower limit of quantification was 4 ng/mL for compound <b>11</b>, using a plasma volume of 25 μL. Plasma proteins were precipitated with an excess of methanol containing the internal standard, and the corresponding supernatant was injected on a C18 column. Analytes were eluted out the HPLC system by increasing the percentage of the organic mobile phase. An API5500 QTRAP mass spectrometer (ABSciex) was used for the detection and quantification of compound <b>11</b>. Pharmacokinetic parameters were calculated after averaging individual plasma concentrations, by noncompartmental analysis using WinNonlin software (Pharsight, version 5.2): maximum plasma concentration, <i>C</i><sub>max</sub> (ng/mL) with the corresponding time, <i>t</i><sub>max</sub> (h) for po treatment; area under the plasma concentration versus time curve up to 24 h, AUC<sub>(0–24h)</sub> (ng·h/mL), calculated according to the log linear up/log down trapezoidal method; apparent terminal elimination half-life <i>t</i><sub>1/2</sub> (h) which was only reported if three or more time points were used for linear regression and if <i>r</i><sup>2</sup> > 0.90. Plasma levels were compiled (average of the plasma levels of the three mice at each sampling time), and the corresponding plasma exposure-time profiles were plotted. Mean values may be below the limit of quantification. SEM values were tabulated only if more than two values were above the limit of quantification.</div><div class="NLM_p last">For the analysis of LPA 18:2 plasma peak areas, plasma proteins from a 10 μL aliquot were precipitated with an excess of methanol containing the internal standard LPA 17:0. After centrifugation, the corresponding supernatant was diluted and injected on a C18 column. Analytes were eluted out of the column under isocratic conditions. An API5500 QTRAP mass spectrometer (ABSciex) was used for the detection of LPA 18:2. No calibration curve was prepared for LPA 18:2, and all quantifications were performed based on peak area ratios (LPA 18:2/LPA 17:0). LPA data were finally expressed as percentage of reduction (% reduction) using the following formula: 100 – [((LPA value at time point <i>t</i>)/(mean of LPA value at the same time point <i>t</i> in vehicle group)) × 100].</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Mouse 21-Day BLM-Induced Pulmonary Fibrosis Model</h3><div class="NLM_p last">An intranasal challenge of BLM, 30 μg/50 μL, was administered to anesthetized C57Bl/6 male mice (Charles River, Italy), 11 weeks old at delivery. Control animals received a challenge of PBS. Pirfenidone formulated in 0.5% CMC was given by oral route at 50 mg/kg twice a day. Compound <b>11</b> was dissolved in PEG 200/0.5% MC (25/75, v/v) and orally administered at 10 or 30 mg/kg twice a day. The volume of administration was 10 mL/kg, and a 7.5 h interval was observed between two daily dosings. Control groups received vehicle. Treatments started on day of intranasal instillations of BLM and were performed for 21 days. At initiation, 14–24 mice were allocated to the different groups. At necropsy, lungs were removed, weighed, formalin-fixed, paraffin-embedded in toto, and stained according to Mallory method for connective tissue. The efficacy of compound <b>11</b> and pirfenidone was essentially evaluated via histopathological changes in lungs using Matsuse’s modification of the Ashcroft score.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This score was defined as follows: 1 for normal tissue (no fibrosis), 2 for minimal fibrotic thickening of alveolar or bronchial walls (network of fine collagen fibrils), 3 for moderate fibrotic thickening of walls without obvious damage to lung architecture, 4 for fibrosis with damage of pulmonary structure (coarse fibrous bands or small fibrous masses, intra-alveolar collagen fibrils), 5 for large fibrous area with severe distortion of lung structure. Total score for each animal was calculated as the mean of 10 low-power fields covering whole pulmonary area. Statistical analysis was performed using group median and nonparametric Mann–Whitney test. In addition, bronchoalveolar lavages consisting of two instillations of 0.5 mL of ice cold saline were performed in satellite groups in order to assess LPA species concentration. BALF was collected 2 h after administration of 30 mg/kg of compound <b>11</b>. LPA 18:2 was quantified by LC–MS/MS in the BALF of PBS + vehicle, BLM exposed and treated mice after 21 days of experiment.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00032">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00032" class="ext-link">10.1021/acs.jmedchem.7b00032</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Preparation and characterization for additional final compounds, <i>K</i><sub>i</sub> determination for compound <b>11</b>, and cocrystallization protocol (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_001.pdf">jm7b00032_si_001.pdf (506.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_002.csv">jm7b00032_si_002.csv (1.76 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code of cocrystal structure of compound <b>11</b> with ATX is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MHP">5MHP</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00032" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Desroy</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4879-3439" title="Orcid link">http://orcid.org/0000-0002-4879-3439</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#600e09030f0c01134e040513120f1920070c10074e030f0d"><span class="__cf_email__" data-cfemail="3a54535955565b49145e5f494855437a5d564a5d14595557">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bertrand Heckmann</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d5b7b0a7a1a7b4bbb1fbbdb0b6beb8b4bbbb95b2b9a5b2fbb6bab8"><span class="__cf_email__" data-cfemail="036166717771626d672d6b6660686e626d6d43646f73642d606c6e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Housseman</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Bock</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnès Joncour</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natacha Bienvenu</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laëtitia Cherel</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Virginie Labeguere</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emilie Rondet</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Peixoto</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Marie Grassot</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Picolet</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denis Annoot</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Triballeau</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alain Monjardet</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuelle Wakselman</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veronique Roncoroni</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandrine Le Tallec</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Blanque</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celine Cottereaux</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nele Vandervoort</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Christophe</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Mollat</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marieke Lamers</span> - <span class="hlFld-Affiliation affiliation">Charles
River Laboratories, Chesterford Research Park, CB10 1XL Saffron Walden, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marielle Auberval</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boska Hrvacic</span> - <span class="hlFld-Affiliation affiliation">Fidelta
Ltd., Prilaz baruna Filipovića
29, Zagreb, HR-10000, Croatia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jovica Ralic</span> - <span class="hlFld-Affiliation affiliation">Fidelta
Ltd., Prilaz baruna Filipovića
29, Zagreb, HR-10000, Croatia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Line Oste</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ellen van der Aar</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reginald Brys</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): N. Desroy, C. Housseman, X. Bock, A. Joncour, N. Bienvenu, L. Cherel, V. Labeguere, C. Peixoto, O. Picolet, D. Annoot, N. Triballeau, A. Monjardet, E. Wakselman, V. Roncoroni, S. Le Tallec, R. Blanque, C. Cottereaux, P. Mollat, M. Auberval, and B. Heckmann are employees of Galapagos SASU, France. N. Vandervoort, T. Christophe, L. Oste, E. van der Aar, and R. Brys are employees of Galapagos NV, Belgium.<br /></br></div></li></ul></div><div class="ack" id="ACK-d134e2711-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Florence Bonnaterre for her contribution to the writing of the manuscript. Intermediate <b>12</b> was synthesized at Mercachem.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> Abbreviations Used</h2><tr><td class="NLM_term">ATX</td><td class="NLM_def"><p class="first last">autotaxin</p></td></tr><tr><td class="NLM_term">BALF</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage fluid</p></td></tr><tr><td class="NLM_term">BLM</td><td class="NLM_def"><p class="first last">bleomycin</p></td></tr><tr><td class="NLM_term">CYP3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">IPF</td><td class="NLM_def"><p class="first last">idiopathic pulmonary fibrosis</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">JohnPhos</td><td class="NLM_def"><p class="first last">(2-biphenyl)di-<i>tert</i>-butylphosphine</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">lysophosphatidic acid</p></td></tr><tr><td class="NLM_term">LPC</td><td class="NLM_def"><p class="first last">lysophosphatidylcholine</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methylcellulose</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">QC</td><td class="NLM_def"><p class="first last">quality control</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time-dependent inhibition</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakanaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span> </span><span class="NLM_article-title">Autotaxin-an LPA producing enzyme with diverse functions</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1093/jb/mvq052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1093%2Fjb%2Fmvq052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=20495010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=13-24&author=K.+Nakanagaauthor=K.+Hamaauthor=J.+Aoki&title=Autotaxin-an+LPA+producing+enzyme+with+diverse+functions&doi=10.1093%2Fjb%2Fmvq052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-an LPA producing enzyme with diverse functions</span></div><div class="casAuthors">Nakanaga, Keita; Hama, Kotaro; Aoki, Junken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is an ecto-enzyme responsible for lysophosphatidic acid (LPA) prodn. in blood.  ATX is present in various biol. fluids such as cerebrospinal and seminal fluids and accounts for bulk LPA prodn. in these fluids.  ATX is a member of the nucleotide pyrophosphatase/phosphodiesterase (NPP) family and was originally isolated from conditioned medium of melanoma cells as an autocrine motility stimulating factor.  LPA, a second-generation lipid mediator, binds to its cognate G protein-coupled receptors through which it exerts a no. of biol. functions including influencing cell motility and proliferation stimulating activity.  Some of the biol. roles of LPA can be mediated by ATX.  However, there are other LPA-producing pathways independent of ATX.  The accumulating evidences for physiol. and pathol. functions of ATX strongly support that ATX is an important therapeutic target.  This review summarizes the historical aspects, structural basis, pathophysiol. functions identified in mice studies and clin. relevance discovered by measuring the blood ATX level in human.  The general features and functions of each NPP family member will be also briefly reviewed.  The presence of the ATX gene in other model organisms and recently developed ATX inhibitors, both of which will be definitely useful for further functional anal. of ATX, will also be mentioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd2JaqHS4pL7Vg90H21EOLACvtfcHk0lgW8FnWg6OKHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D&md5=584a80ff7d28d8bdec20ff6615897a25</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvq052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvq052%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DK.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26atitle%3DAutotaxin-an%2520LPA%2520producing%2520enzyme%2520with%2520diverse%2520functions%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D148%26spage%3D13%26epage%3D24%26doi%3D10.1093%2Fjb%2Fmvq052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">Autotaxin: structure-function and signaling</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span><span class="refDoi"> DOI: 10.1194/jlr.R046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1194%2Fjlr.R046391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24548887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1010-1018&author=A.+Perrakisauthor=W.+H.+Moolenaar&title=Autotaxin%3A+structure-function+and+signaling&doi=10.1194%2Fjlr.R046391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin: structure-function and signaling</span></div><div class="casAuthors">Perrakis, Anastassis; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase-2, is a secreted lysophospholipase D (lysoPLD) that hydrolyzes extracellular lysophospholipids into the lipid mediator lysophosphatidic acid (LPA), a ligand for specific G protein-coupled receptors.  ATX-LPA signaling is essential for development and has been implicated in a great diversity of (patho)physiol. processes, ranging from lymphocyte homing to tumor progression.  Structural and functional studies have revealed what makes ATX a unique lysoPLD, and how secreted ATX binds to its target cells.  The ATX catalytic domain shows a characteristic bimetallic active site followed by a shallow binding groove that can accommodate nucleotides as well as the glycerol moiety of lysophospholipids, and by a deep lipid-binding pocket.  In addn., the catalytic domain has an open tunnel of unknown function adjacent to the active site.  Here, the authors discuss the authors' current understanding of ATX structure-function relationships and signaling mechanisms, and how ATX isoforms use distinct mechanisms to target LPA prodn. to the plasma membrane, notably binding to integrins and heparan sulfate proteoglycans.  The authors also briefly discuss the development of drug-like inhibitors of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVdFme7XRfLVg90H21EOLACvtfcHk0lgW8FnWg6OKHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D&md5=d4813d9b7b37541e5e8ae739cebddc09</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046391%26sid%3Dliteratum%253Aachs%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DAutotaxin%253A%2520structure-function%2520and%2520signaling%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1010%26epage%3D1018%26doi%3D10.1194%2Fjlr.R046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bandoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/S0014-5793(00)01827-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2FS0014-5793%2800%2901827-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2000&pages=159-165&author=K.+Bandohauthor=J.+Aokiauthor=A.+Tairaauthor=M.+Tsujimotoauthor=H.+Araiauthor=K.+Inoue&title=Lysophosphatidic+acid+%28LPA%29+receptors+of+the+EDG+family+are+differentially+activated+by+LPA+species&doi=10.1016%2FS0014-5793%2800%2901827-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2800%2901827-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252800%252901827-5%26sid%3Dliteratum%253Aachs%26aulast%3DBandoh%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DTaira%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%2520of%2520the%2520EDG%2520family%2520are%2520differentially%2520activated%2520by%2520LPA%2520species%26jtitle%3DFEBS%2520Lett.%26date%3D2000%26volume%3D478%26spage%3D159%26epage%3D165%26doi%3D10.1016%2FS0014-5793%2800%2901827-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1016/j.prostaglandins.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.prostaglandins.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=20331961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=130-138&author=M.+E.+Linauthor=D.+R.+Herrauthor=J.+Chun&title=Lysophosphatidic+acid+%28LPA%29+receptors%3A+Signaling+properties+and+disease+relevance&doi=10.1016%2Fj.prostaglandins.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span></div><div class="casAuthors">Lin, Mu-En; Herr, Deron R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a water-sol. phospholipid, has gained significant attention in recent years since the discovery that it acts as a potent signaling mol. with wide-ranging effects on many different target tissues.  There are currently five identified G protein-coupled receptors for LPA and more are undergoing validation.  The complexity of the expression pattern and signaling properties of LPA receptors results in multiple influences on developmental, physiol., and pathol. processes.  This review provides a summary of LPA receptor signaling and current views on the potential involvement of this pathway in human diseases that include cardiovascular, cancer, neuropathic pain, neuropsychiatric disorders, reproductive disorders, and fibrosis.  The involvement of LPA signaling in these processes implicates multiple, potential drug targets including LPA receptor subtypes and LPA metabolizing enzymes.  Modulation of LPA signaling may thus provide therapeutic inroads for the treatment of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIqNSV9ngb7Vg90H21EOLACvtfcHk0lgy127khdRBCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D&md5=097555859468db9673c1ccf9ea8c2a60</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%253A%2520Signaling%2520properties%2520and%2520disease%2520relevance%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D130%26epage%3D138%26doi%3D10.1016%2Fj.prostaglandins.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span> <span class="citation_source-journal">Biomol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.4062/biomolther.2014.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.4062%2Fbiomolther.2014.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1-11&author=N.+C.+Stoddardauthor=J.+Chun&title=Promising+pharmacological+directions+in+the+world+of+lysophosphatidic+acid+signaling&doi=10.4062%2Fbiomolther.2014.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span></div><div class="casAuthors">Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BTIHA3</span>;
        ISSN:<span class="NLM_cas:issn">1976-9148</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a signaling lipid that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6.  These receptors initiate signaling cascades relevant to development, maintenance, and healing processes throughout the body.  The diversity and specificity of LPA signaling, esp. in relation to cancer and autoimmune disorders, makes LPA receptor modulation an attractive target for drug development.  Several LPAR-specific analogs and small mols. have been synthesized and are efficacious in attenuating pathol. in disease models.  To date, at least three compds. have passed phase I and phase II clin. trials for idiopathic pulmonary fibrosis and systemic sclerosis.  This review focuses on the promising therapeutic directions emerging in LPA signaling toward ameliorating several diseases, including cancer, fibrosis, arthritis, hydrocephalus, and traumatic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEf1nGhuRyPrVg90H21EOLACvtfcHk0lgy127khdRBCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D&md5=53d877ee381f9363918850f0b499bb11</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.4062%2Fbiomolther.2014.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4062%252Fbiomolther.2014.109%26sid%3Dliteratum%253Aachs%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DPromising%2520pharmacological%2520directions%2520in%2520the%2520world%2520of%2520lysophosphatidic%2520acid%2520signaling%26jtitle%3DBiomol.%2520Ther.%26date%3D2015%26volume%3D23%26spage%3D1%26epage%3D11%26doi%3D10.4062%2Fbiomolther.2014.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="note"><p class="first last">Reviews:</p></div><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Chemical evolution of autotaxin inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span><span class="refDoi"> DOI: 10.1021/cr2003213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2003213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=2593-2603&author=H.+M.+H.+G.+Albersauthor=H.+Ovaa&title=Chemical+evolution+of+autotaxin+inhibitors&doi=10.1021%2Fcr2003213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fcr2003213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2003213%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DChemical%2520evolution%2520of%2520autotaxin%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D2593%26epage%3D2603%26doi%3D10.1021%2Fcr2003213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barbayianni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrioti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutevelis-Minakakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokotos, G.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1517/13543776.2013.796364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1517%2F13543776.2013.796364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=23641951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1123-1132&author=E.+Barbayianniauthor=V.+Magriotiauthor=P.+Moutevelis-Minakakisauthor=G.+Kokotos&title=Autotaxin+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2013.796364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin inhibitors: a patent review</span></div><div class="casAuthors">Barbayianni, Efrosini; Magrioti, Victoria; Moutevelis-Minakakis, Panagiota; Kokotos, George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1123-1132</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Autotaxin (ATX) is a lysophospholipase D enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA) and choline.  LPA is a bioactive lipid mediator that activates several transduction pathways, and is involved in migration, proliferation and survival of various cells.  Thus, ATX is an attractive medicinal target.  Areas covered: The aim of this review is to summarize ATX inhibitors, reported in patents from 2006 up to now, describing their discovery and biol. evaluation.  Expert opinion: ATX has been implicated in various pathol. conditions, such as cancer, chronic inflammation, neuropathic pain, fibrotic diseases, etc.  Although there is an intensive effort on the discovery of potent and selective ATX inhibitors in order to identify novel medicinal agents, up to now, no ATX inhibitor has reached clin. trials.  However, the use of ATX inhibitors seems an attractive strategy for the development of novel medicinal agents, for example anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrIPRU28R5LVg90H21EOLACvtfcHk0lhGC5V9t2YSyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF&md5=517c590694d78587305229ce500e228a</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.796364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.796364%26sid%3Dliteratum%253Aachs%26aulast%3DBarbayianni%26aufirst%3DE.%26aulast%3DMagrioti%26aufirst%3DV.%26aulast%3DMoutevelis-Minakakis%26aufirst%3DP.%26aulast%3DKokotos%26aufirst%3DG.%26atitle%3DAutotaxin%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1123%26epage%3D1132%26doi%3D10.1517%2F13543776.2013.796364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span> </span><span class="NLM_article-title">Development of autotaxin inhibitors: an overview of the patent and primary literature</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5604</span><span class="NLM_x">–</span> <span class="NLM_lpage">5621</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5604-5621&author=D.+Castagnaauthor=D.+C.+Buddauthor=S.+J.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+Watson&title=Development+of+autotaxin+inhibitors%3A+an+overview+of+the+patent+and+primary+literature&doi=10.1021%2Facs.jmedchem.5b01599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature</span></div><div class="casAuthors">Castagna, Diana; Budd, David C.; MacDonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5604-5621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others.  As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities.  This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clin. trial data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzWQadusHW7Vg90H21EOLACvtfcHk0lhGC5V9t2YSyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D&md5=68ca29436fd3b0a1728a9a52fbaf2cb0</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01599%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26atitle%3DDevelopment%2520of%2520autotaxin%2520inhibitors%253A%2520an%2520overview%2520of%2520the%2520patent%2520and%2520primary%2520literature%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5604%26epage%3D5621%26doi%3D10.1021%2Facs.jmedchem.5b01599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="note"><p class="first last">Recent reports of autotaxin inhibitors:</p></div><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Structural basis for specific inhibition of autotaxin by a DNA aptamer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1038/nsmb.3200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnsmb.3200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27043297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=395-401&author=K.+Katoauthor=H.+Ikedaauthor=S.+Miyakawaauthor=S.+Futakawaauthor=Y.+Nonakaauthor=M.+Fujiwaraauthor=S.+Okudairaauthor=K.+Kanoauthor=J.+Aokiauthor=J.+Moritaauthor=R.+Ishitaniauthor=H.+Nishimasuauthor=Y.+Nakamuraauthor=O.+Nureki&title=Structural+basis+for+specific+inhibition+of+autotaxin+by+a+DNA+aptamer&doi=10.1038%2Fnsmb.3200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for specific inhibition of Autotaxin by a DNA aptamer</span></div><div class="casAuthors">Kato, Kazuki; Ikeda, Hisako; Miyakawa, Shin; Futakawa, Satoshi; Nonaka, Yosuke; Fujiwara, Masatoshi; Okudaira, Shinichi; Kano, Kuniyuki; Aoki, Junken; Morita, Junko; Ishitani, Ryuichiro; Nishimasu, Hiroshi; Nakamura, Yoshikazu; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ATX is a plasma lysophospholipase D that hydrolyzes lysophosphatidylcholine (LPC) and produces lysophosphatidic acid.  To date, no ATX-inhibition-mediated treatment strategies for human diseases have been established.  Here, we report anti-ATX DNA aptamers that inhibit ATX with high specificity and efficacy.  We solved the crystal structure of ATX in complex with the anti-ATX aptamer RB011, at 2.0-Å resoln.  RB011 binds in the vicinity of the active site through base-specific interactions, thus preventing the access of the choline moiety of LPC substrates.  Using the structural information, we developed the modified anti-ATX DNA aptamer RB014, which exhibited in vivo efficacy in a bleomycin-induced pulmonary fibrosis mouse model.  Our findings reveal the structural basis for the specific inhibition of ATX by the anti-ATX aptamer and highlight the therapeutic potential of anti-ATX aptamers for the treatment of human diseases, such as pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NHdAXL4UqLVg90H21EOLACvtfcHk0lhGC5V9t2YSyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D&md5=aca4be211ddf67faad6a2decadd73a12</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3200%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DMiyakawa%26aufirst%3DS.%26aulast%3DFutakawa%26aufirst%3DS.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DKano%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DMorita%26aufirst%3DJ.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DStructural%2520basis%2520for%2520specific%2520inhibition%2520of%2520autotaxin%2520by%2520a%2520DNA%2520aptamer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D395%26epage%3D401%26doi%3D10.1038%2Fnsmb.3200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimkowski, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirunavukkarasu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, B. H.</span><span> </span><span class="NLM_article-title">Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=857-861&author=S.+B.+Jonesauthor=L.+A.+Pfeiferauthor=T.+J.+Bleischauthor=T.+J.+Beauchampauthor=J.+D.+Durbinauthor=V.+J.+Klimkowskiauthor=N.+E.+Hughesauthor=C.+J.+Ritoauthor=Y.+Daoauthor=J.+M.+Gruberauthor=H.+Buiauthor=M.+G.+Chambersauthor=S.+Chandrasekharauthor=C.+Linauthor=D.+J.+McCannauthor=D.+R.+Mudraauthor=J.+L.+Oskinsauthor=C.+A.+Swearingenauthor=K.+Thirunavukkarasuauthor=B.+H.+Norman&title=Novel+autotaxin+inhibitors+for+the+treatment+of+osteoarthritis+pain%3A+lead+optimization+via+structure-based+drug+design&doi=10.1021%2Facsmedchemlett.6b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design</span></div><div class="casAuthors">Jones, Spencer B.; Pfeifer, Lance A.; Bleisch, Thomas J.; Beauchamp, Thomas J.; Durbin, Jim D.; Klimkowski, V. Joseph; Hughes, Norman E.; Rito, Christopher J.; Dao, Yen; Gruber, Joseph M.; Bui, Hai; Chambers, Mark G.; Chandrasekhar, Srinivasan; Lin, Chaohua; McCann, Denis J.; Mudra, Daniel R.; Oskins, Jennifer L.; Swearingen, Craig A.; Thirunavukkarasu, Kannan; Norman, Bryan H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">857-861</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, the authors set out to develop an inhibitor for autotaxin with excellent potency and phys. properties to allow for the clin. investigation of autotaxin-induced nociceptive and neuropathic pain.  An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC50 of 500 nM.  X-ray crystallog. enabled the optimization to a lead compd. I that demonstrated favorable potency (IC50 = 2 nM), PK properties, and a robust PK/PD relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8LOQIFg8_0bVg90H21EOLACvtfcHk0li-j5ty1TeWYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K&md5=c167f3fb691f8916fbce425701f8c7e8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BB.%26aulast%3DPfeifer%26aufirst%3DL.%2BA.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DDurbin%26aufirst%3DJ.%2BD.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DDao%26aufirst%3DY.%26aulast%3DGruber%26aufirst%3DJ.%2BM.%26aulast%3DBui%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DOskins%26aufirst%3DJ.%2BL.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520autotaxin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%2520pain%253A%2520lead%2520optimization%2520via%2520structure-based%2520drug%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D857%26epage%3D861%26doi%3D10.1021%2Facsmedchemlett.6b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheasty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farooq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejeune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeete, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of the lysophospholipase autotaxin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5403</span><span class="NLM_x">–</span> <span class="NLM_lpage">5410</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.bmcl.2016.10.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5403-5410&author=P.+Shahauthor=A.+Cheastyauthor=C.+Foxtonauthor=T.+Raynhamauthor=M.+Farooqauthor=I.+F.+Gutierrezauthor=A.+Lejeuneauthor=M.+Pritchardauthor=A.+Turnbullauthor=L.+Pangauthor=P.+Owenauthor=S.+Boydauthor=A.+Stowellauthor=A.+Jordanauthor=N.+M.+Hamiltonauthor=J.+R.+Hitchinauthor=M.+Stockleyauthor=E.+MacDonaldauthor=M.+J.+Quesadaauthor=E.+Trivierauthor=J.+Skeeteauthor=H.+Ovaaauthor=W.+H.+Moolenaarauthor=H.+Ryder&title=Discovery+of+potent+inhibitors+of+the+lysophospholipase+autotaxin&doi=10.1016%2Fj.bmcl.2016.10.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DP.%26aulast%3DCheasty%26aufirst%3DA.%26aulast%3DFoxton%26aufirst%3DC.%26aulast%3DRaynham%26aufirst%3DT.%26aulast%3DFarooq%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DI.%2BF.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3DPritchard%26aufirst%3DM.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DOwen%26aufirst%3DP.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DStowell%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DN.%2BM.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DStockley%26aufirst%3DM.%26aulast%3DMacDonald%26aufirst%3DE.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26aulast%3DTrivier%26aufirst%3DE.%26aulast%3DSkeete%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DRyder%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520the%2520lysophospholipase%2520autotaxin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5403%26epage%3D5410%26doi%3D10.1016%2Fj.bmcl.2016.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">The emerging role of lysophosphatidic acid in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1038/nrc1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnrc1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=12894246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvV2iu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=582-591&author=G.+B.+Millsauthor=W.+H.+Moolenaar&title=The+emerging+role+of+lysophosphatidic+acid+in+cancer&doi=10.1038%2Fnrc1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of lysophosphatidic acid in cancer</span></div><div class="casAuthors">Mills, Gordon B.; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">582-591</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bioactive phospholipid lysophosphatidic acid (LPA) stimulates cell proliferation, migration and survival by acting on its cognate G-protein-coupled receptors.  Aberrant LPA prodn., receptor expression and signaling probably contribute to cancer initiation, progression and metastasis.  The recent identification of ecto-enzymes that mediate the prodn. and degrdn. of LPA, as well as the development of receptor-selective analogs, indicate mechanisms by which LPA prodn. or action could be modulated for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHTv-V2F621bVg90H21EOLACvtfcHk0li-j5ty1TeWYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvV2iu7w%253D&md5=22a89dafdb8544b4aec043c365c2034b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrc1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1143%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DThe%2520emerging%2520role%2520of%2520lysophosphatidic%2520acid%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D582%26epage%3D591%26doi%3D10.1038%2Fnrc1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leblanc, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyruchaud, O.</span><span> </span><span class="NLM_article-title">New insights into the autotaxin/LPA axis in cancer development and metastasis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1016/j.yexcr.2014.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.yexcr.2014.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=25460336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2015&pages=183-189&author=R.+Leblancauthor=O.+Peyruchaud&title=New+insights+into+the+autotaxin%2FLPA+axis+in+cancer+development+and+metastasis&doi=10.1016%2Fj.yexcr.2014.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the autotaxin/LPA axis in cancer development and metastasis</span></div><div class="casAuthors">Leblanc, Raphael; Peyruchaud, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-189</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a simple lipid with a single fatty acyl chain linked to a glycerophosphate backbone.  Despite the simplicity of its structure but owing to its interactions with a series of at least six G protein-coupled receptors (LPA1-6), LPA exerts pleiotropic bioactivities including stimulation of proliferation, migration and survival of many cell types.  Autotaxin (ATX) is a unique enzyme with a lysophospholipase D (lysoPLD) activity that is responsible for the levels of LPA in the blood circulation.  Both LPA receptor family members and ATX/LysoPLD are aberrantly expressed in many human cancers.  This review will present the more striking as well as novel exptl. evidences using cell lines, cancer mouse models and transgenic animals identifying the roles for ATX and LPA receptors in cancer progression, tumor cell invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYBvc__AK4sLVg90H21EOLACvtfcHk0lj-IMM6Z_MVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgs73P&md5=ae2e8d79492719a44399d5e491517571</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2014.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2014.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DLeblanc%26aufirst%3DR.%26aulast%3DPeyruchaud%26aufirst%3DO.%26atitle%3DNew%2520insights%2520into%2520the%2520autotaxin%252FLPA%2520axis%2520in%2520cancer%2520development%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2015%26volume%3D333%26spage%3D183%26epage%3D189%26doi%3D10.1016%2Fj.yexcr.2014.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Benesch, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc Mullen, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindley, D. N.</span><span> </span><span class="NLM_article-title">Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">588</span><span class="NLM_x">, </span> <span class="NLM_fpage">2712</span><span class="NLM_x">–</span> <span class="NLM_lpage">2727</span><span class="refDoi"> DOI: 10.1016/j.febslet.2014.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.febslet.2014.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24560789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlSrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2014&pages=2712-2727&author=M.+G.+Beneschauthor=Y.+M.+Koauthor=T.+P.+Mc+Mullenauthor=D.+N.+Brindley&title=Autotaxin+in+the+crosshairs%3A+taking+aim+at+cancer+and+other+inflammatory+conditions&doi=10.1016%2Fj.febslet.2014.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin in the crosshairs: Taking aim at cancer and other inflammatory conditions</span></div><div class="casAuthors">Benesch, Matthew G. K.; Ko, Yi M.; McMullen, Todd P. W.; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">588</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2712-2727</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Autotaxin is a secreted enzyme that produces most of the extracellular lysophosphatidate from lysophosphatidylcholine, the most abundant phospholipid in blood plasma.  Lysophosphatidate mediates many physiol. and pathol. processes by signaling through at least six G-protein coupled receptors to promote cell survival, proliferation and migration.  The autotaxin/lysophosphatidate signaling axis is involved in wound healing and tissue remodeling, and it drives many chronic inflammatory conditions from fibrosis to colitis, asthma and cancer.  In cancer, lysophosphatidate signaling promotes resistance to chemotherapy and radiotherapy, and increases both angiogenesis and metastasis.  Research into autotaxin inhibitors is accelerating, both as primary and adjuvant therapy.  Historically, autotaxin inhibitors had poor bioavailability profiles and thus had limited efficacy in vivo.  This situation is now changing, esp. since the recent crystal structure of autotaxin is now enabling rational inhibitor design.  In this review, we will summarize current knowledge on autotaxin-mediated disease processes including cancer, and discuss recent advancements in the development of autotaxin-targeting strategies.  We will also provide new insights into autotaxin as an inflammatory mediator in the tumor microenvironment that promotes cancer progression and therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsrY7-J9l3NbVg90H21EOLACvtfcHk0lj-IMM6Z_MVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlSrs74%253D&md5=c10bc1550f945c437e938a72846b463b</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2014.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2014.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DBenesch%26aufirst%3DM.%2BG.%26aulast%3DKo%26aufirst%3DY.%2BM.%26aulast%3DMc%2BMullen%26aufirst%3DT.%2BP.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DAutotaxin%2520in%2520the%2520crosshairs%253A%2520taking%2520aim%2520at%2520cancer%2520and%2520other%2520inflammatory%2520conditions%26jtitle%3DFEBS%2520Lett.%26date%3D2014%26volume%3D588%26spage%3D2712%26epage%3D2727%26doi%3D10.1016%2Fj.febslet.2014.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contos, J. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span> </span><span class="NLM_article-title">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1038/nm1060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnm1060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=15195086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=712-714&author=M.+Inoueauthor=M.+H.+Rashidauthor=R.+Fujitaauthor=J.+J.+A.+Contosauthor=J.+Chunauthor=H.+Ueda&title=Initiation+of+neuropathic+pain+requires+lysophosphatidic+acid+receptor+signaling&doi=10.1038%2Fnm1060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span></div><div class="casAuthors">Inoue, Makoto; Rashid, Md Harunor; Fujita, Ryousuke; Contos, James J. A.; Chun, Jerold; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">712-718</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid with activity in the nervous system mediated by G-protein-coupled receptors.  Here, we examd. the role of LPA signaling in the development of neuropathic pain by pharmacol. and genetic approaches, including the use of mice lacking the LPA1 receptor.  Wild-type animals with nerve injury develop behavioral allodynia and hyperalgesia paralleled by demyelination in the dorsal root and increased expression of both the protein kinase C γ-isoform within the spinal cord dorsal horn and the α2δ1 calcium channel subunit in dorsal root ganglia.  Intrathecal injection of LPA induced behavioral, morphol. and biochem. changes similar to those obsd. after nerve ligation.  In contrast, mice lacking a single LPA receptor (LPA1, also known as EDG2) that activates the Rho-Rho kinase pathway do not develop signs of neuropathic pain after peripheral nerve injury.  Inhibitors of Rho and Rho kinase also prevented these signs of neuropathic pain.  These results imply that receptor-mediated LPA signaling is crucial in the initiation of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTzbCOHf9jX7Vg90H21EOLACvtfcHk0lj-IMM6Z_MVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D&md5=15f4760e4fd3b46c97c289be7b430058</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnm1060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1060%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DRashid%26aufirst%3DM.%2BH.%26aulast%3DFujita%26aufirst%3DR.%26aulast%3DContos%26aufirst%3DJ.%2BJ.%2BA.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DInitiation%2520of%2520neuropathic%2520pain%2520requires%2520lysophosphatidic%2520acid%2520receptor%2520signaling%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D712%26epage%3D714%26doi%3D10.1038%2Fnm1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thirunavukkarasu, K.; Swearingen, C. A.; Oskins, J. L.; Lin, C.; Bui, H. H.; Jones, S. B.; Pfeifer, L. A.; Norman, B. H.; Mitchell, P. G.; Chambers, M. G.</span><span> </span><span class="NLM_article-title">Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain</span>.  <span class="citation_source-journal">Osteoarthritis Cartilage</span>. [Online early access]. DOI: <span class="refDoi"> DOI: 10.1016/j.joca.2016.09.006</span> . Published Online: September 13,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.joca.2016.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27638130" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+Thirunavukkarasu&author=C.+A.+Swearingen&author=J.+L.+Oskins&author=C.+Lin&author=H.+H.+Bui&author=S.+B.+Jones&author=L.+A.+Pfeifer&author=B.+H.+Norman&author=P.+G.+Mitchell&author=M.+G.+Chambers&title=Identification+and+pharmacological+characterization+of+a+novel+inhibitor+of+autotaxin+in+rodent+models+of+joint+pain&doi=10.1016%2Fj.joca.2016.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2016.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2016.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520inhibitor%2520of%2520autotaxin%2520in%2520rodent%2520models%2520of%2520joint%2520pain%26jtitle%3DOsteoarthritis%2520Cartilage%26doi%3D10.1016%2Fj.joca.2016.09.006%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kremer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaap, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiper, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiners, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raap, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Buuren, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Erpecum, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rust, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Elferink, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuers, U.</span><span> </span><span class="NLM_article-title">Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1391</span><span class="NLM_x">–</span> <span class="NLM_lpage">1400</span><span class="refDoi"> DOI: 10.1002/hep.25748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1002%2Fhep.25748" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1391-1400&author=A.+E.+Kremerauthor=R.+van+Dijkauthor=P.+Leckieauthor=F.+G.+Schaapauthor=E.+M.+Kuiperauthor=T.+Mettangauthor=K.+S.+Reinersauthor=U.+Raapauthor=H.+R.+van+Buurenauthor=K.+J.+van+Erpecumauthor=N.+A.+Daviesauthor=C.+Rustauthor=A.+Engertauthor=R.+Jalanauthor=R.+P.+Oude+Elferinkauthor=U.+Beuers&title=Serum+autotaxin+is+increased+in+pruritus+of+cholestasis%2C+but+not+of+other+origin%2C+and+responds+to+therapeutic+interventions&doi=10.1002%2Fhep.25748"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1002%2Fhep.25748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.25748%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DA.%2BE.%26aulast%3Dvan%2BDijk%26aufirst%3DR.%26aulast%3DLeckie%26aufirst%3DP.%26aulast%3DSchaap%26aufirst%3DF.%2BG.%26aulast%3DKuiper%26aufirst%3DE.%2BM.%26aulast%3DMettang%26aufirst%3DT.%26aulast%3DReiners%26aufirst%3DK.%2BS.%26aulast%3DRaap%26aufirst%3DU.%26aulast%3Dvan%2BBuuren%26aufirst%3DH.%2BR.%26aulast%3Dvan%2BErpecum%26aufirst%3DK.%2BJ.%26aulast%3DDavies%26aufirst%3DN.%2BA.%26aulast%3DRust%26aufirst%3DC.%26aulast%3DEngert%26aufirst%3DA.%26aulast%3DJalan%26aufirst%3DR.%26aulast%3DOude%2BElferink%26aufirst%3DR.%2BP.%26aulast%3DBeuers%26aufirst%3DU.%26atitle%3DSerum%2520autotaxin%2520is%2520increased%2520in%2520pruritus%2520of%2520cholestasis%252C%2520but%2520not%2520of%2520other%2520origin%252C%2520and%2520responds%2520to%2520therapeutic%2520interventions%26jtitle%3DHepatology%26date%3D2012%26volume%3D56%26spage%3D1391%26epage%3D1400%26doi%3D10.1002%2Fhep.25748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wunsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neurath, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, P.</span><span> </span><span class="NLM_article-title">Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30847</span><span class="refDoi"> DOI: 10.1038/srep30847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fsrep30847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27506882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCitr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30847&author=E.+Wunschauthor=M.+Krawczykauthor=M.+Milkiewiczauthor=J.+Trottierauthor=O.+Barbierauthor=M.+F.+Neurathauthor=F.+Lammertauthor=A.+E.+Kremerauthor=P.+Milkiewicz&title=Serum+autotaxin+is+a+marker+of+the+severity+of+liver+injury+and+overall+survival+in+patients+with+cholestatic+liver+diseases&doi=10.1038%2Fsrep30847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases</span></div><div class="casAuthors">Wunsch, Ewa; Krawczyk, Marcin; Milkiewicz, Malgorzata; Trottier, Jocelyn; Barbier, Olivier; Neurath, Markus F.; Lammert, Frank; Kremer, Andreas E.; Milkiewicz, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30847</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is involved in the synthesis of lysophosphatidic acid.  Both have recently been linked to cholestatic pruritus and liver injury.  We aimed to investigate whether ATX is an indicator of cholestatic liver injury, health-related quality of life (HRQoL) and prognosis based on a group of 233 patients, 118 with primary biliary cholangitis (PBC) and 115 with primary sclerosing cholangitis (PSC).  Patients were followed for 1-60 mo, cumulative survival rates were calcd.  ATX activity was significantly higher in both groups than in the 103 controls, particularly in patients with cirrhosis and in patients with longer disease duration.  Ursodeoxycholic acid (UDCA) non-responders with PBC exhibited increased ATX activity.  ATX activity was correlated with liver biochem., MELD, Mayo Risk scores and was assocd. with worse disease-specific HRQoL aspects.  In both groups, Cox model anal. indicated that ATX was a neg. predictor of survival.  Increased ATX levels were assocd. with a 4-fold higher risk of death/liver transplantation in patients with PBC and a 2.6-fold higher risk in patients with PSC.  We conclude that in patients with cholestatic conditions, ATX is not only assocd. with pruritus but also indicates impairment of other HRQoL aspects, liver dysfunction, and can serve as a predictor of survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGQJnRzDI6NLVg90H21EOLACvtfcHk0liutk7_3AnQng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCitr%252FI&md5=50b20687784f1c549896920898fdd0f7</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fsrep30847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep30847%26sid%3Dliteratum%253Aachs%26aulast%3DWunsch%26aufirst%3DE.%26aulast%3DKrawczyk%26aufirst%3DM.%26aulast%3DMilkiewicz%26aufirst%3DM.%26aulast%3DTrottier%26aufirst%3DJ.%26aulast%3DBarbier%26aufirst%3DO.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DLammert%26aufirst%3DF.%26aulast%3DKremer%26aufirst%3DA.%2BE.%26aulast%3DMilkiewicz%26aufirst%3DP.%26atitle%3DSerum%2520autotaxin%2520is%2520a%2520marker%2520of%2520the%2520severity%2520of%2520liver%2520injury%2520and%2520overall%2520survival%2520in%2520patients%2520with%2520cholestatic%2520liver%2520diseases%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D30847%26doi%3D10.1038%2Fsrep30847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Selective inhibition of autotaxin is efficacious in mouse models of liver fibrosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1124/jpet.116.237156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1124%2Fjpet.116.237156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27754931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2017&pages=1-13&author=G.+Bainauthor=K.+E.+Shannonauthor=F.+Huangauthor=J.+Darlingtonauthor=L.+Gouletauthor=P.+Prodanovichauthor=G.+L.+Maauthor=A.+M.+Santiniauthor=A.+J.+Steinauthor=D.+Lonerganauthor=C.+D.+Kingauthor=I.+Calderonauthor=A.+Laiauthor=J.+H.+Hutchinsonauthor=J.+F.+Evans&title=Selective+inhibition+of+autotaxin+is+efficacious+in+mouse+models+of+liver+fibrosis&doi=10.1124%2Fjpet.116.237156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis</span></div><div class="casAuthors">Bain Gretchen; Shannon Kristen E; Huang Fei; Darlington Janice; Goulet Lance; Prodanovich Patricia; Ma Gina L; Santini Angelina M; Stein Adam J; Lonergan Dave; King Christopher D; Calderon Imelda; Lai Andiliy; Hutchinson John H; Evans Jilly F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autotaxin (ATX) is a secreted glycoprotein that converts lysophosphatidylcholine (LPC) to the bioactive phospholipid lysophosphatidic acid (LPA) and is the major enzyme generating circulating LPA.  Inhibition of LPA signaling has profound antifibrotic effects in multiple organ systems, including lung, kidney, skin, and peritoneum.  However, other LPA-generating pathways exist, and the role of ATX in localized tissue LPA production and fibrosis remains unclear and controversial.  In this study, we describe the preclinical pharmacologic, pharmacokinetic, and pharmacodynamic properties of a novel small-molecule ATX inhibitor, PAT-505 [3-((6-chloro-2-cyclopropyl-1-(1-ethyl-1H-pyrazol-4-yl)-7-fluoro-1H-indol-3-yl) thio)-2-fluorobenzoic acid sodium salt].  PAT-505 is a potent, selective, noncompetitive inhibitor that displays significant inhibition of ATX activity in plasma and liver tissue after oral administration.  When dosed therapeutically in a Stelic Mouse Animal Model of nonalcoholic steatohepatitis (NASH), PAT-505 treatment resulted in a small but significant improvement in fibrosis with only minor improvements in hepatocellular ballooning and hepatic inflammation.  In a choline-deficient, high-fat diet model of NASH, therapeutic treatment with PAT-505 robustly reduced liver fibrosis with no significant effect on steatosis, hepatocellular ballooning, or inflammation.  These data demonstrate that inhibiting autotaxin is antifibrotic and may represent a novel therapeutic approach for the treatment of multiple fibrotic liver diseases, including NASH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSL-FO7LhxeeTjk2McQZ6XmfW6udTcc2eZH-SmlXvvvnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D&md5=0ecd238167807657b30f436c05180dce</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237156%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DG.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DSelective%2520inhibition%2520of%2520autotaxin%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520liver%2520fibrosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D360%26spage%3D1%26epage%3D13%26doi%3D10.1124%2Fjpet.116.237156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafyatis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">An autotaxin/lysophosphatidic acid/interleukin-6 amplification loop drives scleroderma fibrosis</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2974</span><span class="refDoi"> DOI: 10.1002/art.39797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1002%2Fart.39797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27390295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGgsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=2964-2974&author=F.+V.+Castelinoauthor=G.+Bainauthor=V.+A.+Paceauthor=K.+E.+Blackauthor=L.+Georgeauthor=C.+K.+Probstauthor=L.+Gouletauthor=R.+Lafyatisauthor=A.+M.+Tager&title=An+autotaxin%2Flysophosphatidic+acid%2Finterleukin-6+amplification+loop+drives+scleroderma+fibrosis&doi=10.1002%2Fart.39797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis</span></div><div class="casAuthors">Castelino, Flavia V.; Bain, Gretchen; Pace, Veronica A.; Black, Katharine E.; George, Leaya; Probst, Clemens K.; Goulet, Lance; Lafyatis, Robert; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2964-2974</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : We previously implicated the lipid mediator lysophosphatidic acid (LPA) as having a role in dermal fibrosis in systemic sclerosis (SSc).  The aim of this study was to identify the role of the LPA-producing enzyme autotaxin (ATX), and to connect the ATX/LPA and interleukin-6 (IL-6) pathways in SSc.  Methods : We evaluated the effect of a novel ATX inhibitor, PAT-048, on fibrosis and IL-6 expression in the mouse model of bleomycin-induced dermal fibrosis.  We used dermal fibroblasts from SSc patients and control subjects to evaluate LPA-induced expression of IL-6, and IL-6-induced expression of ATX.  We next evaluated whether LPA-induced ATX expression is dependent on IL-6, and whether baseline IL-6 expression in fibroblasts from SSc patients is dependent on ATX.  Finally, we compared ATX and IL-6 expression in the skin of patients with SSc and healthy control subjects.  Results : PAT-048 markedly attenuated bleomycin-induced dermal fibrosis when treatment was initiated before or after the development of fibrosis.  LPA stimulated expression of IL-6 in human dermal fibroblasts, and IL-6 stimulated fibroblast expression of ATX, connecting the ATX/LPA and IL-6 pathways in an amplification loop.  IL-6 knockdown abrogated LPA-induced ATX expression in fibroblasts, and ATX inhibition attenuated IL-6 expression in fibroblasts and the skin of bleomycin-challenged mice.  Expression of both ATX and IL-6 was increased in SSc skin, and LPA-induced IL-6 levels and IL-6-induced ATX levels were increased in fibroblasts from SSc patients compared with controls.  Conclusion : ATX is required for the development and maintenance of dermal fibrosis in a mouse model of bleomycin-induced SSc and enables 2 major mediators of SSc fibrogenesis, LPA and IL-6, to amplify the prodn. of each other.  Our results suggest that concurrent inhibition of these 2 pathways may be an effective therapeutic strategy for dermal fibrosis in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAR8zNaWGdv7Vg90H21EOLACvtfcHk0ljyuCH-jksbCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGgsLjO&md5=c31da9bcfea17bbc19f27bce5bd9d1c5</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1002%2Fart.39797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39797%26sid%3Dliteratum%253Aachs%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DPace%26aufirst%3DV.%2BA.%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DGeorge%26aufirst%3DL.%26aulast%3DProbst%26aufirst%3DC.%2BK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLafyatis%26aufirst%3DR.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAn%2520autotaxin%252Flysophosphatidic%2520acid%252Finterleukin-6%2520amplification%2520loop%2520drives%2520scleroderma%2520fibrosis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D2964%26epage%3D2974%26doi%3D10.1002%2Fart.39797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bourgion, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span> </span><span class="NLM_article-title">Autotaxin and lysophospholipids in rheumatoid arthritis</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=515-526&author=S.+G.+Bourgionauthor=C.+Zhao&title=Autotaxin+and+lysophospholipids+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBourgion%26aufirst%3DS.%2BG.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DAutotaxin%2520and%2520lysophospholipids%2520in%2520rheumatoid%2520arthritis%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D515%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Park, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorshkova, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpurapu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranjan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbridge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidinis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christman, J. W.</span><span> </span><span class="NLM_article-title">Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">928</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.1164/rccm.201306-1014OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1164%2Frccm.201306-1014OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24050723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslymsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2013&pages=928-940&author=G.+Y.+Parkauthor=Y.+G.+Leeauthor=E.+Berdyshevauthor=S.+Nyenhuisauthor=J.+Duauthor=P.+Fuauthor=I.+A.+Gorshkovaauthor=Y.+Liauthor=S.+Chungauthor=M.+Karpurapuauthor=J.+Dengauthor=R.+Ranjanauthor=L.+Xiaoauthor=H.+A.+Jaffeauthor=S.+J.+Corbridgeauthor=E.+A.+Kellyauthor=N.+N.+Jarjourauthor=J.+Chunauthor=G.+D.+Prestwichauthor=E.+Kaffeauthor=I.+Ninouauthor=V.+Aidinisauthor=A.+J.+Morrisauthor=S.+S.+Smythauthor=S.+J.+Ackermanauthor=V.+Natarajanauthor=J.+W.+Christman&title=Autotaxin+production+of+lysophosphatidic+acid+mediates+allergic+asthmatic+inflammation&doi=10.1164%2Frccm.201306-1014OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation</span></div><div class="casAuthors">Park, Gye Young; Lee, Yong Gyu; Berdyshev, Evgeny; Nyenhuis, Sharmilee; Du, Jian; Fu, Panfeng; Gorshkova, Irina A.; Li, Yongchao; Chung, Sangwoon; Karpurapu, Manjula; Deng, Jing; Ranjan, Ravi; Xiao, Lei; Jaffe, H. Ari; Corbridge, Susan J.; Kelly, Elizabeth A. B.; Jarjour, Nizar N.; Chun, Jerold; Prestwich, Glenn D.; Kaffe, Eleanna; Ninou, Ioanna; Aidinis, Vassilis; Morris, Andrew J.; Smyth, Susan S.; Ackerman, Steven J.; Natarajan, Viswanathan; Christman, John W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Bioactive lipid mediators, derived from membrane lipid precursors, are released into the airway and airspace where they bind high-affinity cognate receptors and may mediate asthma pathogenesis.  Lysophosphatidic acid (LPA), a bioactive lipid mediator generated by the enzymic activity of extracellular autotaxin (ATX), binds LPA receptors, resulting in an array of biol. actions on cell proliferation, migration, survival, differentiation, and motility, and therefore could mediate asthma pathogenesis.  Objectives: To define a role for the ATX-LPA pathway in human asthma pathogenesis and a murine model of allergic lung inflammation.  Methods: We investigated the profiles of LPA mol. species and the level of ATX exoenzyme in bronchoalveolar lavage fluids of human patients with asthma subjected to subsegmental bronchoprovocation with allergen.  We interrogated the role of the ATX-LPA pathway in allergic lung inflammation using a murine allergic asthma model in ATX-LPA pathway-specific genetically modified mice.  Measurements and Main Results: Subsegmental bronchoprovocation with allergen in patients with mild asthma resulted in a remarkable increase in bronchoalveolar lavage fluid levels of LPA enriched in polyunsatd. 22:5 and 22:6 fatty acids in assocn. with increased concns. of ATX protein.  Using a triple-allergen mouse asthma model, we showed that ATX-overexpressing transgenic mice had a more severe asthmatic phenotype, whereas blocking ATX activity and knockdown of the LPA2 receptor in mice produced a marked attenuation of Th2 cytokines and allergic lung inflammation.  Conclusions: The ATX-LPA pathway plays a crit. role in the pathogenesis of asthma.  These preclin. data indicate that targeting the ATX-LPA pathway could be an effective antiasthma treatment strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BrXkeNAJRrVg90H21EOLACvtfcHk0ljyuCH-jksbCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslymsLfF&md5=dbf28845b5268777693188e0e122f0e5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1164%2Frccm.201306-1014OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201306-1014OC%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DG.%2BY.%26aulast%3DLee%26aufirst%3DY.%2BG.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DNyenhuis%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DP.%26aulast%3DGorshkova%26aufirst%3DI.%2BA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DKarpurapu%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DRanjan%26aufirst%3DR.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DJaffe%26aufirst%3DH.%2BA.%26aulast%3DCorbridge%26aufirst%3DS.%2BJ.%26aulast%3DKelly%26aufirst%3DE.%2BA.%26aulast%3DJarjour%26aufirst%3DN.%2BN.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DKaffe%26aufirst%3DE.%26aulast%3DNinou%26aufirst%3DI.%26aulast%3DAidinis%26aufirst%3DV.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DSmyth%26aufirst%3DS.%2BS.%26aulast%3DAckerman%26aufirst%3DS.%2BJ.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DChristman%26aufirst%3DJ.%2BW.%26atitle%3DAutotaxin%2520production%2520of%2520lysophosphatidic%2520acid%2520mediates%2520allergic%2520asthmatic%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2013%26volume%3D188%26spage%3D928%26epage%3D940%26doi%3D10.1164%2Frccm.201306-1014OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) and its receptors: Role in airway inflammation and remodeling</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1831</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2012.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.bbalip.2012.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=22809994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=86-92&author=Y.+Zhaoauthor=V.+Natarajan&title=Lysophosphatidic+acid+%28LPA%29+and+its+receptors%3A+Role+in+airway+inflammation+and+remodeling&doi=10.1016%2Fj.bbalip.2012.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) and its receptors: Role in airway inflammation and remodeling</span></div><div class="casAuthors">Zhao, Yutong; Natarajan, Viswanathan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1831</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-92</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a simple bioactive phospholipid, is present in biol. fluids such as plasma and bronchoalveolar lavage (BAL).  It appears to have both pro- and anti-inflammatory roles in inflammatory lung diseases.  Exogenous LPA promotes inflammatory responses by regulating the expression of chemokines, cytokines, and cytokine receptors in lung epithelial cells.  In addn. to the modulation of inflammatory responses, LPA regulates cytoskeleton rearrangement and confers protection against lung injury by enhancing lung epithelial cell barrier integrity and remodeling.  The biol. effects of LPA are mediated through its cell surface G-protein coupled LPA1-7 receptors.  The roles of LPA receptors in lung fibrosis, asthma, and acute lung injury have been investigated using genetically engineered LPA receptor deficient mice and there appears to be a definitive role for endogenous LPA and its receptors in the pathogenesis of pulmonary inflammatory diseases.  This review summarizes recent reports on the role of LPA and its receptors in the regulation of lung epithelial inflammatory responses and remodeling.  This article is part of a Special Issue entitled: Advances in Lysophospholipid Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEic0M3fm3hbVg90H21EOLACvtfcHk0ljyuCH-jksbCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahtLvN&md5=ef51a05f3a4920b78597e8c2f1efa46c</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2012.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2012.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520and%2520its%2520receptors%253A%2520Role%2520in%2520airway%2520inflammation%2520and%2520remodeling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2013%26volume%3D1831%26spage%3D86%26epage%3D92%26doi%3D10.1016%2Fj.bbalip.2012.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hui, D. Y.</span><span> </span><span class="NLM_article-title">Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease</span> <span class="citation_source-journal">Curr. Opin. Lipidol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1097/MOL.0000000000000334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1097%2FMOL.0000000000000334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27438680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVemtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=507-512&author=D.+Y.+Hui&title=Intestinal+phospholipid+and+lysophospholipid+metabolism+in+cardiometabolic+disease&doi=10.1097%2FMOL.0000000000000334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease</span></div><div class="casAuthors">Hui, David Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Lipidology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-512</span>CODEN:
                <span class="NLM_cas:coden">COPLEU</span>;
        ISSN:<span class="NLM_cas:issn">0957-9672</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Phospholipids are major constituents in the intestinal lumen after meal consumption.  This article highlights current literature suggesting the contributory role of intestinal phospholipid metab. toward cardiometabolic disease manifestation.  Recent findings: Group 1b phospholipase A2 (PLA2g1b) catalyzes phospholipid hydrolysis in the intestinal lumen.  The digestive product lysophospholipid, particularly lysophosphatidylcholine (LPC), has a direct role in mediating chylomicron assembly and secretion.  The LPC in the digestive tract is further catabolized into lysophosphatidic acid and choline via autotaxin-mediated and autotaxin-independent mechanisms.  The LPC and lysophosphatidic acid absorbed through the digestive tract and transported to the plasma directly promote systemic inflammation and cell dysfunction, leading to increased risk of cardiovascular disease and obesity/diabetes.  The choline moiety generated in the digestive tract can also be used by gut bacteria to generate trimethylamine, which is subsequently transported to the liver and oxidized into trimethylamine-N-oxide that also enhances atherosclerosis and cardiovascular abnormalities.  Summary: Products of phospholipid metab. in the intestine through PLA2g1b and autotaxin-mediated pathways directly contribute to cardiometabolic diseases through multiple mechanisms.  The implication of these studies is that therapeutic inhibition of PLA2g1b and autotaxin in the digestive tract may be a viable approach for cardiovascular and metabolic disease intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNnRXsdag26bVg90H21EOLACvtfcHk0liISzKtdR0VJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVemtbrK&md5=ea6703596f377164c18b771591124b0f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2FMOL.0000000000000334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOL.0000000000000334%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DD.%2BY.%26atitle%3DIntestinal%2520phospholipid%2520and%2520lysophospholipid%2520metabolism%2520in%2520cardiometabolic%2520disease%26jtitle%3DCurr.%2520Opin.%2520Lipidol.%26date%3D2016%26volume%3D27%26spage%3D507%26epage%3D512%26doi%3D10.1097%2FMOL.0000000000000334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span> </span><span class="NLM_article-title">Development of lysophosphatidic acid pathway modulators as therapies for fibrosis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span><span class="refDoi"> DOI: 10.4155/fmc.13.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.4155%2Ffmc.13.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24175745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1935-1952&author=D.+C.+Buddauthor=Y.+Qian&title=Development+of+lysophosphatidic+acid+pathway+modulators+as+therapies+for+fibrosis&doi=10.4155%2Ffmc.13.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of lysophosphatidic acid pathway modulators as therapies for fibrosis</span></div><div class="casAuthors">Budd, David C.; Qian, Yimin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1935-1952</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a class of bioactive phospholipid that displays a wide range of cellular effects via LPA receptors, of which six have been identified (LPAR1-6).  In serum and plasma, LPA prodn. occurs mainly by the hydrolysis of lysophosphatidylcholine by the phospholipase D activity of autotaxin (ATX).  The involvement of the LPA pathway in driving chronic wound-healing conditions, such as idiopathic pulmonary fibrosis, has suggested targets in this pathway could provide potential therapeutic approaches.  Mice with LPAR1 knockout or tissue-specific ATX deletion have demonstrated reduced lung fibrosis following bleomycin challenge.  Therefore, strategies aimed at antagonizing LPA receptors or inhibiting ATX have gained considerable attention.  This Review will summarize the current status of identifying small-mol. modulators of the LPA pathway.  The therapeutic utility of LPA modulators for the treatment of fibrotic diseases will soon be revealed as clin. trials are already in progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Jpew1zYC8rVg90H21EOLACvtfcHk0liISzKtdR0VJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislynsg%253D%253D&md5=ee2db60359f2a0217de52a3bf115dd22</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.154%26sid%3Dliteratum%253Aachs%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DQian%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520lysophosphatidic%2520acid%2520pathway%2520modulators%2520as%2520therapies%2520for%2520fibrosis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1935%26epage%3D1952%26doi%3D10.4155%2Ffmc.13.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P.</span><span> </span><span class="NLM_article-title">Autotaxin-LPA receptor axis in the pathogenesis of lung diseases</span> <span class="citation_source-journal">Int. J. Clin. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">17117</span><span class="NLM_x">–</span> <span class="NLM_lpage">17122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=26770305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVKqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=17117-17122&author=X.+Chuauthor=X.+Weiauthor=S.+Luauthor=P.+He&title=Autotaxin-LPA+receptor+axis+in+the+pathogenesis+of+lung+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-LPA receptor axis in the pathogenesis of lung diseases</span></div><div class="casAuthors">Chu, Xiangpeng; Wei, Xiaojie; Lu, Shaolin; He, Peijian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">17117-17122</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a small lipid which mediates a variety of cellular functions via the activation of LPA receptors.  LPA is generated from lysophosphatidylcholine by the extracellular enzyme, autotaxin (ATX).  Elevated ATX expression, LPA prodn. and their signaling pathways have been reported in multiple pathol. conditions of lung tissue, including inflammation, fibrosis and cancer.  Emerging evidence has highlighted the importance of ATX and LPA receptors in the pathogenesis of lung diseases.  Here, we briefly review the current knowledge of different roles of the ATX-LPA receptor axis in lung diseases focusing on inflammation, fibrosis and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXIh6-lgHGkLVg90H21EOLACvtfcHk0liISzKtdR0VJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVKqs7w%253D&md5=c0bcf6499ae1e3732f507666988a9b48</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DP.%26atitle%3DAutotaxin-LPA%2520receptor%2520axis%2520in%2520the%2520pathogenesis%2520of%2520lung%2520diseases%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D17117%26epage%3D17122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Oikonomou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouratis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzouvelekis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valavanis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaras, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karameris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidinis, V.</span><span> </span><span class="NLM_article-title">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1165/rcmb.2012-0004OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1165%2Frcmb.2012-0004OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=22744859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=566-574&author=N.+Oikonomouauthor=M.+A.+Mouratisauthor=A.+Tzouvelekisauthor=E.+Kaffeauthor=C.+Valavanisauthor=G.+Vilarasauthor=A.+Karamerisauthor=G.+D.+Prestwichauthor=D.+Bourosauthor=V.+Aidinis&title=Pulmonary+autotaxin+expression+contributes+to+the+pathogenesis+of+pulmonary+fibrosis&doi=10.1165%2Frcmb.2012-0004OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span></div><div class="casAuthors">Oikonomou Nikos; Mouratis Marios-Angelos; Tzouvelekis Argyris; Kaffe Eleanna; Valavanis Christos; Vilaras George; Karameris Andreas; Prestwich Glenn D; Bouros Demosthenes; Aidinis Vassilis</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory cell and molecular biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">566-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic form of diffuse lung disease occurring mainly in older adults.  Increased lysophosphatidic acid (LPA) concentrations have been reported in the alveolar space of both idiopathic pulmonary fibrosis patients and a corresponding animal model, whereas the genetic deletion or pharmacological inhibition of LPA receptor 1 attenuated the development of the modeled disease, suggesting a direct involvement of LPA in disease pathogenesis.  In this report, increased concentrations of autotaxin (ATX; ENPP2), the enzyme largely responsible for extracellular LPA production, were detected in both murine and human fibrotic lungs.  The genetic deletion of ATX from bronchial epithelial cells or macrophages attenuated disease severity, establishing ATX as a novel player in IPF pathogenesis.  Furthermore, the pharmacological inhibition of ATX attenuated the development of the modeled disease, suggesting that ATX is a possible therapeutic target in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLNdXayAacMr5XHngOXiV_fW6udTcc2ebvcZQVMGaUDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D&md5=f89e6297df4584c0b50c4ef5a33b0565</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0004OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0004OC%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomou%26aufirst%3DN.%26aulast%3DMouratis%26aufirst%3DM.%2BA.%26aulast%3DTzouvelekis%26aufirst%3DA.%26aulast%3DKaffe%26aufirst%3DE.%26aulast%3DValavanis%26aufirst%3DC.%26aulast%3DVilaras%26aufirst%3DG.%26aulast%3DKarameris%26aufirst%3DA.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DBouros%26aufirst%3DD.%26aulast%3DAidinis%26aufirst%3DV.%26atitle%3DPulmonary%2520autotaxin%2520expression%2520contributes%2520to%2520the%2520pathogenesis%2520of%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D566%26epage%3D574%26doi%3D10.1165%2Frcmb.2012-0004OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Funke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1165/rcmb.2010-0155OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1165%2Frcmb.2010-0155OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=22021336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=355-364&author=M.+Funkeauthor=Z.+Zhaoauthor=Y.+Xuauthor=J.+Chunauthor=A.+M.+Tager&title=The+lysophosphatidic+acid+receptor+LPA1+promotes+epithelial+cell+apoptosis+after+lung+injury&doi=10.1165%2Frcmb.2010-0155OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span></div><div class="casAuthors">Funke, Manuela; Zhao, Zhenwen; Xu, Yan; Chun, Jerold; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Increased epithelial cell apoptosis in response to lung injury has been implicated in the development of idiopathic pulmonary fibrosis (IPF), but the mol. pathways promoting epithelial cell apoptosis in this disease have yet to be fully identified.  Lysophosphatidic acid (LPA), which we have previously demonstrated to mediate bleomycin lung injury-induced fibroblast recruitment and vascular leak in mice and fibroblast recruitment in patients with IPF, is an important regulator of survival and apoptosis in many cell types.  We now show that LPA signaling through its receptor LPA1 promotes epithelial cell apoptosis induced by bleomycin injury.  The no. of apoptotic cells present in the alveolar and bronchial epithelia of LPA1-deficient mice was significantly reduced compared with wild-type mice at Day 3 after bleomycin challenge, as was lung caspase-3 activity.  Consistent with these in vivo results, we found that LPA signaling through LPA1 induced apoptosis in normal human bronchial epithelial cells in culture.  LPA-LPA1 signaling appeared to specifically mediate anoikis, the apoptosis of anchorage-dependent cells induced by their detachment.  Similarly, LPA neg. regulated attachment of R3/1 rat alveolar epithelial cell line cells.  In contrast, LPA signaling through LPA1 promoted the resistance of lung fibroblasts to apoptosis, which has also been implicated in IPF.  The ability of LPA-LPA1 signaling to promote epithelial cell apoptosis and fibroblast resistance to apoptosis may therefore contribute to the capacity of this signaling pathway to regulate the development of pulmonary fibrosis after lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_okuklehf2bVg90H21EOLACvtfcHk0ljNTCYM2LWQnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D&md5=ae97ec6b86cb2006ed7c3ce6b7d35c0b</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2010-0155OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2010-0155OC%26sid%3Dliteratum%253Aachs%26aulast%3DFunke%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520promotes%2520epithelial%2520cell%2520apoptosis%2520after%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26spage%3D355%26epage%3D364%26doi%3D10.1165%2Frcmb.2010-0155OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCamera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Shah, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nm1685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+A.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak&doi=10.1038%2Fnm1685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0ljNTCYM2LWQnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D45%26epage%3D54%26doi%3D10.1038%2Fnm1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Xu, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violette, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAnulty, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, G.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span><span class="refDoi"> DOI: 10.2353/ajpath.2009.080160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.2353%2Fajpath.2009.080160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=19147812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2009&pages=1264-1279&author=M.+Y.+Xuauthor=J.+Porteauthor=A.+J.+Knoxauthor=P.+H.+Weinrebauthor=T.+M.+Maherauthor=S.+M.+Violetteauthor=R.+J.+McAnultyauthor=D.+Sheppardauthor=G.+Jenkins&title=Lysophosphatidic+acid+induces+%CE%B1v%CE%B26+integrin-mediated+TGF-%CE%B2+activation+via+the+LPA2+receptor+and+the+small+G+protein+G%CE%B1q&doi=10.2353%2Fajpath.2009.080160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq</span></div><div class="casAuthors">Xu, Ming Yan; Porte, Joanne; Knox, Alan J.; Weinreb, Paul H.; Maher, Toby M.; Violette, Shelia M.; McAnulty, Robin J.; Sheppard, Dean; Jenkins, Gisli</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1264-1279</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Activation of latent transforming growth factor β (TGF-β) by αvβ6 integrin is crit. in the pathogenesis of lung injury and fibrosis.  We have previously demonstrated that the stimulation of protease activated receptor 1 promotes αvβ6 integrin-mediated TGF-β activation via RhoA, which is known to modulate cell contraction.  However, whether other G protein-coupled receptors can also induce αvβ6 integrin-mediated TGF-β activation is unknown; in addn., the αvβ6 integrin signaling pathway has not yet been fully characterized.  In this study, we show that lysophosphatidic acid (LPA) induces αvβ6-mediated TGF-β activation in human epithelial cells via both RhoA and Rho kinase.  Furthermore, we demonstrate that LPA-induced αvβ6 integrin-mediated TGF-β activity is mediated via the LPA2 receptor, which signals via Gαq.  Finally, we show that the expression levels of both the LPA2 receptor and αvβ6 integrin are up-regulated and are spatially and temporally assocd. following bleomycin-induced lung injury.  Furthermore, both the LPA2 receptor and αvβ6 integrin are up-regulated in the overlying epithelial areas of fibrosis in patients with usual interstitial pneumonia.  These studies demonstrate that LPA induces αvβ6 integrin-mediated TGF-β activation in epithelial cells via LPA2, Gαq, RhoA, and Rho kinase, and that this pathway might be clin. relevant to the development of lung injury and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRLfe65xAfj7Vg90H21EOLACvtfcHk0lj_xH6oBXDpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D&md5=0b9c319e5b3e4f6794333d2810edd958</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.080160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.080160%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%2BY.%26aulast%3DPorte%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DA.%2BJ.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DViolette%26aufirst%3DS.%2BM.%26aulast%3DMcAnulty%26aufirst%3DR.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DG.%26atitle%3DLysophosphatidic%2520acid%2520induces%2520%25CE%25B1v%25CE%25B26%2520integrin-mediated%2520TGF-%25CE%25B2%2520activation%2520via%2520the%2520LPA2%2520receptor%2520and%2520the%2520small%2520G%2520protein%2520G%25CE%25B1q%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D174%26spage%3D1264%26epage%3D1279%26doi%3D10.2353%2Fajpath.2009.080160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harijith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1165/rcmb.2013-0070OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1165%2Frcmb.2013-0070OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=23808384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyhu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=912-922&author=L.+S.+Huangauthor=P.+Fuauthor=P.+Patelauthor=A.+Harijithauthor=T.+Sunauthor=Y.+Zhaoauthor=J.+G.+Garciaauthor=J.+Chunauthor=V.+Natarajan&title=Lysophosphatidic+acid+receptor-2+deficiency+confers+protection+against+bleomycin-induced+lung+injury+and+fibrosis+in+mice&doi=10.1165%2Frcmb.2013-0070OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice</span></div><div class="casAuthors">Huang, Long Shuang; Fu, Panfeng; Patel, Priya; Harijith, Anantha; Sun, Tianjiao; Zhao, Yutong; Garcia, Joe G. N.; Chun, Jerold; Natarajan, Viswanathan</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">912-922</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis is a devastating disease characterized by alveolar epithelial cell injury, the accumulation of fibroblasts/myofibroblasts, and the deposition of extracellular matrix proteins.  Lysophosphatidic acid (LPA) signaling through its G protein-coupled receptors is crit. for its various biol. functions.  Recently, LPA and LPA receptor 1 were implicated in lung fibrogenesis.  However, the role of other LPA receptors in fibrosis remains unclear.  Here, we use a bleomycin-induced pulmonary fibrosis model to investigate the roles of LPA2 in pulmonary fibrogenesis.  In the present study, we found that LPA2 knockout (Lpar2-/-) mice were protected against bleomycin-induced lung injury, fibrosis, and mortality, compared with wild-type control mice.  Furthermore, LPA2 deficiency attenuated the bleomycin-induced expression of fibronectin (FN), α-smooth muscle actin (α-SMA), and collagen in lung tissue, as well as levels of IL-6, transforming growth factor-β (TGF-β), and total protein in bronchoalveolar lavage fluid.  In human lung fibroblasts, the knockdown of LPA2 attenuated the LPA-induced expression of TGF-β1 and the differentiation of lung fibroblasts to myofibroblasts, resulting in the decreased expression of FN, α-SMA, and collagen, as well as decreased activation of extracellular regulated kinase 1/2, Akt, Smad3, and p38 mitogen-activated protein kinase.  Moreover, the knockdown of LPA2 with small interfering RNA also mitigated the TGF-β1-induced differentiation of lung fibroblasts.  In addn., LPA2 deficiency significantly attenuated the bleomycin-induced apoptosis of alveolar and bronchial epithelial cells in the mouse lung.  Together, our data indicate that the knockdown of LPA2 attenuated bleomycin-induced lung injury and pulmonary fibrosis, and this may be related to an inhibition of the LPA-induced expression of TGF-β and the activation and differentiation of fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlKYtpTWIkfbVg90H21EOLACvtfcHk0lj_xH6oBXDpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyhu7bN&md5=e15e9a67c81d49cb5874bc768a283111</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2013-0070OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2013-0070OC%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%2BS.%26aulast%3DFu%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DHarijith%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DLysophosphatidic%2520acid%2520receptor-2%2520deficiency%2520confers%2520protection%2520against%2520bleomycin-induced%2520lung%2520injury%2520and%2520fibrosis%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2013%26volume%3D49%26spage%3D912%26epage%3D922%26doi%3D10.1165%2Frcmb.2013-0070OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Desroy, N.; Heckmann, B.; Brys, R. C. X.; Joncour, A.; Peixoto, C.; Bock, X.</span><span> </span><span class="NLM_article-title">Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders</span>. PCT Int. Appl. WO2014/139882 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Desroy&author=B.+Heckmann&author=R.+C.+X.+Brys&author=A.+Joncour&author=C.+Peixoto&author=X.+Bock&title=Compounds+and+pharmaceutical+compositions+thereof+for+the+treatment+of+inflammatory+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DCompounds%2520and%2520pharmaceutical%2520compositions%2520thereof%2520for%2520the%2520treatment%2520of%2520inflammatory%2520disorders%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Desroy, N.; Joncour, A.; Bock, X.; Housseman, C.; Peixoto, C.; Bienvenu, N.; Labeguere, V.; Cherel, L.; Annoot, D.; Christophe, T.; Conrath, K.; Triballeau, N.; Mollat, P.; Wohlkonig, A.; Blanque, R.; Cottereaux, C.; Hrvacic, B.; Borgonovi, M.; Monjardet, A.; Van der Aar, E.; Brys, R.; Heckmann, B.</span><span> </span><span class="NLM_article-title">Discovery of GLPG1690: A first-in-class autotaxin inhibitor in clinical development for the treatment of idiopathic pulmonary fibrosis</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 251st National Meeting & Exposition of the American Chemical Society, San Diego, CA, U.S., March 13–17, 2016; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>; MEDI-254.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Desroy%2C+N.%3B+Joncour%2C+A.%3B+Bock%2C+X.%3B+Housseman%2C+C.%3B+Peixoto%2C+C.%3B+Bienvenu%2C+N.%3B+Labeguere%2C+V.%3B+Cherel%2C+L.%3B+Annoot%2C+D.%3B+Christophe%2C+T.%3B+Conrath%2C+K.%3B+Triballeau%2C+N.%3B+Mollat%2C+P.%3B+Wohlkonig%2C+A.%3B+Blanque%2C+R.%3B+Cottereaux%2C+C.%3B+Hrvacic%2C+B.%3B+Borgonovi%2C+M.%3B+Monjardet%2C+A.%3B+Van+der+Aar%2C+E.%3B+Brys%2C+R.%3B+Heckmann%2C+B.+Discovery+of+GLPG1690%3A+A+first-in-class+autotaxin+inhibitor+in+clinical+development+for+the+treatment+of+idiopathic+pulmonary+fibrosis.+Abstracts+of+Papers%2C+251st+National+Meeting+%26+Exposition+of+the+American+Chemical+Society%2C+San+Diego%2C+CA%2C+U.S.%2C+March+13%E2%80%9317%2C+2016%3B+American+Chemical+Society%3A+Washington%2C+DC%3B+MEDI-254."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520GLPG1690%253A%2520A%2520first-in-class%2520autotaxin%2520inhibitor%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Usui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komuro, S.</span><span> </span><span class="NLM_article-title">Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2383</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1124/dmd.109.028860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1124%2Fdmd.109.028860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=19720731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=2383-2392&author=T.+Usuiauthor=M.+Miseauthor=T.+Hashizumeauthor=M.+Yabukiauthor=S.+Komuro&title=Evaluation+of+the+potential+for+drug-induced+liver+injury+based+on+in+vitro+covalent+binding+to+human+liver+proteins&doi=10.1124%2Fdmd.109.028860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins</span></div><div class="casAuthors">Usui, Toru; Mise, Masashi; Hashizume, Takanori; Yabuki, Masashi; Komuro, Setsuko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2383-2392</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Prediction of idiosyncratic drug-induced liver injury (DILI) is difficult, and the underlying mechanisms are not fully understood.  However, many drugs causing DILI are considered to form reactive metabolites and covalently bind to cellular macromols. in the liver.  The objective of this study was to clarify whether the risk of idiosyncratic DILI can be estd. by comparing in vitro covalent binding (CB) levels among 12 pos. compds. (acetaminophen, alpidem, bromfenac, carbamazepine, diclofenac, flutamide, imipramine, nefazodone, tacrine, ticlopidine, tienilic acid, and troglitazone) for DILI and 12 neg. compds. (acetylsalicylic acid, caffeine, dexamethasone, losartan, ibuprofen, paroxetine, pioglitazone, rosiglitazone, sertraline, theophylline, venlafaxine, and zolpidem).  After incubation with human liver microsomes in the presence of NADPH, there was a large overlap in the distribution of CB amts. between the pos. and neg. groups.  On addn. of UDP-glucuronic acid (UDPGA) as a cofactor for glucuronidation, the CB levels of bromfenac and diclofenac were increased.  With addn. of nucleophilic glutathione (GSH), values for most compds. were decreased.  However, sepn. of the two groups on the basis of CB could not be improved by UDPGA or GSH.  Furthermore, CB with human hepatocytes also failed to discriminate pos. from neg. compds.  Therefore, the CB amt. alone is not sufficient for risk assessment of DILI.  In contrast, when the CB amt. was multiplied by the max. daily dose, which may reflect max. hepatic exposure, the two groups did become discriminated.  Taken together, our findings suggest that the combination of CB amt. and daily dose can est. the risk of idiosyncratic DILI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvQoojI97OgLVg90H21EOLACvtfcHk0ljwgnWOiZZh0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr7K&md5=19ffc916995d60f9cb0b6b3a2074a082</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.028860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.028860%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DMise%26aufirst%3DM.%26aulast%3DHashizume%26aufirst%3DT.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DKomuro%26aufirst%3DS.%26atitle%3DEvaluation%2520of%2520the%2520potential%2520for%2520drug-induced%2520liver%2520injury%2520based%2520on%2520in%2520vitro%2520covalent%2520binding%2520to%2520human%2520liver%2520proteins%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D2383%26epage%3D2392%26doi%3D10.1124%2Fdmd.109.028860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0ljwgnWOiZZh0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moutou, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J.-J.</span><span> </span><span class="NLM_article-title">A two-steps benzotriazole-assisted synthesis of 3-amino-2-ethoxycarbonyl imidazo [1,2-a] pyridines and related compounds</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1787</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span><span class="refDoi"> DOI: 10.1016/0040-4039(96)00132-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2F0040-4039%2896%2900132-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=1787-1790&author=J.-L.+Moutouauthor=M.+Schmittauthor=V.+Collotauthor=J.-J.+Bourguignon&title=A+two-steps+benzotriazole-assisted+synthesis+of+3-amino-2-ethoxycarbonyl+imidazo+%5B1%2C2-a%5D+pyridines+and+related+compounds&doi=10.1016%2F0040-4039%2896%2900132-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2896%2900132-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252896%252900132-3%26sid%3Dliteratum%253Aachs%26aulast%3DMoutou%26aufirst%3DJ.-L.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DCollot%26aufirst%3DV.%26aulast%3DBourguignon%26aufirst%3DJ.-J.%26atitle%3DA%2520two-steps%2520benzotriazole-assisted%2520synthesis%2520of%25203-amino-2-ethoxycarbonyl%2520imidazo%2520%255B1%252C2-a%255D%2520pyridines%2520and%2520related%2520compounds%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D1787%26epage%3D1790%26doi%3D10.1016%2F0040-4039%2896%2900132-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Katritzky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urogdi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayence, A.</span><span> </span><span class="NLM_article-title">The chemistry of <i>N</i>-substituted benzotriazoles Part 23. Synthesis of tertiary α-amino esters</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">1989</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1055/s-1989-27244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1055%2Fs-1989-27244" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1989&publication_year=1989&pages=323-327&author=A.+R.+Katritzkyauthor=L.+Urogdiauthor=A.+Mayence&title=The+chemistry+of+N-substituted+benzotriazoles+Part+23.+Synthesis+of+tertiary+%CE%B1-amino+esters&doi=10.1055%2Fs-1989-27244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1055%2Fs-1989-27244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1989-27244%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DUrogdi%26aufirst%3DL.%26aulast%3DMayence%26aufirst%3DA.%26atitle%3DThe%2520chemistry%2520of%2520N-substituted%2520benzotriazoles%2520Part%252023.%2520Synthesis%2520of%2520tertiary%2520%25CE%25B1-amino%2520esters%26jtitle%3DSynthesis%26date%3D1989%26volume%3D1989%26spage%3D323%26epage%3D327%26doi%3D10.1055%2Fs-1989-27244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gonzalez Lio, L.; Camacho Gomez, J. A.</span><span> </span><span class="NLM_article-title">New compounds as adenosine A1 receptor antagonists</span>. PCT Int. Appl. WO2009044250 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Gonzalez+Lio&author=J.+A.+Camacho+Gomez&title=New+compounds+as+adenosine+A1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%2BLio%26aufirst%3DL.%26atitle%3DNew%2520compounds%2520as%2520adenosine%2520A1%2520receptor%2520antagonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">King, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryden, I.</span><span> </span><span class="NLM_article-title">The reaction of ketones with formamidine disulfide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1947</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1813</span><span class="NLM_x">–</span> <span class="NLM_lpage">1814</span><span class="refDoi"> DOI: 10.1021/ja01199a072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01199a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1947&pages=1813-1814&author=L.+C.+Kingauthor=I.+Ryden&title=The+reaction+of+ketones+with+formamidine+disulfide&doi=10.1021%2Fja01199a072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fja01199a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01199a072%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DL.%2BC.%26aulast%3DRyden%26aufirst%3DI.%26atitle%3DThe%2520reaction%2520of%2520ketones%2520with%2520formamidine%2520disulfide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1947%26volume%3D69%26spage%3D1813%26epage%3D1814%26doi%3D10.1021%2Fja01199a072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Insights into autotaxin: how to produce and present a lipid mediator</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1038/nrm3188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnrm3188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=21915140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=674-679&author=W.+H.+Moolenaarauthor=A.+Perrakis&title=Insights+into+autotaxin%3A+how+to+produce+and+present+a+lipid+mediator&doi=10.1038%2Fnrm3188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into autotaxin: how to produce and present a lipid mediator</span></div><div class="casAuthors">Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is a secreted phosphodiesterase that produces the lipid mediator lysophosphatidic acid (LPA).  LPA acts through specific guanine-nucleotide-binding protein (G protein)-coupled receptors to stimulate migration, proliferation, survival and other functions in many cell types.  ATX is important in vivo for processes as diverse as vasculogenesis, lymphocyte trafficking and tumor progression.  However, the inner workings of ATX have long been elusive, in terms of both its substrate specificity and how localized LPA signalling is achieved.  Structural studies have shown how ATX recognizes its substrates and may interact with the cell surface to promote specificity in LPA signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm3UHhjy0QP7Vg90H21EOLACvtfcHk0lgs0_CPEKjXEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ&md5=96ab96a9e7f6cd70f5dcc1be0363d298</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1038%2Fnrm3188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3188%26sid%3Dliteratum%253Aachs%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DInsights%2520into%2520autotaxin%253A%2520how%2520to%2520produce%2520and%2520present%2520a%2520lipid%2520mediator%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D674%26epage%3D679%26doi%3D10.1038%2Fnrm3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Crystal structure of autotaxin an insight into GPCR activation by lipid mediators</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/nsmb.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnsmb.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=21240269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=205-213&author=H.+Nishimasuauthor=S.+Okudairaauthor=K.+Hamaauthor=E.+Miharaauthor=N.+Dohmaeauthor=A.+Inoueauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+structure+of+autotaxin+an+insight+into+GPCR+activation+by+lipid+mediators&doi=10.1038%2Fnsmb.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span></div><div class="casAuthors">Nishimasu, Hiroshi; Okudaira, Shinichi; Hama, Kotaro; Mihara, Emiko; Dohmae, Naoshi; Inoue, Asuka; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as Enpp2) is a secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine to generate lysophosphatidic acid (LPA), a lipid mediator that activates G protein-coupled receptors to evoke various cellular responses.  Here, we report the crystal structures of mouse ATX alone and in complex with LPAs with different acyl-chain lengths and saturations.  These structures reveal that the multidomain architecture helps to maintain the structural rigidity of the lipid-binding pocket, which accommodates the resp. LPA mols. in distinct conformations.  They indicate that a loop region in the catalytic domain is a major determinant for the substrate specificity of the Enpp family enzymes.  Furthermore, along with biochem. and biol. data, these structures suggest that the produced LPAs are delivered from the active site to cognate G protein-coupled receptors through a hydrophobic channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9dHNmB6yTbVg90H21EOLACvtfcHk0lgs0_CPEKjXEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D&md5=f2f9ccaadf5c7de7bfd8431e5f954b2a</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1998%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520structure%2520of%2520autotaxin%2520an%2520insight%2520into%2520GPCR%2520activation%2520by%2520lipid%2520mediators%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D205%26epage%3D213%26doi%3D10.1038%2Fnsmb.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moeller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ask, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warburton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauldie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, M.</span><span> </span><span class="NLM_article-title">The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span><span class="refDoi"> DOI: 10.1016/j.biocel.2007.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.biocel.2007.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=17936056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVentrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=362-382&author=A.+Moellerauthor=K.+Askauthor=D.+Warburtonauthor=J.+Gauldieauthor=M.+Kolb&title=The+bleomycin+animal+model%3A+a+useful+tool+to+investigate+treatment+options+for+idiopathic+pulmonary+fibrosis%3F&doi=10.1016%2Fj.biocel.2007.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?</span></div><div class="casAuthors">Moeller, Antje; Ask, Kjetil; Warburton, David; Gauldie, Jack; Kolb, Martin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">362-382</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Different animal models of pulmonary fibrosis were developed to investigate potential therapies for idiopathic pulmonary fibrosis (IPF).  The most common is the bleomycin model in rodents (mouse, rat and hamster).  Over the years, numerous agents were shown to inhibit fibrosis in this model.  However, to date none of these compds. are used in the clin. management of IPF and none has shown a comparable antifibrotic effect in humans.  We performed a systematic review of publications on drug efficacy studies in the bleomycin model to evaluate the value of this model regarding transferability to clin. use.  Between 1980 and 2006 we identified 240 exptl. studies describing beneficial antifibrotic compds. in the bleomycin model. 222 of those used a preventive regimen (drug given ≤7 days after last bleomycin application), only 13 were therapeutic trials (>7 days after last bleomycin application).  In 5 studies we did not find enough details about the timing of drug application to allow inter-study comparison.  It is crit. to distinguish between drugs interfering with the inflammatory and early fibrogenic response from those preventing progression of fibrosis, the latter likely much more meaningful for clin. application.  All potential antifibrotic compds. should be evaluated in the phase of established fibrosis rather than in the early period of bleomycin-induced inflammation for assessment of its antifibrotic properties.  Further care should be taken in extrapolation of drugs successfully tested in the bleomycin model due to partial reversibility of bleomycin-induced fibrosis over time.  The use of alternative and more robust animal models, which better reflect human IPF, is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO707NgQcoCLVg90H21EOLACvtfcHk0li70yxMQlcn6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVentrg%253D&md5=2d9caf63cbe8d6092cdf4b011e46dfce</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2007.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2007.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DMoeller%26aufirst%3DA.%26aulast%3DAsk%26aufirst%3DK.%26aulast%3DWarburton%26aufirst%3DD.%26aulast%3DGauldie%26aufirst%3DJ.%26aulast%3DKolb%26aufirst%3DM.%26atitle%3DThe%2520bleomycin%2520animal%2520model%253A%2520a%2520useful%2520tool%2520to%2520investigate%2520treatment%2520options%2520for%2520idiopathic%2520pulmonary%2520fibrosis%253F%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2008%26volume%3D40%26spage%3D362%26epage%3D382%26doi%3D10.1016%2Fj.biocel.2007.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renteria, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravindran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogaboam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, C. S.</span><span> </span><span class="NLM_article-title">Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">e59348</span><span class="refDoi"> DOI: 10.1371/journal.pone.0059348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1371%2Fjournal.pone.0059348" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e59348&issue=4&author=R.+Pengauthor=S.+Sridharauthor=G.+Tyagiauthor=J.+E.+Phillipsauthor=R.+Garridoauthor=P.+Harrisauthor=L.+Burnsauthor=L.+Renteriaauthor=J.+Woodsauthor=L.+Chenauthor=J.+Allardauthor=P.+Ravindranauthor=H.+Bitterauthor=Z.+Liangauthor=C.+M.+Hogaboamauthor=C.+Kitsonauthor=D.+C.+Buddauthor=J.+S.+Fineauthor=C.+M.+Bauerauthor=C.+S.+Stevenson&title=Bleomycin+induces+molecular+changes+directly+relevant+to+idiopathic+pulmonary+fibrosis%3A+a+model+for+%22active%22+disease&doi=10.1371%2Fjournal.pone.0059348"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0059348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0059348%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DSridhar%26aufirst%3DS.%26aulast%3DTyagi%26aufirst%3DG.%26aulast%3DPhillips%26aufirst%3DJ.%2BE.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DBurns%26aufirst%3DL.%26aulast%3DRenteria%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAllard%26aufirst%3DJ.%26aulast%3DRavindran%26aufirst%3DP.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DHogaboam%26aufirst%3DC.%2BM.%26aulast%3DKitson%26aufirst%3DC.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DBauer%26aufirst%3DC.%2BM.%26aulast%3DStevenson%26aufirst%3DC.%2BS.%26atitle%3DBleomycin%2520induces%2520molecular%2520changes%2520directly%2520relevant%2520to%2520idiopathic%2520pulmonary%2520fibrosis%253A%2520a%2520model%2520for%2520%2522active%2522%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D4%26spage%3De59348%26doi%3D10.1371%2Fjournal.pone.0059348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Noble, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costabel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassberg, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardatzke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, T. E.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahn, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szwarcberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeyre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Bois, R. M.</span><span> </span><span class="NLM_article-title">CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1769</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60405-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2FS0140-6736%2811%2960405-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=1760-1769&author=P.+W.+Nobleauthor=C.+Alberaauthor=W.+Z.+Bradfordauthor=U.+Costabelauthor=M.+K.+Glassbergauthor=D.+Kardatzkeauthor=T.+E.+Kingauthor=L.+Lancasterauthor=S.+A.+Sahnauthor=J.+Szwarcbergauthor=D.+Valeyreauthor=R.+M.+du+Bois&title=CAPACITY+Study+Group.+Pirfenidone+in+patients+with+idiopathic+pulmonary+fibrosis+%28CAPACITY%29%3A+two+randomised+trials&doi=10.1016%2FS0140-6736%2811%2960405-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960405-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960405-4%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DP.%2BW.%26aulast%3DAlbera%26aufirst%3DC.%26aulast%3DBradford%26aufirst%3DW.%2BZ.%26aulast%3DCostabel%26aufirst%3DU.%26aulast%3DGlassberg%26aufirst%3DM.%2BK.%26aulast%3DKardatzke%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DT.%2BE.%26aulast%3DLancaster%26aufirst%3DL.%26aulast%3DSahn%26aufirst%3DS.%2BA.%26aulast%3DSzwarcberg%26aufirst%3DJ.%26aulast%3DValeyre%26aufirst%3DD.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26atitle%3DCAPACITY%2520Study%2520Group.%2520Pirfenidone%2520in%2520patients%2520with%2520idiopathic%2520pulmonary%2520fibrosis%2520%2528CAPACITY%2529%253A%2520two%2520randomised%2520trials%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D1760%26epage%3D1769%26doi%3D10.1016%2FS0140-6736%2811%2960405-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ashcroft, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timbrell, V.</span><span> </span><span class="NLM_article-title">Simple method of estimating severity of pulmonary fibrosis on a numerical scale</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1136/jcp.41.4.467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1136%2Fjcp.41.4.467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=3366935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A280%3ADyaL1c3htlOltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1988&pages=467-470&author=T.+Ashcroftauthor=J.+M.+Simpsonauthor=V.+Timbrell&title=Simple+method+of+estimating+severity+of+pulmonary+fibrosis+on+a+numerical+scale&doi=10.1136%2Fjcp.41.4.467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Simple method of estimating severity of pulmonary fibrosis on a numerical scale</span></div><div class="casAuthors">Ashcroft T; Simpson J M; Timbrell V</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-70</span>
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">A continuous numerical scale for determining the degree of fibrosis in lung specimens was devised for correlation with other pulmonary variables such as lung function tests or mineral burden.  Grading was scored on a scale from 0 to 8, using the average of microscope field scores.  The system allows fibrosis to be measured in small samples of tissue (1 cm) which can provide a detailed description of the changes in a lung, currently not possible with most existing methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5mGFCkDKSIzUE-swuRqsHfW6udTcc2eZfwhYhn3QR7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3htlOltg%253D%253D&md5=d1da07e3ba735d309aa78d3955474bfd</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1136%2Fjcp.41.4.467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.41.4.467%26sid%3Dliteratum%253Aachs%26aulast%3DAshcroft%26aufirst%3DT.%26aulast%3DSimpson%26aufirst%3DJ.%2BM.%26aulast%3DTimbrell%26aufirst%3DV.%26atitle%3DSimple%2520method%2520of%2520estimating%2520severity%2520of%2520pulmonary%2520fibrosis%2520on%2520a%2520numerical%2520scale%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1988%26volume%3D41%26spage%3D467%26epage%3D470%26doi%3D10.1136%2Fjcp.41.4.467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Matsuse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuhashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uejima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouchi, Y.</span><span> </span><span class="NLM_article-title">ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1183%2F09031936.99.13107199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10836326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlymsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=71-77&author=T.+Matsuseauthor=S.+Teramotoauthor=H.+Katayamaauthor=E.+Sudoauthor=H.+Ekimotoauthor=H.+Mitsuhashiauthor=Y.+Uejimaauthor=Y.+Fukuchiauthor=Y.+Ouchi&title=ICAM-1+mediates+lung+leukocyte+recruitment+but+not+pulmonary+fibrosis+in+a+murine+model+of+bleomycin-induced+lung+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury</span></div><div class="casAuthors">Matsuse, T.; Teramoto, S.; Katayama, H.; Sudo, E.; Ekimoto, H.; Mitsuhashi, H.; Uejima, Y.; Fukuchi, Y.; Ouchi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Bleomycin-induced lung injury has been extensively used as a model of interstitial pneumonia and pulmonary fibrosis.  Intercellular adhesion mol. (ICAM)-1 is a ligand for lymphocyte function-assocd. antigen (LFA)-1α and has been shown to be required for leukocyte migration into inflamed areas.  The purpose here was to investigate the role of the ICAM-1/LFA-1α pathway in a murine model of bleomycin-induced lung injury.  Animals received 75 mg/kg-1 bleomycin (BLM) i.v. followed by treatment with phosphate-buffered saline (BLM group), anti-ICAM-1 and LFA-1α monoclonal antibodies (mAb) (BLM+mAb group).  Inflammatory cell counts of bronchoalveolar lavage (BAL) fluid, hydroxyproline content, and histol. findings were compared between these groups.  In the BLM group, increases in total cell count, macrophage count, and neutrophil count of BAL fluid were obsd. on days 7 and 14.  In the BLM+mAb group, bleomycin-induced accumulation of neutrophils was reduced on days 7 and 14.  However, the administration of mAb to ICAM-1 and LFA-1α did not decrease the lung hydroxyproline content or the histopathol. fibrosis grading score, indicating that the antagonism of ICAM-1 and LFA-1α did not attenuate bleomycin-induced pulmonary fibrosis.  Apparently, the ICAM-1/LFA-1α pathway mediates the accumulation of inflammatory cells in the injured lung caused by bleomycin; however, other mechanisms are important for the subsequent development of pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp1vLl5CSzmLVg90H21EOLACvtfcHk0li70yxMQlcn6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlymsL4%253D&md5=eaae85d8e5354d6eb20c74c643481c91</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1183%2F09031936.99.13107199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.99.13107199%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuse%26aufirst%3DT.%26aulast%3DTeramoto%26aufirst%3DS.%26aulast%3DKatayama%26aufirst%3DH.%26aulast%3DSudo%26aufirst%3DE.%26aulast%3DEkimoto%26aufirst%3DH.%26aulast%3DMitsuhashi%26aufirst%3DH.%26aulast%3DUejima%26aufirst%3DY.%26aulast%3DFukuchi%26aufirst%3DY.%26aulast%3DOuchi%26aufirst%3DY.%26atitle%3DICAM-1%2520mediates%2520lung%2520leukocyte%2520recruitment%2520but%2520not%2520pulmonary%2520fibrosis%2520in%2520a%2520murine%2520model%2520of%2520bleomycin-induced%2520lung%2520injury%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1999%26volume%3D13%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><div class="note"><p class="first last">This result will be further discussed in a future pharmacology publication. It contradicts observations made with another autotaxin inhibitor in the following article:</p></div><span class="NLM_contrib-group">Black, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagares, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahluwalia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2450</span><span class="refDoi"> DOI: 10.1096/fj.201500197R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1096%2Ffj.201500197R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=2435-2450&author=K.+E.+Blackauthor=E.+Berdyshevauthor=G.+Bainauthor=F.+V.+Castelinoauthor=B.+S.+Sheaauthor=C.+K.+Probstauthor=B.+A.+Fontaineauthor=I.+Bronovaauthor=L.+Gouletauthor=D.+Lagaresauthor=N.+Ahluwaliaauthor=R.+S.+Knipeauthor=V.+Natarajanauthor=A.+M.+Tager&title=Autotaxin+activity+increases+locally+following+lung+injury%2C+but+is+not+required+for+pulmonary+lysophosphatidic+acid+production+or+fibrosis&doi=10.1096%2Ffj.201500197R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1096%2Ffj.201500197R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201500197R%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DProbst%26aufirst%3DC.%2BK.%26aulast%3DFontaine%26aufirst%3DB.%2BA.%26aulast%3DBronova%26aufirst%3DI.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLagares%26aufirst%3DD.%26aulast%3DAhluwalia%26aufirst%3DN.%26aulast%3DKnipe%26aufirst%3DR.%2BS.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAutotaxin%2520activity%2520increases%2520locally%2520following%2520lung%2520injury%252C%2520but%2520is%2520not%2520required%2520for%2520pulmonary%2520lysophosphatidic%2520acid%2520production%2520or%2520fibrosis%26jtitle%3DFASEB%2520J.%26date%3D2016%26volume%3D30%26spage%3D2435%26epage%3D2450%26doi%3D10.1096%2Ffj.201500197R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12a','cit12b','cit12c','cit12d'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b'],'ref18':['cit18a','cit18b'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 64 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Marcus Litchfield, Melinda Wuest, Daryl Glubrecht, Emmanuelle Briard, Yves P. Auberson, Todd P. W. McMullen, David N. Brindley, <span class="NLM_string-name hlFld-ContribAuthor">Frank Wuest</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography Imaging of Autotaxin in Thyroid and Breast Cancer Models Using [18F]PRIMATX. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.1c00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.1c00265%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DPositron%252BEmission%252BTomography%252BImaging%252Bof%252BAutotaxin%252Bin%252BThyroid%252Band%252BBreast%252BCancer%252BModels%252BUsing%252B%25255B18F%25255DPRIMATX%26aulast%3DLitchfield%26aufirst%3DMarcus%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04042021%26date%3D19072021%26date%3D17072021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bin Ma, Lei Zhang, Lihong Sun, Zhili Xin, Gnanasambandam Kumaravel, Douglas Marcotte, Jayanth V. Chodaparambil, Qin Wang, Angela Wehr, Jing Jing, Victor Sukbong Hong, Ti Wang, Carol Huang, Zhaohui Shao, <span class="NLM_string-name hlFld-ContribAuthor">Sha Mi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1124-1129. <a href="https://doi.org/10.1021/acsmedchemlett.1c00211" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00211%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPotent%252BSelective%252BNonzinc%252BBinding%252BAutotaxin%252BInhibitor%252BBIO-32546%26aulast%3DMa%26aufirst%3DBin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D10062021%26date%3D14062021%26volume%3D12%26issue%3D7%26spage%3D1124%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Charlotte Juillet, Ludmila Ermolenko, Dina Boyarskaya, Blandine Baratte, Béatrice Josselin, Hristo Nedev, Stéphane Bach, Bogdan I. Iorga, Jérôme Bignon, Sandrine Ruchaud, <span class="NLM_string-name hlFld-ContribAuthor">Ali Al-Mourabit</span>. </span><span class="cited-content_cbyCitation_article-title">From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1197-1219. <a href="https://doi.org/10.1021/acs.jmedchem.0c02064" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BSynthetic%252BSimplified%252BMarine%252BMetabolite%252BAnalogues%252Bto%252BNew%252BSelective%252BAllosteric%252BInhibitor%252Bof%252BAurora%252BB%252BKinase%26aulast%3DJuillet%26aufirst%3DCharlotte%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27112020%26date%3D08012021%26volume%3D64%26issue%3D2%26spage%3D1197%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hartmut Beck, Tobias Thaler, Daniel Meibom, Mark Meininghaus, Hannah Jörißen, Lisa Dietz, Carsten Terjung, Michaela Bairlein, Clemens-Jeremias von Bühler, Sonja Anlauf, Chantal Fürstner, Timo Stellfeld, Dirk Schneider, Kersten M. Gericke, Thomas Buyck, Kai Lovis, Uwe Münster, Johanna Anlahr, Elisabeth Kersten, Guillaume Levilain, Virginia Marossek, <span class="NLM_string-name hlFld-ContribAuthor">Raimund Kast</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11639-11662. <a href="https://doi.org/10.1021/acs.jmedchem.0c00834" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00834%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSelective%252BHuman%252BProstaglandin%252BF%252B%252528FP%252529%252BReceptor%252BAntagonist%252B%252528BAY-6672%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%252B%252528IPF%252529%26aulast%3DBeck%26aufirst%3DHartmut%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16052020%26date%3D08102020%26date%3D24092020%26volume%3D63%26issue%3D20%26spage%3D11639%26epage%3D11662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Neetu Dayal, Modi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Herman O. Sintim</span>. </span><span class="cited-content_cbyCitation_article-title">HSD1787, a Tetrahydro-3H-Pyrazolo[4,3-f]Quinoline Compound Synthesized via Povarov Reaction, Potently Inhibits Proliferation of Cancer Cell Lines at Nanomolar Concentrations. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (37)
                                     , 23799-23807. <a href="https://doi.org/10.1021/acsomega.0c03001" title="DOI URL">https://doi.org/10.1021/acsomega.0c03001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c03001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c03001%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DHSD1787%25252C%252Ba%252BTetrahydro-3H-Pyrazolo%25255B4%25252C3-f%25255DQuinoline%252BCompound%252BSynthesized%252Bvia%252BPovarov%252BReaction%25252C%252BPotently%252BInhibits%252BProliferation%252Bof%252BCancer%252BCell%252BLines%252Bat%252BNanomolar%252BConcentrations%26aulast%3DDayal%26aufirst%3DNeetu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23062020%26date%3D28082020%26date%3D11092020%26volume%3D5%26issue%3D37%26spage%3D23799%26epage%3D23807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">John W. Cuozzo, Matthew A. Clark, Anthony D. Keefe, Anna Kohlmann, Mark Mulvihill, Haihong Ni, Louis M. Renzetti, Daniel I. Resnicow, Frank Ruebsam, Eric A. Sigel, Heather A. Thomson, Ce Wang, Zhifeng Xie, <span class="NLM_string-name hlFld-ContribAuthor">Ying Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7840-7856. <a href="https://doi.org/10.1021/acs.jmedchem.0c00688" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00688%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BAutotaxin%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%25253A%252BA%252BClinical%252BCandidate%252BDiscovered%252BUsing%252BDNA-Encoded%252BChemistry%26aulast%3DCuozzo%26aufirst%3DJohn%2BW.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24042020%26date%3D09072020%26date%3D25062020%26volume%3D63%26issue%3D14%26spage%3D7840%26epage%3D7856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hongrui Lei, Ming Guo, Xiaopeng Li, Fang Jia, Changtao Li, Yu Yang, Meng Cao, Nan Jiang, Enlong Ma, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Indole-Based Allosteric Highly Potent ATX Inhibitors with Great In Vivo Efficacy in a Mouse Lung Fibrosis Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 7326-7346. <a href="https://doi.org/10.1021/acs.jmedchem.0c00506" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00506</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00506%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BIndole-Based%252BAllosteric%252BHighly%252BPotent%252BATX%252BInhibitors%252Bwith%252BGreat%252BIn%252BVivo%252BEfficacy%252Bin%252Ba%252BMouse%252BLung%252BFibrosis%252BModel%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27032020%26date%3D12062020%26date%3D01062020%26volume%3D63%26issue%3D13%26spage%3D7326%26epage%3D7346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hongrui Lei, Yu Yang, Changtao Li, Fang Jia, Nan Jiang, Ping Gong, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free Cyclization- and Curtius Rearrangement-Induced Functional Group Transformation: An Improved Synthetic Strategy of First-in-Class ATX Inhibitor Ziritaxestat (GLPG-1690). </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (6)
                                     , 997-1005. <a href="https://doi.org/10.1021/acs.oprd.9b00511" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00511%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DCatalyst-Free%252BCyclization-%252Band%252BCurtius%252BRearrangement-Induced%252BFunctional%252BGroup%252BTransformation%25253A%252BAn%252BImproved%252BSynthetic%252BStrategy%252Bof%252BFirst-in-Class%252BATX%252BInhibitor%252BZiritaxestat%252B%252528GLPG-1690%252529%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29112019%26date%3D08052020%26date%3D23042020%26volume%3D24%26issue%3D6%26spage%3D997%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mitsuyasu Kawaguchi, Takayoshi Okabe, Shinichi Okudaira, Kotaro Hama, Kuniyuki Kano, Hiroshi Nishimasu, Hidehiko Nakagawa, Ryuichiro Ishitani, Hirotatsu Kojima, Osamu Nureki, Junken Aoki, <span class="NLM_string-name hlFld-ContribAuthor">Tetsuo Nagano</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Potent In Vivo Autotaxin Inhibitors that Bind to Both Hydrophobic Pockets and Channels in the Catalytic Domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3188-3204. <a href="https://doi.org/10.1021/acs.jmedchem.9b01967" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01967%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotent%252BIn%252BVivo%252BAutotaxin%252BInhibitors%252Bthat%252BBind%252Bto%252BBoth%252BHydrophobic%252BPockets%252Band%252BChannels%252Bin%252Bthe%252BCatalytic%252BDomain%26aulast%3DKawaguchi%26aufirst%3DMitsuyasu%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26112019%26date%3D13032020%26date%3D05032020%26volume%3D63%26issue%3D6%26spage%3D3188%26epage%3D3204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aikaterini Nikolaou, Ioanna Ninou, Maroula G. Kokotou, Eleanna Kaffe, Antreas Afantitis, Vassilis Aidinis, <span class="NLM_string-name hlFld-ContribAuthor">George Kokotos</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3697-3711. <a href="https://doi.org/10.1021/acs.jmedchem.8b00232" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00232%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHydroxamic%252BAcids%252BConstitute%252Ba%252BNovel%252BClass%252Bof%252BAutotaxin%252BInhibitors%252Bthat%252BExhibit%252Bin%252BVivo%252BEfficacy%252Bin%252Ba%252BPulmonary%252BFibrosis%252BModel%26aulast%3DNikolaou%26aufirst%3DAikaterini%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12022018%26date%3D18042018%26date%3D05042018%26volume%3D61%26issue%3D8%26spage%3D3697%26epage%3D3711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Denis Bucher, Pieter Stouten, <span class="NLM_string-name hlFld-ContribAuthor">Nicolas Triballeau</span>. </span><span class="cited-content_cbyCitation_article-title">Shedding Light on Important Waters for Drug Design: Simulations versus Grid-Based Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (3)
                                     , 692-699. <a href="https://doi.org/10.1021/acs.jcim.7b00642" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DShedding%252BLight%252Bon%252BImportant%252BWaters%252Bfor%252BDrug%252BDesign%25253A%252BSimulations%252Bversus%252BGrid-Based%252BMethods%26aulast%3DBucher%26aufirst%3DDenis%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D03112017%26date%3D05032018%26date%3D28022018%26volume%3D58%26issue%3D3%26spage%3D692%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ran Cheng, Wakana Mori, Longle Ma, Mireille Alhouayek, Akiko Hatori, Yiding Zhang, Daisuke Ogasawara, Gengyang Yuan, Zhen Chen, Xiaofei Zhang, Hang Shi, Tomoteru Yamasaki, Lin Xie, Katsushi Kumata, Masayuki Fujinaga, Yuji Nagai, Takafumi Minamimoto, Mona Svensson, Lu Wang, Yunfei Du, Mary Jo Ondrechen, Neil Vasdev, Benjamin F. Cravatt, Christopher Fowler, Ming-Rong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and in Vivo Evaluation of 11C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2278-2291. <a href="https://doi.org/10.1021/acs.jmedchem.7b01400" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01400%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252B11C-Labeled%252BAzetidinecarboxylates%252Bfor%252BImaging%252BMonoacylglycerol%252BLipase%252Bby%252BPET%252BImaging%252BStudies%26aulast%3DCheng%26aufirst%3DRan%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21092017%26date%3D09032018%26date%3D26022018%26volume%3D61%26issue%3D6%26spage%3D2278%26epage%3D2291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian A.  Kuttruff</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Tom  Bretschneider</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Sandra  Handschuh</span>, <span class="hlFld-ContribAuthor ">Bernd  Nosse</span>, <span class="hlFld-ContribAuthor ">Helmut  Romig</span>, <span class="hlFld-ContribAuthor ">Paul  Nicklin</span>, and <span class="hlFld-ContribAuthor ">Gerald J.  Roth</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 1252-1257. <a href="https://doi.org/10.1021/acsmedchemlett.7b00312" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00312%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BBI-2545%25253A%252BA%252BNovel%252BAutotaxin%252BInhibitor%252BThat%252BSignificantly%252BReduces%252BLPA%252BLevels%252Bin%252BVivo%26aulast%3DKuttruff%26aufirst%3DChristian%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05082017%26date%3D08112017%26date%3D14112017%26date%3D14122017%26date%3D08112017%26volume%3D8%26issue%3D12%26spage%3D1252%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnès  Joncour</span>, <span class="hlFld-ContribAuthor ">Nicolas  Desroy</span>, <span class="hlFld-ContribAuthor ">Christopher  Housseman</span>, <span class="hlFld-ContribAuthor ">Xavier  Bock</span>, <span class="hlFld-ContribAuthor ">Natacha  Bienvenu</span>, <span class="hlFld-ContribAuthor ">Laëtitia  Cherel</span>, <span class="hlFld-ContribAuthor ">Virginie  Labeguere</span>, <span class="hlFld-ContribAuthor ">Christophe  Peixoto</span>, <span class="hlFld-ContribAuthor ">Denis  Annoot</span>, <span class="hlFld-ContribAuthor ">Luce  Lepissier</span>, <span class="hlFld-ContribAuthor ">Jörg  Heiermann</span>, <span class="hlFld-ContribAuthor ">Willem Jan  Hengeveld</span>, <span class="hlFld-ContribAuthor ">Gregor  Pilzak</span>, <span class="hlFld-ContribAuthor ">Alain  Monjardet</span>, <span class="hlFld-ContribAuthor ">Emanuelle  Wakselman</span>, <span class="hlFld-ContribAuthor ">Veronique  Roncoroni</span>, <span class="hlFld-ContribAuthor ">Sandrine  Le Tallec</span>, <span class="hlFld-ContribAuthor ">René  Galien</span>, <span class="hlFld-ContribAuthor ">Christelle  David</span>, <span class="hlFld-ContribAuthor ">Nele  Vandervoort</span>, <span class="hlFld-ContribAuthor ">Thierry  Christophe</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>, <span class="hlFld-ContribAuthor ">Mia  Jans</span>, <span class="hlFld-ContribAuthor ">Alexandre  Wohlkonig</span>, <span class="hlFld-ContribAuthor ">Sameh  Soror</span>, <span class="hlFld-ContribAuthor ">Jan  Steyaert</span>, <span class="hlFld-ContribAuthor ">Robert  Touitou</span>, <span class="hlFld-ContribAuthor ">Damien  Fleury</span>, <span class="hlFld-ContribAuthor ">Lionel  Vercheval</span>, <span class="hlFld-ContribAuthor ">Patrick  Mollat</span>, <span class="hlFld-ContribAuthor ">Nicolas  Triballeau</span>, <span class="hlFld-ContribAuthor ">Ellen  van der Aar</span>, <span class="hlFld-ContribAuthor ">Reginald  Brys</span>, and <span class="hlFld-ContribAuthor ">Bertrand  Heckmann</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7371-7392. <a href="https://doi.org/10.1021/acs.jmedchem.7b00647" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00647%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationship%25252C%252Band%252BBinding%252BMode%252Bof%252Ban%252BImidazo%25255B1%25252C2-a%25255Dpyridine%252BSeries%252Bof%252BAutotaxin%252BInhibitors%26aulast%3DJoncour%26aufirst%3DAgn%25C3%25A8s%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03052017%26date%3D18082017%26date%3D14092017%26date%3D21072017%26volume%3D60%26issue%3D17%26spage%3D7371%26epage%3D7392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luiz Henrique Medeiros  Geraldo</span>, <span class="hlFld-ContribAuthor ">Tânia Cristina Leite de Sampaio  Spohr</span>, <span class="hlFld-ContribAuthor ">Rackele Ferreira do  Amaral</span>, <span class="hlFld-ContribAuthor ">Anna Carolina Carvalho da  Fonseca</span>, <span class="hlFld-ContribAuthor ">Celina  Garcia</span>, <span class="hlFld-ContribAuthor ">Fabio de Almeida  Mendes</span>, <span class="hlFld-ContribAuthor ">Catarina  Freitas</span>, <span class="hlFld-ContribAuthor ">Marcos Fabio  dosSantos</span>, <span class="hlFld-ContribAuthor ">Flavia Regina Souza  Lima</span>. </span><span class="cited-content_cbyCitation_article-title">Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00367-5" title="DOI URL">https://doi.org/10.1038/s41392-020-00367-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00367-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00367-5%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DRole%252Bof%252Blysophosphatidic%252Bacid%252Band%252Bits%252Breceptors%252Bin%252Bhealth%252Band%252Bdisease%25253A%252Bnovel%252Btherapeutic%252Bstrategies%26aulast%3DGeraldo%26aufirst%3DLuiz%2BHenrique%2BMedeiros%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioanna  Nikitopoulou</span>, <span class="hlFld-ContribAuthor ">Ioanna  Ninou</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Manitsopoulos</span>, <span class="hlFld-ContribAuthor ">Ioanna  Dimopoulou</span>, <span class="hlFld-ContribAuthor ">Stylianos E.  Orfanos</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>, <span class="hlFld-ContribAuthor ">Anastasia  Kotanidou</span>. </span><span class="cited-content_cbyCitation_article-title">A role for bronchial epithelial autotaxin in ventilator-induced lung injury. </span><span class="cited-content_cbyCitation_journal-name">Intensive Care Medicine Experimental</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40635-021-00379-7" title="DOI URL">https://doi.org/10.1186/s40635-021-00379-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40635-021-00379-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40635-021-00379-7%26sid%3Dliteratum%253Aachs%26jtitle%3DIntensive%2520Care%2520Medicine%2520Experimental%26atitle%3DA%252Brole%252Bfor%252Bbronchial%252Bepithelial%252Bautotaxin%252Bin%252Bventilator-induced%252Blung%252Binjury%26aulast%3DNikitopoulou%26aufirst%3DIoanna%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Bai</span>, <span class="hlFld-ContribAuthor ">Yunhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng  Chu</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Qi</span>, <span class="hlFld-ContribAuthor ">Xu  Han</span>, <span class="hlFld-ContribAuthor ">Baojing  Zhang</span>, <span class="hlFld-ContribAuthor ">Huijun  Sun</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Lixue  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of selenogefitinib for reducing bleomycin-induced pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128238. <a href="https://doi.org/10.1016/j.bmcl.2021.128238" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128238%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bselenogefitinib%252Bfor%252Breducing%252Bbleomycin-induced%252Bpulmonary%252Bfibrosis%26aulast%3DBai%26aufirst%3DYue%26date%3D2021%26volume%3D48%26spage%3D128238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moez  Ghumman</span>, <span class="hlFld-ContribAuthor ">Dinesh  Dhamecha</span>, <span class="hlFld-ContribAuthor ">Andrea  Gonsalves</span>, <span class="hlFld-ContribAuthor ">Lauren  Fortier</span>, <span class="hlFld-ContribAuthor ">Parand  Sorkhdini</span>, <span class="hlFld-ContribAuthor ">Yang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jyothi U.  Menon</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutics and Biopharmaceutics</span><span> <strong>2021,</strong> <em>164 </em>, 1-12. <a href="https://doi.org/10.1016/j.ejpb.2021.03.017" title="DOI URL">https://doi.org/10.1016/j.ejpb.2021.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejpb.2021.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejpb.2021.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutics%2520and%2520Biopharmaceutics%26atitle%3DEmerging%252Bdrug%252Bdelivery%252Bstrategies%252Bfor%252Bidiopathic%252Bpulmonary%252Bfibrosis%252Btreatment%26aulast%3DGhumman%26aufirst%3DMoez%26date%3D2021%26volume%3D164%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Celia  Dobersalske</span>, <span class="hlFld-ContribAuthor ">Manuel  Grundmann</span>, <span class="hlFld-ContribAuthor ">Andreas  Timmermann</span>, <span class="hlFld-ContribAuthor ">Laura  Theisen</span>, <span class="hlFld-ContribAuthor ">Florian  Kölling</span>, <span class="hlFld-ContribAuthor ">Raymond C.  Harris</span>, <span class="hlFld-ContribAuthor ">Chantal  Fuerstner</span>, <span class="hlFld-ContribAuthor ">Michael S.  Becker</span>, <span class="hlFld-ContribAuthor ">Frank  Wunder</span>. </span><span class="cited-content_cbyCitation_article-title">Establishment of a novel, cell-based autotaxin assay. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2021,</strong> <em>158 </em>, 114322. <a href="https://doi.org/10.1016/j.ab.2021.114322" title="DOI URL">https://doi.org/10.1016/j.ab.2021.114322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2021.114322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2021.114322%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DEstablishment%252Bof%252Ba%252Bnovel%25252C%252Bcell-based%252Bautotaxin%252Bassay%26aulast%3DDobersalske%26aufirst%3DCelia%26date%3D2021%26volume%3D158%26spage%3D114322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zehui  Tan</span>, <span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">An updated patent review of autotaxin inhibitors (2017–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (5)
                                     , 421-434. <a href="https://doi.org/10.1080/13543776.2021.1867106" title="DOI URL">https://doi.org/10.1080/13543776.2021.1867106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1867106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1867106%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAn%252Bupdated%252Bpatent%252Breview%252Bof%252Bautotaxin%252Binhibitors%252B%2525282017%2525E2%252580%252593present%252529%26aulast%3DTan%26aufirst%3DZehui%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D5%26spage%3D421%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaotian  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengmiao  Li</span>, <span class="hlFld-ContribAuthor ">Nan  Yin</span>, <span class="hlFld-ContribAuthor ">Junjie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The Expression Regulation and Biological Function of Autotaxin. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     , 939. <a href="https://doi.org/10.3390/cells10040939" title="DOI URL">https://doi.org/10.3390/cells10040939</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10040939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10040939%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DThe%252BExpression%252BRegulation%252Band%252BBiological%252BFunction%252Bof%252BAutotaxin%26aulast%3DZhang%26aufirst%3DXiaotian%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D4%26spage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iris  Alroy</span>, <span class="hlFld-ContribAuthor ">Wissam  Mansour</span>, <span class="hlFld-ContribAuthor ">Mordehay  Klepfish</span>, <span class="hlFld-ContribAuthor ">Yoni  Sheinberger</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding small-molecule target space to mRNA translation regulation. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>26 </em>
                                    (3)
                                     , 786-793. <a href="https://doi.org/10.1016/j.drudis.2020.11.017" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.11.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.11.017%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DExpanding%252Bsmall-molecule%252Btarget%252Bspace%252Bto%252BmRNA%252Btranslation%252Bregulation%26aulast%3DAlroy%26aufirst%3DIris%26date%3D2021%26volume%3D26%26issue%3D3%26spage%3D786%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart  van Beusekom</span>, <span class="hlFld-ContribAuthor ">George  Damaskos</span>, <span class="hlFld-ContribAuthor ">Maarten L.  Hekkelman</span>, <span class="hlFld-ContribAuthor ">Fernando  Salgado-Polo</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Hiruma</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>, <span class="hlFld-ContribAuthor ">Robbie P.  Joosten</span>. </span><span class="cited-content_cbyCitation_article-title">LAHMA
              : structure analysis through local annotation of homology-matched amino acids. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Structural Biology</span><span> <strong>2021,</strong> <em>77 </em>
                                    (1)
                                     , 28-40. <a href="https://doi.org/10.1107/S2059798320014473" title="DOI URL">https://doi.org/10.1107/S2059798320014473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2059798320014473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2059798320014473%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Structural%2520Biology%26atitle%3DLAHMA%252B%25253A%252Bstructure%252Banalysis%252Bthrough%252Blocal%252Bannotation%252Bof%252Bhomology-matched%252Bamino%252Bacids%26aulast%3Dvan%2BBeusekom%26aufirst%3DBart%26date%3D2021%26date%3D2021%26volume%3D77%26issue%3D1%26spage%3D28%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Fang</span>, <span class="hlFld-ContribAuthor ">Jingya  Tian</span>, <span class="hlFld-ContribAuthor ">Yumei  Fan</span>, <span class="hlFld-ContribAuthor ">Pengxiu  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biology Reports</span><span> <strong>2020,</strong> <em>47 </em>
                                    (12)
                                     , 9811-9820. <a href="https://doi.org/10.1007/s11033-020-06000-6" title="DOI URL">https://doi.org/10.1007/s11033-020-06000-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11033-020-06000-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11033-020-06000-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biology%2520Reports%26atitle%3DLatest%252Bprogress%252Bon%252Bthe%252Bmolecular%252Bmechanisms%252Bof%252Bidiopathic%252Bpulmonary%252Bfibrosis%26aulast%3DFang%26aufirst%3DYue%26date%3D2020%26date%3D2020%26volume%3D47%26issue%3D12%26spage%3D9811%26epage%3D9820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang  Jia</span>, <span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Tong  Li</span>, <span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Zhi  Cao</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based linker exploration: Discovery of 1-ethyl-1H-indole analogs as novel ATX inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (22)
                                     , 115795. <a href="https://doi.org/10.1016/j.bmc.2020.115795" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115795%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Blinker%252Bexploration%25253A%252BDiscovery%252Bof%252B1-ethyl-1H-indole%252Banalogs%252Bas%252Bnovel%252BATX%252Binhibitors%26aulast%3DJia%26aufirst%3DFang%26date%3D2020%26volume%3D28%26issue%3D22%26spage%3D115795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiana  Magkrioti</span>, <span class="hlFld-ContribAuthor ">Eleanna  Kaffe</span>, <span class="hlFld-ContribAuthor ">Elli-Anna  Stylianaki</span>, <span class="hlFld-ContribAuthor ">Camelia  Sidahmet</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7002. <a href="https://doi.org/10.3390/ijms21197002" title="DOI URL">https://doi.org/10.3390/ijms21197002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197002%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BNovel%252BChemical%252BClasses%252Bof%252BAutotaxin%252BInhibitors%26aulast%3DMagkrioti%26aufirst%3DChristiana%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Changtao  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Yang</span>, <span class="hlFld-ContribAuthor ">Fang  Jia</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Minglin  Zhu</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Structure guided design of potent indole-based ATX inhibitors bearing hydrazone moiety with tumor suppression effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112456. <a href="https://doi.org/10.1016/j.ejmech.2020.112456" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112456%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Bguided%252Bdesign%252Bof%252Bpotent%252Bindole-based%252BATX%252Binhibitors%252Bbearing%252Bhydrazone%252Bmoiety%252Bwith%252Btumor%252Bsuppression%252Beffects%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2020%26volume%3D201%26spage%3D112456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Zhenhua  Guan</span>, <span class="hlFld-ContribAuthor ">Na  Dong</span>, <span class="hlFld-ContribAuthor ">Xueliang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A novel LC–MS/MS method for the determination of ziritaxestat in rat plasma and its pharmacokinetic study. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Chromatography</span><span> <strong>2020,</strong> <em>34 </em>
                                    (8)
                                     <a href="https://doi.org/10.1002/bmc.4863" title="DOI URL">https://doi.org/10.1002/bmc.4863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bmc.4863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbmc.4863%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Chromatography%26atitle%3DA%252Bnovel%252BLC%2525E2%252580%252593MS%25252FMS%252Bmethod%252Bfor%252Bthe%252Bdetermination%252Bof%252Bziritaxestat%252Bin%252Brat%252Bplasma%252Band%252Bits%252Bpharmacokinetic%252Bstudy%26aulast%3DChen%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanmin  Meng</span>, <span class="hlFld-ContribAuthor ">Melinda  Wuest</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Tang</span>, <span class="hlFld-ContribAuthor ">Jennifer  Dufour</span>, <span class="hlFld-ContribAuthor ">Todd P.W.  McMullen</span>, <span class="hlFld-ContribAuthor ">Frank  Wuest</span>, <span class="hlFld-ContribAuthor ">David  Murray</span>, <span class="hlFld-ContribAuthor ">David N.  Brindley</span>. </span><span class="cited-content_cbyCitation_article-title">Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 999. <a href="https://doi.org/10.3390/cancers12040999" title="DOI URL">https://doi.org/10.3390/cancers12040999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12040999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12040999%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDexamethasone%252BAttenuates%252BX-Ray-Induced%252BActivation%252Bof%252Bthe%252BAutotaxin-Lysophosphatidate-Inflammatory%252BCycle%252Bin%252BBreast%252BTissue%252Band%252BSubsequent%252BBreast%252BFibrosis%26aulast%3DMeng%26aufirst%3DGuanmin%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuyao  Huang</span>, <span class="hlFld-ContribAuthor ">Hui  Dong</span>, <span class="hlFld-ContribAuthor ">Bingbing  Li</span>, <span class="hlFld-ContribAuthor ">Wenhao  Hu</span>, <span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium catalyzed direct C3-ethoxycarbonylmethylation of imidazo[1,2-a]pyridines with ethyl diazoacetate. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (10)
                                     , 130998. <a href="https://doi.org/10.1016/j.tet.2020.130998" title="DOI URL">https://doi.org/10.1016/j.tet.2020.130998</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.130998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.130998%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRhodium%252Bcatalyzed%252Bdirect%252BC3-ethoxycarbonylmethylation%252Bof%252Bimidazo%25255B1%25252C2-a%25255Dpyridines%252Bwith%252Bethyl%252Bdiazoacetate%26aulast%3DHuang%26aufirst%3DQiuyao%26date%3D2020%26volume%3D76%26issue%3D10%26spage%3D130998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Xia  Ren</span>, <span class="hlFld-ContribAuthor ">Rui-Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1107. <a href="https://doi.org/10.3390/molecules25051107" title="DOI URL">https://doi.org/10.3390/molecules25051107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051107%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIdentifying%252BNovel%252BATX%252BInhibitors%252Bvia%252BCombinatory%252BVirtual%252BScreening%252BUsing%252BCrystallography-Derived%252BPharmacophore%252BModelling%25252C%252BDocking%252BStudy%25252C%252Band%252BQSAR%252BAnalysis%26aulast%3DRen%26aufirst%3DJi-Xia%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Liu</span>, <span class="hlFld-ContribAuthor ">Xu  Zheng</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Meng</span>, <span class="hlFld-ContribAuthor ">Huijun  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Sun</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (2)
                                     , 182-187. <a href="https://doi.org/10.1002/cmdc.201900606" title="DOI URL">https://doi.org/10.1002/cmdc.201900606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900606%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%252BPyrimidines%252Bas%252BMultitarget%252BProtein%252BTyrosine%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%252B%252528IPF%252529%26aulast%3DSun%26aufirst%3DBo%26date%3D2020%26date%3D2019%26volume%3D15%26issue%3D2%26spage%3D182%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keisuke  Yanagida</span>, <span class="hlFld-ContribAuthor ">William J.  Valentine</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable Lysophospholipid Signaling Pathways. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 137-176. <a href="https://doi.org/10.1007/978-3-030-50621-6_7" title="DOI URL">https://doi.org/10.1007/978-3-030-50621-6_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50621-6_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50621-6_7%26sid%3Dliteratum%253Aachs%26atitle%3DDruggable%252BLysophospholipid%252BSignaling%252BPathways%26aulast%3DYanagida%26aufirst%3DKeisuke%26date%3D2020%26date%3D2020%26spage%3D137%26epage%3D176%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDruggable%252BLipid%252BSignaling%252BPathways%26aulast%3DKihara%26aufirst%3DYasuyuki%26date%3D2020%26volume%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deron R.  Herr</span>, <span class="hlFld-ContribAuthor ">Wee Siong  Chew</span>, <span class="hlFld-ContribAuthor ">R. L.  Satish</span>, <span class="hlFld-ContribAuthor ">Wei-Yi  Ong</span>. </span><span class="cited-content_cbyCitation_article-title">Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2020,</strong> <em>57 </em>
                                    (1)
                                     , 372-392. <a href="https://doi.org/10.1007/s12035-019-01719-1" title="DOI URL">https://doi.org/10.1007/s12035-019-01719-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-019-01719-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-019-01719-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DPleotropic%252BRoles%252Bof%252BAutotaxin%252Bin%252Bthe%252BNervous%252BSystem%252BPresent%252BOpportunities%252Bfor%252Bthe%252BDevelopment%252Bof%252BNovel%252BTherapeutics%252Bfor%252BNeurological%252BDiseases%26aulast%3DHerr%26aufirst%3DDeron%2BR.%26date%3D2020%26date%3D2019%26volume%3D57%26issue%3D1%26spage%3D372%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanming  Zhu</span>, <span class="hlFld-ContribAuthor ">Xu  Zheng</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiuli  Sun</span>, <span class="hlFld-ContribAuthor ">Huijun  Sun</span>, <span class="hlFld-ContribAuthor ">Tengyue  Ma</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Lixue  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (2)
                                     , 115254. <a href="https://doi.org/10.1016/j.bmc.2019.115254" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115254%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bthieno%25255B3%25252C2-d%25255Dpyrimidines%252Bas%252Bpotent%252BJAK3%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bidiopathic%252Bpulmonary%252Bfibrosis%26aulast%3DZhu%26aufirst%3DYanming%26date%3D2020%26volume%3D28%26issue%3D2%26spage%3D115254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Tang</span>, <span class="hlFld-ContribAuthor ">Melinda  Wuest</span>, <span class="hlFld-ContribAuthor ">Matthew G.K.  Benesch</span>, <span class="hlFld-ContribAuthor ">Jennifer  Dufour</span>, <span class="hlFld-ContribAuthor ">YuanYuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Curtis</span>, <span class="hlFld-ContribAuthor ">Alain  Monjardet</span>, <span class="hlFld-ContribAuthor ">Bertrand  Heckmann</span>, <span class="hlFld-ContribAuthor ">David  Murray</span>, <span class="hlFld-ContribAuthor ">Frank  Wuest</span>, <span class="hlFld-ContribAuthor ">David N.  Brindley</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     , 63-74. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0386" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0386%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DInhibition%252Bof%252BAutotaxin%252Bwith%252BGLPG1690%252BIncreases%252Bthe%252BEfficacy%252Bof%252BRadiotherapy%252Band%252BChemotherapy%252Bin%252Ba%252BMouse%252BModel%252Bof%252BBreast%252BCancer%26aulast%3DTang%26aufirst%3DXiaoyun%26date%3D2020%26date%3D2019%26volume%3D19%26issue%3D1%26spage%3D63%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Zulfikar</span>, <span class="hlFld-ContribAuthor ">Sarah  Mulholland</span>, <span class="hlFld-ContribAuthor ">Huzaifa  Adamali</span>, <span class="hlFld-ContribAuthor ">Shaney L  Barratt</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives</p>. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology: Advances and Applications</span><span> <strong>2020,</strong> <em>Volume 12 </em>, 97-108. <a href="https://doi.org/10.2147/CPAA.S228362" title="DOI URL">https://doi.org/10.2147/CPAA.S228362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/CPAA.S228362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FCPAA.S228362%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%253A%2520Advances%2520and%2520Applications%26atitle%3D%25253Cp%25253EInhibitors%252Bof%252Bthe%252BAutotaxin-Lysophosphatidic%252BAcid%252BAxis%252Band%252BTheir%252BPotential%252Bin%252Bthe%252BTreatment%252Bof%252BInterstitial%252BLung%252BDisease%25253A%252BCurrent%252BPerspectives%25253C%25252Fp%25253E%26aulast%3DZulfikar%26aufirst%3DSabrina%26date%3D2020%26date%3D2020%26volume%3DVolume%252012%26spage%3D97%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Boltjes</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">The Groebke-Blackburn-Bienaymé Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (42)
                                     , 7007-7049. <a href="https://doi.org/10.1002/ejoc.201901124" title="DOI URL">https://doi.org/10.1002/ejoc.201901124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901124%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThe%252BGroebke-Blackburn-Bienaym%2525C3%2525A9%252BReaction%26aulast%3DBoltjes%26aufirst%3DAndr%25C3%25A9%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D42%26spage%3D7007%26epage%3D7049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sacha  Flammier</span>, <span class="hlFld-ContribAuthor ">Olivier  Peyruchaud</span>, <span class="hlFld-ContribAuthor ">Fanny  Bourguillault</span>, <span class="hlFld-ContribAuthor ">François  Duboeuf</span>, <span class="hlFld-ContribAuthor ">Jean‐Luc  Davignon</span>, <span class="hlFld-ContribAuthor ">Derek D.  Norman</span>, <span class="hlFld-ContribAuthor ">Sylvie  Isaac</span>, <span class="hlFld-ContribAuthor ">Hubert  Marotte</span>, <span class="hlFld-ContribAuthor ">Gabor  Tigyi</span>, <span class="hlFld-ContribAuthor ">Irma  Machuca‐Gayet</span>, <span class="hlFld-ContribAuthor ">Fabienne  Coury</span>. </span><span class="cited-content_cbyCitation_article-title">Osteoclast‐Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss. </span><span class="cited-content_cbyCitation_journal-name">Arthritis & Rheumatology</span><span> <strong>2019,</strong> <em>71 </em>
                                    (11)
                                     , 1801-1811. <a href="https://doi.org/10.1002/art.41005" title="DOI URL">https://doi.org/10.1002/art.41005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/art.41005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fart.41005%26sid%3Dliteratum%253Aachs%26jtitle%3DArthritis%2520%2526%2520Rheumatology%26atitle%3DOsteoclast%2525E2%252580%252590Derived%252BAutotaxin%25252C%252Ba%252BDistinguishing%252BFactor%252Bfor%252BInflammatory%252BBone%252BLoss%26aulast%3DFlammier%26aufirst%3DSacha%26date%3D2019%26date%3D2019%26volume%3D71%26issue%3D11%26spage%3D1801%26epage%3D1811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiana  Magkrioti</span>, <span class="hlFld-ContribAuthor ">Apostolos  Galaris</span>, <span class="hlFld-ContribAuthor ">Paraskevi  Kanellopoulou</span>, <span class="hlFld-ContribAuthor ">Elli-Anna  Stylianaki</span>, <span class="hlFld-ContribAuthor ">Eleanna  Kaffe</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Autotaxin and chronic inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Autoimmunity</span><span> <strong>2019,</strong> <em>104 </em>, 102327. <a href="https://doi.org/10.1016/j.jaut.2019.102327" title="DOI URL">https://doi.org/10.1016/j.jaut.2019.102327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jaut.2019.102327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jaut.2019.102327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Autoimmunity%26atitle%3DAutotaxin%252Band%252Bchronic%252Binflammatory%252Bdiseases%26aulast%3DMagkrioti%26aufirst%3DChristiana%26date%3D2019%26volume%3D104%26spage%3D102327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen  der Aar</span>, <span class="hlFld-ContribAuthor ">Julie  Desrivot</span>, <span class="hlFld-ContribAuthor ">Sonia  Dupont</span>, <span class="hlFld-ContribAuthor ">Bertrand  Heckmann</span>, <span class="hlFld-ContribAuthor ">Ann  Fieuw</span>, <span class="hlFld-ContribAuthor ">Simone  Stutvoet</span>, <span class="hlFld-ContribAuthor ">Liesbeth  Fagard</span>, <span class="hlFld-ContribAuthor ">Karen  Van de Wal</span>, <span class="hlFld-ContribAuthor ">Eric  Helmer</span>. </span><span class="cited-content_cbyCitation_article-title">Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Pharmacology</span><span> <strong>2019,</strong> <em>59 </em>
                                    (10)
                                     , 1366-1378. <a href="https://doi.org/10.1002/jcph.1424" title="DOI URL">https://doi.org/10.1002/jcph.1424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcph.1424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcph.1424%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DSafety%25252C%252BPharmacokinetics%25252C%252Band%252BPharmacodynamics%252Bof%252Bthe%252BAutotaxin%252BInhibitor%252BGLPG1690%252Bin%252BHealthy%252BSubjects%25253A%252BPhase%252B1%252BRandomized%252BTrials%26aulast%3Dder%2BAar%26aufirst%3DEllen%26date%3D2019%26date%3D2019%26volume%3D59%26issue%3D10%26spage%3D1366%26epage%3D1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Salgado-Polo</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>. </span><span class="cited-content_cbyCitation_article-title">The Structural Binding Mode of the Four Autotaxin Inhibitor Types that Differentially Affect Catalytic and Non-Catalytic Functions. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (10)
                                     , 1577. <a href="https://doi.org/10.3390/cancers11101577" title="DOI URL">https://doi.org/10.3390/cancers11101577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11101577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11101577%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BStructural%252BBinding%252BMode%252Bof%252Bthe%252BFour%252BAutotaxin%252BInhibitor%252BTypes%252Bthat%252BDifferentially%252BAffect%252BCatalytic%252Band%252BNon-Catalytic%252BFunctions%26aulast%3DSalgado-Polo%26aufirst%3DFernando%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Lv</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Shuli  Ma</span>, <span class="hlFld-ContribAuthor ">Zutao  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Current advances in idiopathic pulmonary fibrosis: the pathogenesis, therapeutic strategies and candidate molecules. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (19)
                                     , 2595-2620. <a href="https://doi.org/10.4155/fmc-2019-0111" title="DOI URL">https://doi.org/10.4155/fmc-2019-0111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0111%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Badvances%252Bin%252Bidiopathic%252Bpulmonary%252Bfibrosis%25253A%252Bthe%252Bpathogenesis%25252C%252Btherapeutic%252Bstrategies%252Band%252Bcandidate%252Bmolecules%26aulast%3DLv%26aufirst%3DMeng%26date%3D2019%26volume%3D11%26issue%3D19%26spage%3D2595%26epage%3D2620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Taneja</span>, <span class="hlFld-ContribAuthor ">Julie  Desrivot</span>, <span class="hlFld-ContribAuthor ">Paul Matthias  Diderichsen</span>, <span class="hlFld-ContribAuthor ">Roland  Blanqué</span>, <span class="hlFld-ContribAuthor ">Lisa  Allamasey</span>, <span class="hlFld-ContribAuthor ">Liesbeth  Fagard</span>, <span class="hlFld-ContribAuthor ">Ann  Fieuw</span>, <span class="hlFld-ContribAuthor ">Ellen  Van der Aar</span>, <span class="hlFld-ContribAuthor ">Florence  Namour</span>. </span><span class="cited-content_cbyCitation_article-title">Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2019,</strong> <em>58 </em>
                                    (9)
                                     , 1175-1191. <a href="https://doi.org/10.1007/s40262-019-00755-3" title="DOI URL">https://doi.org/10.1007/s40262-019-00755-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-019-00755-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-019-00755-3%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DPopulation%252BPharmacokinetic%252Band%252BPharmacodynamic%252BAnalysis%252Bof%252BGLPG1690%25252C%252Ban%252BAutotaxin%252BInhibitor%25252C%252Bin%252BHealthy%252BVolunteers%252Band%252BPatients%252Bwith%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DTaneja%26aufirst%3DAmit%26date%3D2019%26date%3D2019%26volume%3D58%26issue%3D9%26spage%3D1175%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myeong Hwi  Lee</span>, <span class="hlFld-ContribAuthor ">Dae-Yon  Lee</span>, <span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Jong-Woo  Jeong</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophoric Site Identification and Inhibitor Design for Autotaxin. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (15)
                                     , 2808. <a href="https://doi.org/10.3390/molecules24152808" title="DOI URL">https://doi.org/10.3390/molecules24152808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24152808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24152808%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPharmacophoric%252BSite%252BIdentification%252Band%252BInhibitor%252BDesign%252Bfor%252BAutotaxin%26aulast%3DLee%26aufirst%3DMyeong%2BHwi%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D15%26spage%3D2808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 976-1013. <a href="https://doi.org/10.1002/med.21551" title="DOI URL">https://doi.org/10.1002/med.21551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21551%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDevelopment%252Band%252Btherapeutic%252Bpotential%252Bof%252Bautotaxin%252Bsmall%252Bmolecule%252Binhibitors%25253A%252BFrom%252Bbench%252Bto%252Badvanced%252Bclinical%252Btrials%26aulast%3DMatralis%26aufirst%3DAlexios%2BN.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D976%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Richeldi</span>, <span class="hlFld-ContribAuthor ">Fabiana  Baldi</span>, <span class="hlFld-ContribAuthor ">Giuliana  Pasciuto</span>, <span class="hlFld-ContribAuthor ">Francesco  Macagno</span>, <span class="hlFld-ContribAuthor ">Loredana  Panico</span>. </span><span class="cited-content_cbyCitation_article-title">Current and Future Idiopathic Pulmonary Fibrosis Therapy. </span><span class="cited-content_cbyCitation_journal-name">The American Journal of the Medical Sciences</span><span> <strong>2019,</strong> <em>357 </em>
                                    (5)
                                     , 370-373. <a href="https://doi.org/10.1016/j.amjms.2019.02.006" title="DOI URL">https://doi.org/10.1016/j.amjms.2019.02.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.amjms.2019.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.amjms.2019.02.006%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520American%2520Journal%2520of%2520the%2520Medical%2520Sciences%26atitle%3DCurrent%252Band%252BFuture%252BIdiopathic%252BPulmonary%252BFibrosis%252BTherapy%26aulast%3DRicheldi%26aufirst%3DLuca%26date%3D2019%26volume%3D357%26issue%3D5%26spage%3D370%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toby M  Maher</span>, <span class="hlFld-ContribAuthor ">Michael  Kreuter</span>, <span class="hlFld-ContribAuthor ">David J  Lederer</span>, <span class="hlFld-ContribAuthor ">Kevin K  Brown</span>, <span class="hlFld-ContribAuthor ">Wim  Wuyts</span>, <span class="hlFld-ContribAuthor ">Nadia  Verbruggen</span>, <span class="hlFld-ContribAuthor ">Simone  Stutvoet</span>, <span class="hlFld-ContribAuthor ">Ann  Fieuw</span>, <span class="hlFld-ContribAuthor ">Paul  Ford</span>, <span class="hlFld-ContribAuthor ">Walid  Abi-Saab</span>, <span class="hlFld-ContribAuthor ">Marlies  Wijsenbeek</span>. </span><span class="cited-content_cbyCitation_article-title">Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2). </span><span class="cited-content_cbyCitation_journal-name">BMJ Open Respiratory Research</span><span> <strong>2019,</strong> <em>6 </em>
                                    (1)
                                     , e000422. <a href="https://doi.org/10.1136/bmjresp-2019-000422" title="DOI URL">https://doi.org/10.1136/bmjresp-2019-000422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/bmjresp-2019-000422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fbmjresp-2019-000422%26sid%3Dliteratum%253Aachs%26jtitle%3DBMJ%2520Open%2520Respiratory%2520Research%26atitle%3DRationale%25252C%252Bdesign%252Band%252Bobjectives%252Bof%252Btwo%252Bphase%252BIII%25252C%252Brandomised%25252C%252Bplacebo-controlled%252Bstudies%252Bof%252BGLPG1690%25252C%252Ba%252Bnovel%252Bautotaxin%252Binhibitor%25252C%252Bin%252Bidiopathic%252Bpulmonary%252Bfibrosis%252B%252528ISABELA%252B1%252Band%252B2%252529%26aulast%3DMaher%26aufirst%3DToby%2BM%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D1%26spage%3De000422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuliana  Pasciuto</span>, <span class="hlFld-ContribAuthor ">Riccardo  Inchingolo</span>, <span class="hlFld-ContribAuthor ">Carola  Condoluci</span>, <span class="hlFld-ContribAuthor ">Daniele  Magnini</span>, <span class="hlFld-ContribAuthor ">Bruno  Iovene</span>, <span class="hlFld-ContribAuthor ">Luca  Richeldi</span>. </span><span class="cited-content_cbyCitation_article-title">Approved and Experimental Therapies for Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Current Pulmonology Reports</span><span> <strong>2018,</strong> <em>7 </em>
                                    (4)
                                     , 107-117. <a href="https://doi.org/10.1007/s13665-018-0209-0" title="DOI URL">https://doi.org/10.1007/s13665-018-0209-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13665-018-0209-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13665-018-0209-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pulmonology%2520Reports%26atitle%3DApproved%252Band%252BExperimental%252BTherapies%252Bfor%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DPasciuto%26aufirst%3DGiuliana%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D4%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Rindlisbacher</span>, <span class="hlFld-ContribAuthor ">Cornelia  Schmid</span>, <span class="hlFld-ContribAuthor ">Thomas  Geiser</span>, <span class="hlFld-ContribAuthor ">Cédric  Bovet</span>, <span class="hlFld-ContribAuthor ">Manuela  Funke-Chambour</span>. </span><span class="cited-content_cbyCitation_article-title">Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC. </span><span class="cited-content_cbyCitation_journal-name">Respiratory Research</span><span> <strong>2018,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12931-018-0714-2" title="DOI URL">https://doi.org/10.1186/s12931-018-0714-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12931-018-0714-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12931-018-0714-2%26sid%3Dliteratum%253Aachs%26jtitle%3DRespiratory%2520Research%26atitle%3DSerum%252Bmetabolic%252Bprofiling%252Bidentified%252Ba%252Bdistinct%252Bmetabolic%252Bsignature%252Bin%252Bpatients%252Bwith%252Bidiopathic%252Bpulmonary%252Bfibrosis%252B%2525E2%252580%252593%252Ba%252Bpotential%252Bbiomarker%252Brole%252Bfor%252BLysoPC%26aulast%3DRindlisbacher%26aufirst%3DBarbara%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioanna  Ninou</span>, <span class="hlFld-ContribAuthor ">Eleanna  Kaffe</span>, <span class="hlFld-ContribAuthor ">Stefan  Müller</span>, <span class="hlFld-ContribAuthor ">David C.  Budd</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Stevenson</span>, <span class="hlFld-ContribAuthor ">Christoph  Ullmer</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Pulmonary Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>52 </em>, 32-40. <a href="https://doi.org/10.1016/j.pupt.2018.08.003" title="DOI URL">https://doi.org/10.1016/j.pupt.2018.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pupt.2018.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pupt.2018.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DPulmonary%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DPharmacologic%252Btargeting%252Bof%252Bthe%252BATX%25252FLPA%252Baxis%252Battenuates%252Bbleomycin-induced%252Bpulmonary%252Bfibrosis%26aulast%3DNinou%26aufirst%3DIoanna%26date%3D2018%26volume%3D52%26spage%3D32%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Salgado-Polo</span>, <span class="hlFld-ContribAuthor ">Alex  Fish</span>, <span class="hlFld-ContribAuthor ">Minos-Timotheos  Matsoukas</span>, <span class="hlFld-ContribAuthor ">Tatjana  Heidebrecht</span>, <span class="hlFld-ContribAuthor ">Willem-Jan  Keune</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (37)
                                     , 14312-14327. <a href="https://doi.org/10.1074/jbc.RA118.004450" title="DOI URL">https://doi.org/10.1074/jbc.RA118.004450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.004450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.004450%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DLysophosphatidic%252Bacid%252Bproduced%252Bby%252Bautotaxin%252Bacts%252Bas%252Ban%252Ballosteric%252Bmodulator%252Bof%252Bits%252Bcatalytic%252Befficiency%26aulast%3DSalgado-Polo%26aufirst%3DFernando%26date%3D2018%26volume%3D293%26issue%3D37%26spage%3D14312%26epage%3D14327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toby M  Maher</span>, <span class="hlFld-ContribAuthor ">Ellen M  van der Aar</span>, <span class="hlFld-ContribAuthor ">Olivier  Van de Steen</span>, <span class="hlFld-ContribAuthor ">Lisa  Allamassey</span>, <span class="hlFld-ContribAuthor ">Julie  Desrivot</span>, <span class="hlFld-ContribAuthor ">Sonia  Dupont</span>, <span class="hlFld-ContribAuthor ">Liesbeth  Fagard</span>, <span class="hlFld-ContribAuthor ">Paul  Ford</span>, <span class="hlFld-ContribAuthor ">Ann  Fieuw</span>, <span class="hlFld-ContribAuthor ">Wim  Wuyts</span>. </span><span class="cited-content_cbyCitation_article-title">Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Respiratory Medicine</span><span> <strong>2018,</strong> <em>6 </em>
                                    (8)
                                     , 627-635. <a href="https://doi.org/10.1016/S2213-2600(18)30181-4" title="DOI URL">https://doi.org/10.1016/S2213-2600(18)30181-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S2213-2600(18)30181-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS2213-2600%2818%2930181-4%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Respiratory%2520Medicine%26atitle%3DSafety%25252C%252Btolerability%25252C%252Bpharmacokinetics%25252C%252Band%252Bpharmacodynamics%252Bof%252BGLPG1690%25252C%252Ba%252Bnovel%252Bautotaxin%252Binhibitor%25252C%252Bto%252Btreat%252Bidiopathic%252Bpulmonary%252Bfibrosis%252B%252528FLORA%252529%25253A%252Ba%252Bphase%252B2a%252Brandomised%252Bplacebo-controlled%252Btrial%26aulast%3DMaher%26aufirst%3DToby%2BM%26date%3D2018%26volume%3D6%26issue%3D8%26spage%3D627%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasaman  Ramazani</span>, <span class="hlFld-ContribAuthor ">Noël  Knops</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Elmonem</span>, <span class="hlFld-ContribAuthor ">Tri Q.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Fanny Oliveira  Arcolino</span>, <span class="hlFld-ContribAuthor ">Lambert  van den Heuvel</span>, <span class="hlFld-ContribAuthor ">Elena  Levtchenko</span>, <span class="hlFld-ContribAuthor ">Dirk  Kuypers</span>, <span class="hlFld-ContribAuthor ">Roel  Goldschmeding</span>. </span><span class="cited-content_cbyCitation_article-title">Connective tissue growth factor (CTGF) from basics to clinics. </span><span class="cited-content_cbyCitation_journal-name">Matrix Biology</span><span> <strong>2018,</strong> <em>68-69 </em>, 44-66. <a href="https://doi.org/10.1016/j.matbio.2018.03.007" title="DOI URL">https://doi.org/10.1016/j.matbio.2018.03.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.matbio.2018.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.matbio.2018.03.007%26sid%3Dliteratum%253Aachs%26jtitle%3DMatrix%2520Biology%26atitle%3DConnective%252Btissue%252Bgrowth%252Bfactor%252B%252528CTGF%252529%252Bfrom%252Bbasics%252Bto%252Bclinics%26aulast%3DRamazani%26aufirst%3DYasaman%26date%3D2018%26volume%3D68-69%26spage%3D44%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher G.  Thomson</span>, <span class="hlFld-ContribAuthor ">Darren  Le Grand</span>, <span class="hlFld-ContribAuthor ">Mark  Dowling</span>, <span class="hlFld-ContribAuthor ">Cara E.  Brocklehurst</span>, <span class="hlFld-ContribAuthor ">Colin  Chinn</span>, <span class="hlFld-ContribAuthor ">Lucy  Elphick</span>, <span class="hlFld-ContribAuthor ">Michael  Faller</span>, <span class="hlFld-ContribAuthor ">Mark  Freeman</span>, <span class="hlFld-ContribAuthor ">Vikki  Furminger</span>, <span class="hlFld-ContribAuthor ">Cornelia  Gasser</span>, <span class="hlFld-ContribAuthor ">Ahmed  Hamadi</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Hardaker</span>, <span class="hlFld-ContribAuthor ">Victoria  Head</span>, <span class="hlFld-ContribAuthor ">Johan C.  Hill</span>, <span class="hlFld-ContribAuthor ">Diana I.  Janus</span>, <span class="hlFld-ContribAuthor ">David  Pearce</span>, <span class="hlFld-ContribAuthor ">Anne-Sophie  Poulaud</span>, <span class="hlFld-ContribAuthor ">Emily  Stanley</span>, <span class="hlFld-ContribAuthor ">Lilya  Sviridenko</span>. </span><span class="cited-content_cbyCitation_article-title">Development of autotaxin inhibitors: A series of zinc binding triazoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (13)
                                     , 2279-2284. <a href="https://doi.org/10.1016/j.bmcl.2018.05.030" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bautotaxin%252Binhibitors%25253A%252BA%252Bseries%252Bof%252Bzinc%252Bbinding%252Btriazoles%26aulast%3DThomson%26aufirst%3DChristopher%2BG.%26date%3D2018%26volume%3D28%26issue%3D13%26spage%3D2279%26epage%3D2284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioanna  Ninou</span>, <span class="hlFld-ContribAuthor ">Christiana  Magkrioti</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Autotaxin in Pathophysiology and Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Medicine</span><span> <strong>2018,</strong> <em>5 </em><a href="https://doi.org/10.3389/fmed.2018.00180" title="DOI URL">https://doi.org/10.3389/fmed.2018.00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmed.2018.00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmed.2018.00180%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Medicine%26atitle%3DAutotaxin%252Bin%252BPathophysiology%252Band%252BPulmonary%252BFibrosis%26aulast%3DNinou%26aufirst%3DIoanna%26date%3D2018%26date%3D2018%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiyun  Sun</span>, <span class="hlFld-ContribAuthor ">Huaibin  Ge</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Zhen</span>, <span class="hlFld-ContribAuthor ">Xuechan  An</span>, <span class="hlFld-ContribAuthor ">Guangtao  Zhang</span>, <span class="hlFld-ContribAuthor ">Daisy  Zhang-Negrerie</span>, <span class="hlFld-ContribAuthor ">Yunfei  Du</span>, <span class="hlFld-ContribAuthor ">Kang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">TBHP/AIBN-Mediated Synthesis of 2-Amino-thioazoles from Active Methylene Ketones and Thiourea under Metal-free Conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (17)
                                     , 2107-2114. <a href="https://doi.org/10.1016/j.tet.2018.02.064" title="DOI URL">https://doi.org/10.1016/j.tet.2018.02.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.02.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.02.064%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DTBHP%25252FAIBN-Mediated%252BSynthesis%252Bof%252B2-Amino-thioazoles%252Bfrom%252BActive%252BMethylene%252BKetones%252Band%252BThiourea%252Bunder%252BMetal-free%252BConditions%26aulast%3DSun%26aufirst%3DJiyun%26date%3D2018%26volume%3D74%26issue%3D17%26spage%3D2107%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Myeong Hwi  Lee</span>, <span class="hlFld-ContribAuthor ">Sangeun  Chae</span>, <span class="hlFld-ContribAuthor ">Eunmi  Jung</span>, <span class="hlFld-ContribAuthor ">Woosub  Yoon</span>, <span class="hlFld-ContribAuthor ">Yunki  Kim</span>, <span class="hlFld-ContribAuthor ">So Jung  Son</span>, <span class="hlFld-ContribAuthor ">Jeonghee  Ryu</span>, <span class="hlFld-ContribAuthor ">Dae-Hyuck  Kang</span>, <span class="hlFld-ContribAuthor ">Young-Jae  Yang</span>, <span class="hlFld-ContribAuthor ">Ji-Na  You</span>, <span class="hlFld-ContribAuthor ">Hyunjin  Kwon</span>, <span class="hlFld-ContribAuthor ">Jong-Woo  Jeong</span>, <span class="hlFld-ContribAuthor ">Tae-Sung  Koo</span>, <span class="hlFld-ContribAuthor ">Dae-Yon  Lee</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>148 </em>, 397-409. <a href="https://doi.org/10.1016/j.ejmech.2018.02.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252BATX%252Binhibitors%252Bvia%252Bmodeling%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DBalupuri%26aufirst%3DAnand%26date%3D2018%26volume%3D148%26spage%3D397%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Benesch</span>, <span class="hlFld-ContribAuthor ">Iain  MacIntyre</span>, <span class="hlFld-ContribAuthor ">Todd  McMullen</span>, <span class="hlFld-ContribAuthor ">David  Brindley</span>. </span><span class="cited-content_cbyCitation_article-title">Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (3)
                                     , 73. <a href="https://doi.org/10.3390/cancers10030073" title="DOI URL">https://doi.org/10.3390/cancers10030073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10030073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10030073%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DComing%252Bof%252BAge%252Bfor%252BAutotaxin%252Band%252BLysophosphatidate%252BSignaling%25253A%252BClinical%252BApplications%252Bfor%252BPreventing%25252C%252BDetecting%252Band%252BTargeting%252BTumor-Promoting%252BInflammation%26aulast%3DBenesch%26aufirst%3DMatthew%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D3%26spage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 243-262. <a href="https://doi.org/10.1016/B978-0-08-102788-2.00009-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-102788-2.00009-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102788-2.00009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102788-2.00009-X%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2018%26spage%3D243%26epage%3D262%26pub%3DElsevier%26date%3D2018%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga A  Storozhenko</span>, <span class="hlFld-ContribAuthor ">Alexey A  Festa</span>, <span class="hlFld-ContribAuthor ">Delphine R  Bella Ndoutoume</span>, <span class="hlFld-ContribAuthor ">Alexander V  Aksenov</span>, <span class="hlFld-ContribAuthor ">Alexey V  Varlamov</span>, <span class="hlFld-ContribAuthor ">Leonid G  Voskressensky</span>. </span><span class="cited-content_cbyCitation_article-title">Mn-mediated sequential three-component domino Knoevenagel/cyclization/Michael addition/oxidative cyclization reaction towards annulated imidazo[1,2-
              a
              ]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 3078-3087. <a href="https://doi.org/10.3762/bjoc.14.287" title="DOI URL">https://doi.org/10.3762/bjoc.14.287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.287%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMn-mediated%252Bsequential%252Bthree-component%252Bdomino%252BKnoevenagel%25252Fcyclization%25252FMichael%252Baddition%25252Foxidative%252Bcyclization%252Breaction%252Btowards%252Bannulated%252Bimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%26aulast%3DStorozhenko%26aufirst%3DOlga%2BA%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D3078%26epage%3D3087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Dae-Yon  Lee</span>, <span class="hlFld-ContribAuthor ">Myeong Hwi  Lee</span>, <span class="hlFld-ContribAuthor ">Sangeun  Chae</span>, <span class="hlFld-ContribAuthor ">Eunmi  Jung</span>, <span class="hlFld-ContribAuthor ">Yunki  Kim</span>, <span class="hlFld-ContribAuthor ">Jeonghee  Ryu</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (17)
                                     , 4156-4164. <a href="https://doi.org/10.1016/j.bmcl.2017.07.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bdocking%252Band%252Bbiological%252Bevaluation%252Bof%252B4-phenyl-thiazole%252Bderivatives%252Bas%252Bautotaxin%252B%252528ATX%252529%252Binhibitors%26aulast%3DBalupuri%26aufirst%3DAnand%26date%3D2017%26volume%3D27%26issue%3D17%26spage%3D4156%26epage%3D4164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia Anahi  Valdés-Rives</span>, <span class="hlFld-ContribAuthor ">Aliesha  González-Arenas</span>. </span><span class="cited-content_cbyCitation_article-title">Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development. </span><span class="cited-content_cbyCitation_journal-name">Mediators of Inflammation</span><span> <strong>2017,</strong> <em>2017 </em>, 1-15. <a href="https://doi.org/10.1155/2017/9173090" title="DOI URL">https://doi.org/10.1155/2017/9173090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2017/9173090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2017%2F9173090%26sid%3Dliteratum%253Aachs%26jtitle%3DMediators%2520of%2520Inflammation%26atitle%3DAutotaxin-Lysophosphatidic%252BAcid%25253A%252BFrom%252BInflammation%252Bto%252BCancer%252BDevelopment%26aulast%3DVald%25C3%25A9s-Rives%26aufirst%3DSilvia%2BAnahi%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conversion of LPC into LPA by ATX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hit series and lead compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Formation and Trapping of Reactive Metabolite on Imidazo[1,2-<i>a</i>]pyridine Scaffold</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural modifications from <b>1</b> to <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) EtCHO, benzotriazole, toluene, rt, then KCN, EtOH, rt to 80 °C, (2) AcCl, EtOH, rt, 29%; (b) HCO<sub>2</sub>H, 80 °C, 95%; (c) K<sub>2</sub>CO<sub>3</sub>, MeI, acetone, 80 °C, 93%; (d) HCl, MeOH, 80 °C, 98%; (e) (1) NaH, THF, reflux, (2) <b>17</b>, 40 °C to reflux, 73%; (f) boc-piperazine, <sup><i>t</i></sup>BuONa, Pd<sub>2</sub>dba<sub>3</sub>, JohnPhos, toluene, 115 °C, 82%; (g) HCl, MeOH, rt, 90%; (h) <b>18</b>, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, 81%; (i) pyridine, thiourea, iodine, EtOH, 70 °C to rt, 65%; (j) CuCl<sub>2</sub>, <sup><i>t</i></sup>BuONO, MeCN, rt, 62%; (k) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DCM, rt, 70%.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Overlay of binding modes of compounds <b>11</b> (carbon atoms in light green) and <b>19</b> (carbon atoms in gray). The binding site carbon atoms and local backbone structures of ATX are depicted in dark green or gray. The two zinc atoms of the catalytic site are depicted in magenta in CPK mode. For clarity, the binding site surface has been clipped vertically. (B) Binding mode of compound <b>11</b> cocrystallized with human ATX. Protein–ligand interactions are represented by dashed lines (hydrogen bond in green, cation−π interaction in orange, and hydrophobic contacts in pink). The surface is colored by residue hydrophobicity (from brown for hydrophobic to blue for hydrophilic). For clarity, the surface has been clipped vertically.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mean (±SEM) plasma exposure of <b>11</b> and LPA 18:2 reduction after single oral doses of 3, 10, and 30 mg/kg in mice (<i>n</i> = 3). Plasma exposure of <b>11</b> and LPA 18:2 reduction levels are represented by dashed lines and solid lines, respectively. The horizontal black line corresponds to the IC<sub>50</sub> (ng/mL) of <b>11</b> determined in the mouse plasma assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Activity of compounds in mouse BLM model: Ashcroft score (Matsuse’s modification) at day 21. The efficacy of pirfenidone and compound <b>11</b> was compared to that of PBS-challenged and BLM-challenged groups that received vehicle as treatment. Total score for each animal was calculated as mean of the score obtained for 10 low-power fields selected from the whole pulmonary area. Data are represented as group median: (∗) <i>p</i> < 0.05 vs BLM-vehicle control; (+) <i>p</i> < 0.05 vs BLM-pirfenidone; nonparametric Mann–Whitney test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/medium/jm-2017-000325_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Analysis of LPA 18:2 in BALF of PBS-challenged mice (<i>n</i> = 9) or BLM-challenged mice treated either with vehicle (<i>n</i> = 6) or compound <b>11</b> (30 mg/kg twice daily, <i>n</i> = 7) for 21 days. BALF was collected 2 h after administration of either vehicle or compound <b>11</b>: mean ± SEM, (∗∗∗) <i>p</i> < 0.001 versus BLM-vehicle by one-way ANOVA followed by Dunnett’s multiple comparisons test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-9/acs.jmedchem.7b00032/20170505/images/large/jm-2017-000325_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00032&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakanaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span> </span><span class="NLM_article-title">Autotaxin-an LPA producing enzyme with diverse functions</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1093/jb/mvq052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1093%2Fjb%2Fmvq052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=20495010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=13-24&author=K.+Nakanagaauthor=K.+Hamaauthor=J.+Aoki&title=Autotaxin-an+LPA+producing+enzyme+with+diverse+functions&doi=10.1093%2Fjb%2Fmvq052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-an LPA producing enzyme with diverse functions</span></div><div class="casAuthors">Nakanaga, Keita; Hama, Kotaro; Aoki, Junken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is an ecto-enzyme responsible for lysophosphatidic acid (LPA) prodn. in blood.  ATX is present in various biol. fluids such as cerebrospinal and seminal fluids and accounts for bulk LPA prodn. in these fluids.  ATX is a member of the nucleotide pyrophosphatase/phosphodiesterase (NPP) family and was originally isolated from conditioned medium of melanoma cells as an autocrine motility stimulating factor.  LPA, a second-generation lipid mediator, binds to its cognate G protein-coupled receptors through which it exerts a no. of biol. functions including influencing cell motility and proliferation stimulating activity.  Some of the biol. roles of LPA can be mediated by ATX.  However, there are other LPA-producing pathways independent of ATX.  The accumulating evidences for physiol. and pathol. functions of ATX strongly support that ATX is an important therapeutic target.  This review summarizes the historical aspects, structural basis, pathophysiol. functions identified in mice studies and clin. relevance discovered by measuring the blood ATX level in human.  The general features and functions of each NPP family member will be also briefly reviewed.  The presence of the ATX gene in other model organisms and recently developed ATX inhibitors, both of which will be definitely useful for further functional anal. of ATX, will also be mentioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd2JaqHS4pL7Vg90H21EOLACvtfcHk0liD3h49u2n0FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D&md5=584a80ff7d28d8bdec20ff6615897a25</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvq052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvq052%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DK.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26atitle%3DAutotaxin-an%2520LPA%2520producing%2520enzyme%2520with%2520diverse%2520functions%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D148%26spage%3D13%26epage%3D24%26doi%3D10.1093%2Fjb%2Fmvq052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">Autotaxin: structure-function and signaling</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span><span class="refDoi"> DOI: 10.1194/jlr.R046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1194%2Fjlr.R046391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24548887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1010-1018&author=A.+Perrakisauthor=W.+H.+Moolenaar&title=Autotaxin%3A+structure-function+and+signaling&doi=10.1194%2Fjlr.R046391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin: structure-function and signaling</span></div><div class="casAuthors">Perrakis, Anastassis; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase-2, is a secreted lysophospholipase D (lysoPLD) that hydrolyzes extracellular lysophospholipids into the lipid mediator lysophosphatidic acid (LPA), a ligand for specific G protein-coupled receptors.  ATX-LPA signaling is essential for development and has been implicated in a great diversity of (patho)physiol. processes, ranging from lymphocyte homing to tumor progression.  Structural and functional studies have revealed what makes ATX a unique lysoPLD, and how secreted ATX binds to its target cells.  The ATX catalytic domain shows a characteristic bimetallic active site followed by a shallow binding groove that can accommodate nucleotides as well as the glycerol moiety of lysophospholipids, and by a deep lipid-binding pocket.  In addn., the catalytic domain has an open tunnel of unknown function adjacent to the active site.  Here, the authors discuss the authors' current understanding of ATX structure-function relationships and signaling mechanisms, and how ATX isoforms use distinct mechanisms to target LPA prodn. to the plasma membrane, notably binding to integrins and heparan sulfate proteoglycans.  The authors also briefly discuss the development of drug-like inhibitors of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVdFme7XRfLVg90H21EOLACvtfcHk0liD3h49u2n0FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D&md5=d4813d9b7b37541e5e8ae739cebddc09</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046391%26sid%3Dliteratum%253Aachs%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DAutotaxin%253A%2520structure-function%2520and%2520signaling%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1010%26epage%3D1018%26doi%3D10.1194%2Fjlr.R046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bandoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/S0014-5793(00)01827-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2FS0014-5793%2800%2901827-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2000&pages=159-165&author=K.+Bandohauthor=J.+Aokiauthor=A.+Tairaauthor=M.+Tsujimotoauthor=H.+Araiauthor=K.+Inoue&title=Lysophosphatidic+acid+%28LPA%29+receptors+of+the+EDG+family+are+differentially+activated+by+LPA+species&doi=10.1016%2FS0014-5793%2800%2901827-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2800%2901827-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252800%252901827-5%26sid%3Dliteratum%253Aachs%26aulast%3DBandoh%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DTaira%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%2520of%2520the%2520EDG%2520family%2520are%2520differentially%2520activated%2520by%2520LPA%2520species%26jtitle%3DFEBS%2520Lett.%26date%3D2000%26volume%3D478%26spage%3D159%26epage%3D165%26doi%3D10.1016%2FS0014-5793%2800%2901827-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1016/j.prostaglandins.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.prostaglandins.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=20331961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=130-138&author=M.+E.+Linauthor=D.+R.+Herrauthor=J.+Chun&title=Lysophosphatidic+acid+%28LPA%29+receptors%3A+Signaling+properties+and+disease+relevance&doi=10.1016%2Fj.prostaglandins.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span></div><div class="casAuthors">Lin, Mu-En; Herr, Deron R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a water-sol. phospholipid, has gained significant attention in recent years since the discovery that it acts as a potent signaling mol. with wide-ranging effects on many different target tissues.  There are currently five identified G protein-coupled receptors for LPA and more are undergoing validation.  The complexity of the expression pattern and signaling properties of LPA receptors results in multiple influences on developmental, physiol., and pathol. processes.  This review provides a summary of LPA receptor signaling and current views on the potential involvement of this pathway in human diseases that include cardiovascular, cancer, neuropathic pain, neuropsychiatric disorders, reproductive disorders, and fibrosis.  The involvement of LPA signaling in these processes implicates multiple, potential drug targets including LPA receptor subtypes and LPA metabolizing enzymes.  Modulation of LPA signaling may thus provide therapeutic inroads for the treatment of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIqNSV9ngb7Vg90H21EOLACvtfcHk0lj7zwyysseDBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D&md5=097555859468db9673c1ccf9ea8c2a60</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%253A%2520Signaling%2520properties%2520and%2520disease%2520relevance%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D130%26epage%3D138%26doi%3D10.1016%2Fj.prostaglandins.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span> <span class="citation_source-journal">Biomol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.4062/biomolther.2014.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.4062%2Fbiomolther.2014.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1-11&author=N.+C.+Stoddardauthor=J.+Chun&title=Promising+pharmacological+directions+in+the+world+of+lysophosphatidic+acid+signaling&doi=10.4062%2Fbiomolther.2014.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span></div><div class="casAuthors">Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BTIHA3</span>;
        ISSN:<span class="NLM_cas:issn">1976-9148</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a signaling lipid that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6.  These receptors initiate signaling cascades relevant to development, maintenance, and healing processes throughout the body.  The diversity and specificity of LPA signaling, esp. in relation to cancer and autoimmune disorders, makes LPA receptor modulation an attractive target for drug development.  Several LPAR-specific analogs and small mols. have been synthesized and are efficacious in attenuating pathol. in disease models.  To date, at least three compds. have passed phase I and phase II clin. trials for idiopathic pulmonary fibrosis and systemic sclerosis.  This review focuses on the promising therapeutic directions emerging in LPA signaling toward ameliorating several diseases, including cancer, fibrosis, arthritis, hydrocephalus, and traumatic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEf1nGhuRyPrVg90H21EOLACvtfcHk0lj7zwyysseDBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D&md5=53d877ee381f9363918850f0b499bb11</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.4062%2Fbiomolther.2014.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4062%252Fbiomolther.2014.109%26sid%3Dliteratum%253Aachs%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DPromising%2520pharmacological%2520directions%2520in%2520the%2520world%2520of%2520lysophosphatidic%2520acid%2520signaling%26jtitle%3DBiomol.%2520Ther.%26date%3D2015%26volume%3D23%26spage%3D1%26epage%3D11%26doi%3D10.4062%2Fbiomolther.2014.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="note"><p class="first last">Reviews:</p></div><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Chemical evolution of autotaxin inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span><span class="refDoi"> DOI: 10.1021/cr2003213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2003213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=2593-2603&author=H.+M.+H.+G.+Albersauthor=H.+Ovaa&title=Chemical+evolution+of+autotaxin+inhibitors&doi=10.1021%2Fcr2003213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fcr2003213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2003213%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DChemical%2520evolution%2520of%2520autotaxin%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D2593%26epage%3D2603%26doi%3D10.1021%2Fcr2003213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barbayianni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrioti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutevelis-Minakakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokotos, G.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1517/13543776.2013.796364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1517%2F13543776.2013.796364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=23641951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1123-1132&author=E.+Barbayianniauthor=V.+Magriotiauthor=P.+Moutevelis-Minakakisauthor=G.+Kokotos&title=Autotaxin+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2013.796364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin inhibitors: a patent review</span></div><div class="casAuthors">Barbayianni, Efrosini; Magrioti, Victoria; Moutevelis-Minakakis, Panagiota; Kokotos, George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1123-1132</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Autotaxin (ATX) is a lysophospholipase D enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA) and choline.  LPA is a bioactive lipid mediator that activates several transduction pathways, and is involved in migration, proliferation and survival of various cells.  Thus, ATX is an attractive medicinal target.  Areas covered: The aim of this review is to summarize ATX inhibitors, reported in patents from 2006 up to now, describing their discovery and biol. evaluation.  Expert opinion: ATX has been implicated in various pathol. conditions, such as cancer, chronic inflammation, neuropathic pain, fibrotic diseases, etc.  Although there is an intensive effort on the discovery of potent and selective ATX inhibitors in order to identify novel medicinal agents, up to now, no ATX inhibitor has reached clin. trials.  However, the use of ATX inhibitors seems an attractive strategy for the development of novel medicinal agents, for example anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrIPRU28R5LVg90H21EOLACvtfcHk0lj7zwyysseDBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF&md5=517c590694d78587305229ce500e228a</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.796364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.796364%26sid%3Dliteratum%253Aachs%26aulast%3DBarbayianni%26aufirst%3DE.%26aulast%3DMagrioti%26aufirst%3DV.%26aulast%3DMoutevelis-Minakakis%26aufirst%3DP.%26aulast%3DKokotos%26aufirst%3DG.%26atitle%3DAutotaxin%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1123%26epage%3D1132%26doi%3D10.1517%2F13543776.2013.796364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span> </span><span class="NLM_article-title">Development of autotaxin inhibitors: an overview of the patent and primary literature</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5604</span><span class="NLM_x">–</span> <span class="NLM_lpage">5621</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5604-5621&author=D.+Castagnaauthor=D.+C.+Buddauthor=S.+J.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+Watson&title=Development+of+autotaxin+inhibitors%3A+an+overview+of+the+patent+and+primary+literature&doi=10.1021%2Facs.jmedchem.5b01599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature</span></div><div class="casAuthors">Castagna, Diana; Budd, David C.; MacDonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5604-5621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others.  As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities.  This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clin. trial data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzWQadusHW7Vg90H21EOLACvtfcHk0lj8WeQQ3soNPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D&md5=68ca29436fd3b0a1728a9a52fbaf2cb0</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01599%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26atitle%3DDevelopment%2520of%2520autotaxin%2520inhibitors%253A%2520an%2520overview%2520of%2520the%2520patent%2520and%2520primary%2520literature%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5604%26epage%3D5621%26doi%3D10.1021%2Facs.jmedchem.5b01599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="note"><p class="first last">Recent reports of autotaxin inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Structural basis for specific inhibition of autotaxin by a DNA aptamer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1038/nsmb.3200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnsmb.3200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27043297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=395-401&author=K.+Katoauthor=H.+Ikedaauthor=S.+Miyakawaauthor=S.+Futakawaauthor=Y.+Nonakaauthor=M.+Fujiwaraauthor=S.+Okudairaauthor=K.+Kanoauthor=J.+Aokiauthor=J.+Moritaauthor=R.+Ishitaniauthor=H.+Nishimasuauthor=Y.+Nakamuraauthor=O.+Nureki&title=Structural+basis+for+specific+inhibition+of+autotaxin+by+a+DNA+aptamer&doi=10.1038%2Fnsmb.3200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for specific inhibition of Autotaxin by a DNA aptamer</span></div><div class="casAuthors">Kato, Kazuki; Ikeda, Hisako; Miyakawa, Shin; Futakawa, Satoshi; Nonaka, Yosuke; Fujiwara, Masatoshi; Okudaira, Shinichi; Kano, Kuniyuki; Aoki, Junken; Morita, Junko; Ishitani, Ryuichiro; Nishimasu, Hiroshi; Nakamura, Yoshikazu; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ATX is a plasma lysophospholipase D that hydrolyzes lysophosphatidylcholine (LPC) and produces lysophosphatidic acid.  To date, no ATX-inhibition-mediated treatment strategies for human diseases have been established.  Here, we report anti-ATX DNA aptamers that inhibit ATX with high specificity and efficacy.  We solved the crystal structure of ATX in complex with the anti-ATX aptamer RB011, at 2.0-Å resoln.  RB011 binds in the vicinity of the active site through base-specific interactions, thus preventing the access of the choline moiety of LPC substrates.  Using the structural information, we developed the modified anti-ATX DNA aptamer RB014, which exhibited in vivo efficacy in a bleomycin-induced pulmonary fibrosis mouse model.  Our findings reveal the structural basis for the specific inhibition of ATX by the anti-ATX aptamer and highlight the therapeutic potential of anti-ATX aptamers for the treatment of human diseases, such as pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NHdAXL4UqLVg90H21EOLACvtfcHk0lj8WeQQ3soNPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D&md5=aca4be211ddf67faad6a2decadd73a12</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3200%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DMiyakawa%26aufirst%3DS.%26aulast%3DFutakawa%26aufirst%3DS.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DKano%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DMorita%26aufirst%3DJ.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DStructural%2520basis%2520for%2520specific%2520inhibition%2520of%2520autotaxin%2520by%2520a%2520DNA%2520aptamer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D395%26epage%3D401%26doi%3D10.1038%2Fnsmb.3200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimkowski, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirunavukkarasu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, B. H.</span><span> </span><span class="NLM_article-title">Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=857-861&author=S.+B.+Jonesauthor=L.+A.+Pfeiferauthor=T.+J.+Bleischauthor=T.+J.+Beauchampauthor=J.+D.+Durbinauthor=V.+J.+Klimkowskiauthor=N.+E.+Hughesauthor=C.+J.+Ritoauthor=Y.+Daoauthor=J.+M.+Gruberauthor=H.+Buiauthor=M.+G.+Chambersauthor=S.+Chandrasekharauthor=C.+Linauthor=D.+J.+McCannauthor=D.+R.+Mudraauthor=J.+L.+Oskinsauthor=C.+A.+Swearingenauthor=K.+Thirunavukkarasuauthor=B.+H.+Norman&title=Novel+autotaxin+inhibitors+for+the+treatment+of+osteoarthritis+pain%3A+lead+optimization+via+structure-based+drug+design&doi=10.1021%2Facsmedchemlett.6b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design</span></div><div class="casAuthors">Jones, Spencer B.; Pfeifer, Lance A.; Bleisch, Thomas J.; Beauchamp, Thomas J.; Durbin, Jim D.; Klimkowski, V. Joseph; Hughes, Norman E.; Rito, Christopher J.; Dao, Yen; Gruber, Joseph M.; Bui, Hai; Chambers, Mark G.; Chandrasekhar, Srinivasan; Lin, Chaohua; McCann, Denis J.; Mudra, Daniel R.; Oskins, Jennifer L.; Swearingen, Craig A.; Thirunavukkarasu, Kannan; Norman, Bryan H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">857-861</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, the authors set out to develop an inhibitor for autotaxin with excellent potency and phys. properties to allow for the clin. investigation of autotaxin-induced nociceptive and neuropathic pain.  An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC50 of 500 nM.  X-ray crystallog. enabled the optimization to a lead compd. I that demonstrated favorable potency (IC50 = 2 nM), PK properties, and a robust PK/PD relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8LOQIFg8_0bVg90H21EOLACvtfcHk0liXlF5DYO7_hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K&md5=c167f3fb691f8916fbce425701f8c7e8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BB.%26aulast%3DPfeifer%26aufirst%3DL.%2BA.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DDurbin%26aufirst%3DJ.%2BD.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DDao%26aufirst%3DY.%26aulast%3DGruber%26aufirst%3DJ.%2BM.%26aulast%3DBui%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DOskins%26aufirst%3DJ.%2BL.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520autotaxin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%2520pain%253A%2520lead%2520optimization%2520via%2520structure-based%2520drug%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D857%26epage%3D861%26doi%3D10.1021%2Facsmedchemlett.6b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheasty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farooq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejeune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeete, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of the lysophospholipase autotaxin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5403</span><span class="NLM_x">–</span> <span class="NLM_lpage">5410</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.bmcl.2016.10.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5403-5410&author=P.+Shahauthor=A.+Cheastyauthor=C.+Foxtonauthor=T.+Raynhamauthor=M.+Farooqauthor=I.+F.+Gutierrezauthor=A.+Lejeuneauthor=M.+Pritchardauthor=A.+Turnbullauthor=L.+Pangauthor=P.+Owenauthor=S.+Boydauthor=A.+Stowellauthor=A.+Jordanauthor=N.+M.+Hamiltonauthor=J.+R.+Hitchinauthor=M.+Stockleyauthor=E.+MacDonaldauthor=M.+J.+Quesadaauthor=E.+Trivierauthor=J.+Skeeteauthor=H.+Ovaaauthor=W.+H.+Moolenaarauthor=H.+Ryder&title=Discovery+of+potent+inhibitors+of+the+lysophospholipase+autotaxin&doi=10.1016%2Fj.bmcl.2016.10.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DP.%26aulast%3DCheasty%26aufirst%3DA.%26aulast%3DFoxton%26aufirst%3DC.%26aulast%3DRaynham%26aufirst%3DT.%26aulast%3DFarooq%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DI.%2BF.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3DPritchard%26aufirst%3DM.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DOwen%26aufirst%3DP.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DStowell%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DN.%2BM.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DStockley%26aufirst%3DM.%26aulast%3DMacDonald%26aufirst%3DE.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26aulast%3DTrivier%26aufirst%3DE.%26aulast%3DSkeete%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DRyder%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520the%2520lysophospholipase%2520autotaxin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5403%26epage%3D5410%26doi%3D10.1016%2Fj.bmcl.2016.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">The emerging role of lysophosphatidic acid in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1038/nrc1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnrc1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=12894246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvV2iu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=582-591&author=G.+B.+Millsauthor=W.+H.+Moolenaar&title=The+emerging+role+of+lysophosphatidic+acid+in+cancer&doi=10.1038%2Fnrc1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of lysophosphatidic acid in cancer</span></div><div class="casAuthors">Mills, Gordon B.; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">582-591</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bioactive phospholipid lysophosphatidic acid (LPA) stimulates cell proliferation, migration and survival by acting on its cognate G-protein-coupled receptors.  Aberrant LPA prodn., receptor expression and signaling probably contribute to cancer initiation, progression and metastasis.  The recent identification of ecto-enzymes that mediate the prodn. and degrdn. of LPA, as well as the development of receptor-selective analogs, indicate mechanisms by which LPA prodn. or action could be modulated for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHTv-V2F621bVg90H21EOLACvtfcHk0liXlF5DYO7_hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvV2iu7w%253D&md5=22a89dafdb8544b4aec043c365c2034b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrc1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1143%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DThe%2520emerging%2520role%2520of%2520lysophosphatidic%2520acid%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D582%26epage%3D591%26doi%3D10.1038%2Fnrc1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leblanc, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyruchaud, O.</span><span> </span><span class="NLM_article-title">New insights into the autotaxin/LPA axis in cancer development and metastasis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1016/j.yexcr.2014.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.yexcr.2014.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=25460336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2015&pages=183-189&author=R.+Leblancauthor=O.+Peyruchaud&title=New+insights+into+the+autotaxin%2FLPA+axis+in+cancer+development+and+metastasis&doi=10.1016%2Fj.yexcr.2014.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the autotaxin/LPA axis in cancer development and metastasis</span></div><div class="casAuthors">Leblanc, Raphael; Peyruchaud, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-189</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a simple lipid with a single fatty acyl chain linked to a glycerophosphate backbone.  Despite the simplicity of its structure but owing to its interactions with a series of at least six G protein-coupled receptors (LPA1-6), LPA exerts pleiotropic bioactivities including stimulation of proliferation, migration and survival of many cell types.  Autotaxin (ATX) is a unique enzyme with a lysophospholipase D (lysoPLD) activity that is responsible for the levels of LPA in the blood circulation.  Both LPA receptor family members and ATX/LysoPLD are aberrantly expressed in many human cancers.  This review will present the more striking as well as novel exptl. evidences using cell lines, cancer mouse models and transgenic animals identifying the roles for ATX and LPA receptors in cancer progression, tumor cell invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYBvc__AK4sLVg90H21EOLACvtfcHk0lhWIJCVC0d72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgs73P&md5=ae2e8d79492719a44399d5e491517571</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2014.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2014.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DLeblanc%26aufirst%3DR.%26aulast%3DPeyruchaud%26aufirst%3DO.%26atitle%3DNew%2520insights%2520into%2520the%2520autotaxin%252FLPA%2520axis%2520in%2520cancer%2520development%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2015%26volume%3D333%26spage%3D183%26epage%3D189%26doi%3D10.1016%2Fj.yexcr.2014.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Benesch, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc Mullen, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindley, D. N.</span><span> </span><span class="NLM_article-title">Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">588</span><span class="NLM_x">, </span> <span class="NLM_fpage">2712</span><span class="NLM_x">–</span> <span class="NLM_lpage">2727</span><span class="refDoi"> DOI: 10.1016/j.febslet.2014.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.febslet.2014.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24560789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlSrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2014&pages=2712-2727&author=M.+G.+Beneschauthor=Y.+M.+Koauthor=T.+P.+Mc+Mullenauthor=D.+N.+Brindley&title=Autotaxin+in+the+crosshairs%3A+taking+aim+at+cancer+and+other+inflammatory+conditions&doi=10.1016%2Fj.febslet.2014.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin in the crosshairs: Taking aim at cancer and other inflammatory conditions</span></div><div class="casAuthors">Benesch, Matthew G. K.; Ko, Yi M.; McMullen, Todd P. W.; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">588</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2712-2727</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Autotaxin is a secreted enzyme that produces most of the extracellular lysophosphatidate from lysophosphatidylcholine, the most abundant phospholipid in blood plasma.  Lysophosphatidate mediates many physiol. and pathol. processes by signaling through at least six G-protein coupled receptors to promote cell survival, proliferation and migration.  The autotaxin/lysophosphatidate signaling axis is involved in wound healing and tissue remodeling, and it drives many chronic inflammatory conditions from fibrosis to colitis, asthma and cancer.  In cancer, lysophosphatidate signaling promotes resistance to chemotherapy and radiotherapy, and increases both angiogenesis and metastasis.  Research into autotaxin inhibitors is accelerating, both as primary and adjuvant therapy.  Historically, autotaxin inhibitors had poor bioavailability profiles and thus had limited efficacy in vivo.  This situation is now changing, esp. since the recent crystal structure of autotaxin is now enabling rational inhibitor design.  In this review, we will summarize current knowledge on autotaxin-mediated disease processes including cancer, and discuss recent advancements in the development of autotaxin-targeting strategies.  We will also provide new insights into autotaxin as an inflammatory mediator in the tumor microenvironment that promotes cancer progression and therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsrY7-J9l3NbVg90H21EOLACvtfcHk0lhWIJCVC0d72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlSrs74%253D&md5=c10bc1550f945c437e938a72846b463b</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2014.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2014.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DBenesch%26aufirst%3DM.%2BG.%26aulast%3DKo%26aufirst%3DY.%2BM.%26aulast%3DMc%2BMullen%26aufirst%3DT.%2BP.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DAutotaxin%2520in%2520the%2520crosshairs%253A%2520taking%2520aim%2520at%2520cancer%2520and%2520other%2520inflammatory%2520conditions%26jtitle%3DFEBS%2520Lett.%26date%3D2014%26volume%3D588%26spage%3D2712%26epage%3D2727%26doi%3D10.1016%2Fj.febslet.2014.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contos, J. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span> </span><span class="NLM_article-title">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1038/nm1060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnm1060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=15195086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=712-714&author=M.+Inoueauthor=M.+H.+Rashidauthor=R.+Fujitaauthor=J.+J.+A.+Contosauthor=J.+Chunauthor=H.+Ueda&title=Initiation+of+neuropathic+pain+requires+lysophosphatidic+acid+receptor+signaling&doi=10.1038%2Fnm1060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span></div><div class="casAuthors">Inoue, Makoto; Rashid, Md Harunor; Fujita, Ryousuke; Contos, James J. A.; Chun, Jerold; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">712-718</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid with activity in the nervous system mediated by G-protein-coupled receptors.  Here, we examd. the role of LPA signaling in the development of neuropathic pain by pharmacol. and genetic approaches, including the use of mice lacking the LPA1 receptor.  Wild-type animals with nerve injury develop behavioral allodynia and hyperalgesia paralleled by demyelination in the dorsal root and increased expression of both the protein kinase C γ-isoform within the spinal cord dorsal horn and the α2δ1 calcium channel subunit in dorsal root ganglia.  Intrathecal injection of LPA induced behavioral, morphol. and biochem. changes similar to those obsd. after nerve ligation.  In contrast, mice lacking a single LPA receptor (LPA1, also known as EDG2) that activates the Rho-Rho kinase pathway do not develop signs of neuropathic pain after peripheral nerve injury.  Inhibitors of Rho and Rho kinase also prevented these signs of neuropathic pain.  These results imply that receptor-mediated LPA signaling is crucial in the initiation of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTzbCOHf9jX7Vg90H21EOLACvtfcHk0lhePgzswdps-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D&md5=15f4760e4fd3b46c97c289be7b430058</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnm1060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1060%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DRashid%26aufirst%3DM.%2BH.%26aulast%3DFujita%26aufirst%3DR.%26aulast%3DContos%26aufirst%3DJ.%2BJ.%2BA.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DInitiation%2520of%2520neuropathic%2520pain%2520requires%2520lysophosphatidic%2520acid%2520receptor%2520signaling%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D712%26epage%3D714%26doi%3D10.1038%2Fnm1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thirunavukkarasu, K.; Swearingen, C. A.; Oskins, J. L.; Lin, C.; Bui, H. H.; Jones, S. B.; Pfeifer, L. A.; Norman, B. H.; Mitchell, P. G.; Chambers, M. G.</span><span> </span><span class="NLM_article-title">Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain</span>.  <span class="citation_source-journal">Osteoarthritis Cartilage</span>. [Online early access]. DOI: <span class="refDoi"> DOI: 10.1016/j.joca.2016.09.006</span> . Published Online: September 13,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.joca.2016.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27638130" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+Thirunavukkarasu&author=C.+A.+Swearingen&author=J.+L.+Oskins&author=C.+Lin&author=H.+H.+Bui&author=S.+B.+Jones&author=L.+A.+Pfeifer&author=B.+H.+Norman&author=P.+G.+Mitchell&author=M.+G.+Chambers&title=Identification+and+pharmacological+characterization+of+a+novel+inhibitor+of+autotaxin+in+rodent+models+of+joint+pain&doi=10.1016%2Fj.joca.2016.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2016.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2016.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520inhibitor%2520of%2520autotaxin%2520in%2520rodent%2520models%2520of%2520joint%2520pain%26jtitle%3DOsteoarthritis%2520Cartilage%26doi%3D10.1016%2Fj.joca.2016.09.006%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kremer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaap, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiper, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiners, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raap, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Buuren, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Erpecum, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rust, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Elferink, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuers, U.</span><span> </span><span class="NLM_article-title">Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1391</span><span class="NLM_x">–</span> <span class="NLM_lpage">1400</span><span class="refDoi"> DOI: 10.1002/hep.25748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1002%2Fhep.25748" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1391-1400&author=A.+E.+Kremerauthor=R.+van+Dijkauthor=P.+Leckieauthor=F.+G.+Schaapauthor=E.+M.+Kuiperauthor=T.+Mettangauthor=K.+S.+Reinersauthor=U.+Raapauthor=H.+R.+van+Buurenauthor=K.+J.+van+Erpecumauthor=N.+A.+Daviesauthor=C.+Rustauthor=A.+Engertauthor=R.+Jalanauthor=R.+P.+Oude+Elferinkauthor=U.+Beuers&title=Serum+autotaxin+is+increased+in+pruritus+of+cholestasis%2C+but+not+of+other+origin%2C+and+responds+to+therapeutic+interventions&doi=10.1002%2Fhep.25748"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1002%2Fhep.25748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.25748%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DA.%2BE.%26aulast%3Dvan%2BDijk%26aufirst%3DR.%26aulast%3DLeckie%26aufirst%3DP.%26aulast%3DSchaap%26aufirst%3DF.%2BG.%26aulast%3DKuiper%26aufirst%3DE.%2BM.%26aulast%3DMettang%26aufirst%3DT.%26aulast%3DReiners%26aufirst%3DK.%2BS.%26aulast%3DRaap%26aufirst%3DU.%26aulast%3Dvan%2BBuuren%26aufirst%3DH.%2BR.%26aulast%3Dvan%2BErpecum%26aufirst%3DK.%2BJ.%26aulast%3DDavies%26aufirst%3DN.%2BA.%26aulast%3DRust%26aufirst%3DC.%26aulast%3DEngert%26aufirst%3DA.%26aulast%3DJalan%26aufirst%3DR.%26aulast%3DOude%2BElferink%26aufirst%3DR.%2BP.%26aulast%3DBeuers%26aufirst%3DU.%26atitle%3DSerum%2520autotaxin%2520is%2520increased%2520in%2520pruritus%2520of%2520cholestasis%252C%2520but%2520not%2520of%2520other%2520origin%252C%2520and%2520responds%2520to%2520therapeutic%2520interventions%26jtitle%3DHepatology%26date%3D2012%26volume%3D56%26spage%3D1391%26epage%3D1400%26doi%3D10.1002%2Fhep.25748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wunsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neurath, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, P.</span><span> </span><span class="NLM_article-title">Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30847</span><span class="refDoi"> DOI: 10.1038/srep30847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fsrep30847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27506882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCitr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30847&author=E.+Wunschauthor=M.+Krawczykauthor=M.+Milkiewiczauthor=J.+Trottierauthor=O.+Barbierauthor=M.+F.+Neurathauthor=F.+Lammertauthor=A.+E.+Kremerauthor=P.+Milkiewicz&title=Serum+autotaxin+is+a+marker+of+the+severity+of+liver+injury+and+overall+survival+in+patients+with+cholestatic+liver+diseases&doi=10.1038%2Fsrep30847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases</span></div><div class="casAuthors">Wunsch, Ewa; Krawczyk, Marcin; Milkiewicz, Malgorzata; Trottier, Jocelyn; Barbier, Olivier; Neurath, Markus F.; Lammert, Frank; Kremer, Andreas E.; Milkiewicz, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30847</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is involved in the synthesis of lysophosphatidic acid.  Both have recently been linked to cholestatic pruritus and liver injury.  We aimed to investigate whether ATX is an indicator of cholestatic liver injury, health-related quality of life (HRQoL) and prognosis based on a group of 233 patients, 118 with primary biliary cholangitis (PBC) and 115 with primary sclerosing cholangitis (PSC).  Patients were followed for 1-60 mo, cumulative survival rates were calcd.  ATX activity was significantly higher in both groups than in the 103 controls, particularly in patients with cirrhosis and in patients with longer disease duration.  Ursodeoxycholic acid (UDCA) non-responders with PBC exhibited increased ATX activity.  ATX activity was correlated with liver biochem., MELD, Mayo Risk scores and was assocd. with worse disease-specific HRQoL aspects.  In both groups, Cox model anal. indicated that ATX was a neg. predictor of survival.  Increased ATX levels were assocd. with a 4-fold higher risk of death/liver transplantation in patients with PBC and a 2.6-fold higher risk in patients with PSC.  We conclude that in patients with cholestatic conditions, ATX is not only assocd. with pruritus but also indicates impairment of other HRQoL aspects, liver dysfunction, and can serve as a predictor of survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGQJnRzDI6NLVg90H21EOLACvtfcHk0ljGE8J_gHooEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCitr%252FI&md5=50b20687784f1c549896920898fdd0f7</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fsrep30847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep30847%26sid%3Dliteratum%253Aachs%26aulast%3DWunsch%26aufirst%3DE.%26aulast%3DKrawczyk%26aufirst%3DM.%26aulast%3DMilkiewicz%26aufirst%3DM.%26aulast%3DTrottier%26aufirst%3DJ.%26aulast%3DBarbier%26aufirst%3DO.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DLammert%26aufirst%3DF.%26aulast%3DKremer%26aufirst%3DA.%2BE.%26aulast%3DMilkiewicz%26aufirst%3DP.%26atitle%3DSerum%2520autotaxin%2520is%2520a%2520marker%2520of%2520the%2520severity%2520of%2520liver%2520injury%2520and%2520overall%2520survival%2520in%2520patients%2520with%2520cholestatic%2520liver%2520diseases%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D30847%26doi%3D10.1038%2Fsrep30847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Selective inhibition of autotaxin is efficacious in mouse models of liver fibrosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1124/jpet.116.237156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1124%2Fjpet.116.237156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27754931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2017&pages=1-13&author=G.+Bainauthor=K.+E.+Shannonauthor=F.+Huangauthor=J.+Darlingtonauthor=L.+Gouletauthor=P.+Prodanovichauthor=G.+L.+Maauthor=A.+M.+Santiniauthor=A.+J.+Steinauthor=D.+Lonerganauthor=C.+D.+Kingauthor=I.+Calderonauthor=A.+Laiauthor=J.+H.+Hutchinsonauthor=J.+F.+Evans&title=Selective+inhibition+of+autotaxin+is+efficacious+in+mouse+models+of+liver+fibrosis&doi=10.1124%2Fjpet.116.237156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis</span></div><div class="casAuthors">Bain Gretchen; Shannon Kristen E; Huang Fei; Darlington Janice; Goulet Lance; Prodanovich Patricia; Ma Gina L; Santini Angelina M; Stein Adam J; Lonergan Dave; King Christopher D; Calderon Imelda; Lai Andiliy; Hutchinson John H; Evans Jilly F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autotaxin (ATX) is a secreted glycoprotein that converts lysophosphatidylcholine (LPC) to the bioactive phospholipid lysophosphatidic acid (LPA) and is the major enzyme generating circulating LPA.  Inhibition of LPA signaling has profound antifibrotic effects in multiple organ systems, including lung, kidney, skin, and peritoneum.  However, other LPA-generating pathways exist, and the role of ATX in localized tissue LPA production and fibrosis remains unclear and controversial.  In this study, we describe the preclinical pharmacologic, pharmacokinetic, and pharmacodynamic properties of a novel small-molecule ATX inhibitor, PAT-505 [3-((6-chloro-2-cyclopropyl-1-(1-ethyl-1H-pyrazol-4-yl)-7-fluoro-1H-indol-3-yl) thio)-2-fluorobenzoic acid sodium salt].  PAT-505 is a potent, selective, noncompetitive inhibitor that displays significant inhibition of ATX activity in plasma and liver tissue after oral administration.  When dosed therapeutically in a Stelic Mouse Animal Model of nonalcoholic steatohepatitis (NASH), PAT-505 treatment resulted in a small but significant improvement in fibrosis with only minor improvements in hepatocellular ballooning and hepatic inflammation.  In a choline-deficient, high-fat diet model of NASH, therapeutic treatment with PAT-505 robustly reduced liver fibrosis with no significant effect on steatosis, hepatocellular ballooning, or inflammation.  These data demonstrate that inhibiting autotaxin is antifibrotic and may represent a novel therapeutic approach for the treatment of multiple fibrotic liver diseases, including NASH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSL-FO7LhxeeTjk2McQZ6XmfW6udTcc2eaCKS3AYMLSyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D&md5=0ecd238167807657b30f436c05180dce</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237156%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DG.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DSelective%2520inhibition%2520of%2520autotaxin%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520liver%2520fibrosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D360%26spage%3D1%26epage%3D13%26doi%3D10.1124%2Fjpet.116.237156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafyatis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">An autotaxin/lysophosphatidic acid/interleukin-6 amplification loop drives scleroderma fibrosis</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2974</span><span class="refDoi"> DOI: 10.1002/art.39797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1002%2Fart.39797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27390295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGgsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=2964-2974&author=F.+V.+Castelinoauthor=G.+Bainauthor=V.+A.+Paceauthor=K.+E.+Blackauthor=L.+Georgeauthor=C.+K.+Probstauthor=L.+Gouletauthor=R.+Lafyatisauthor=A.+M.+Tager&title=An+autotaxin%2Flysophosphatidic+acid%2Finterleukin-6+amplification+loop+drives+scleroderma+fibrosis&doi=10.1002%2Fart.39797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis</span></div><div class="casAuthors">Castelino, Flavia V.; Bain, Gretchen; Pace, Veronica A.; Black, Katharine E.; George, Leaya; Probst, Clemens K.; Goulet, Lance; Lafyatis, Robert; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2964-2974</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : We previously implicated the lipid mediator lysophosphatidic acid (LPA) as having a role in dermal fibrosis in systemic sclerosis (SSc).  The aim of this study was to identify the role of the LPA-producing enzyme autotaxin (ATX), and to connect the ATX/LPA and interleukin-6 (IL-6) pathways in SSc.  Methods : We evaluated the effect of a novel ATX inhibitor, PAT-048, on fibrosis and IL-6 expression in the mouse model of bleomycin-induced dermal fibrosis.  We used dermal fibroblasts from SSc patients and control subjects to evaluate LPA-induced expression of IL-6, and IL-6-induced expression of ATX.  We next evaluated whether LPA-induced ATX expression is dependent on IL-6, and whether baseline IL-6 expression in fibroblasts from SSc patients is dependent on ATX.  Finally, we compared ATX and IL-6 expression in the skin of patients with SSc and healthy control subjects.  Results : PAT-048 markedly attenuated bleomycin-induced dermal fibrosis when treatment was initiated before or after the development of fibrosis.  LPA stimulated expression of IL-6 in human dermal fibroblasts, and IL-6 stimulated fibroblast expression of ATX, connecting the ATX/LPA and IL-6 pathways in an amplification loop.  IL-6 knockdown abrogated LPA-induced ATX expression in fibroblasts, and ATX inhibition attenuated IL-6 expression in fibroblasts and the skin of bleomycin-challenged mice.  Expression of both ATX and IL-6 was increased in SSc skin, and LPA-induced IL-6 levels and IL-6-induced ATX levels were increased in fibroblasts from SSc patients compared with controls.  Conclusion : ATX is required for the development and maintenance of dermal fibrosis in a mouse model of bleomycin-induced SSc and enables 2 major mediators of SSc fibrogenesis, LPA and IL-6, to amplify the prodn. of each other.  Our results suggest that concurrent inhibition of these 2 pathways may be an effective therapeutic strategy for dermal fibrosis in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAR8zNaWGdv7Vg90H21EOLACvtfcHk0ljGE8J_gHooEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGgsLjO&md5=c31da9bcfea17bbc19f27bce5bd9d1c5</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1002%2Fart.39797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39797%26sid%3Dliteratum%253Aachs%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DPace%26aufirst%3DV.%2BA.%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DGeorge%26aufirst%3DL.%26aulast%3DProbst%26aufirst%3DC.%2BK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLafyatis%26aufirst%3DR.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAn%2520autotaxin%252Flysophosphatidic%2520acid%252Finterleukin-6%2520amplification%2520loop%2520drives%2520scleroderma%2520fibrosis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D2964%26epage%3D2974%26doi%3D10.1002%2Fart.39797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bourgion, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span> </span><span class="NLM_article-title">Autotaxin and lysophospholipids in rheumatoid arthritis</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=515-526&author=S.+G.+Bourgionauthor=C.+Zhao&title=Autotaxin+and+lysophospholipids+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBourgion%26aufirst%3DS.%2BG.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DAutotaxin%2520and%2520lysophospholipids%2520in%2520rheumatoid%2520arthritis%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D515%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Park, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorshkova, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpurapu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranjan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbridge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidinis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christman, J. W.</span><span> </span><span class="NLM_article-title">Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">928</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.1164/rccm.201306-1014OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1164%2Frccm.201306-1014OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24050723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslymsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2013&pages=928-940&author=G.+Y.+Parkauthor=Y.+G.+Leeauthor=E.+Berdyshevauthor=S.+Nyenhuisauthor=J.+Duauthor=P.+Fuauthor=I.+A.+Gorshkovaauthor=Y.+Liauthor=S.+Chungauthor=M.+Karpurapuauthor=J.+Dengauthor=R.+Ranjanauthor=L.+Xiaoauthor=H.+A.+Jaffeauthor=S.+J.+Corbridgeauthor=E.+A.+Kellyauthor=N.+N.+Jarjourauthor=J.+Chunauthor=G.+D.+Prestwichauthor=E.+Kaffeauthor=I.+Ninouauthor=V.+Aidinisauthor=A.+J.+Morrisauthor=S.+S.+Smythauthor=S.+J.+Ackermanauthor=V.+Natarajanauthor=J.+W.+Christman&title=Autotaxin+production+of+lysophosphatidic+acid+mediates+allergic+asthmatic+inflammation&doi=10.1164%2Frccm.201306-1014OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation</span></div><div class="casAuthors">Park, Gye Young; Lee, Yong Gyu; Berdyshev, Evgeny; Nyenhuis, Sharmilee; Du, Jian; Fu, Panfeng; Gorshkova, Irina A.; Li, Yongchao; Chung, Sangwoon; Karpurapu, Manjula; Deng, Jing; Ranjan, Ravi; Xiao, Lei; Jaffe, H. Ari; Corbridge, Susan J.; Kelly, Elizabeth A. B.; Jarjour, Nizar N.; Chun, Jerold; Prestwich, Glenn D.; Kaffe, Eleanna; Ninou, Ioanna; Aidinis, Vassilis; Morris, Andrew J.; Smyth, Susan S.; Ackerman, Steven J.; Natarajan, Viswanathan; Christman, John W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Bioactive lipid mediators, derived from membrane lipid precursors, are released into the airway and airspace where they bind high-affinity cognate receptors and may mediate asthma pathogenesis.  Lysophosphatidic acid (LPA), a bioactive lipid mediator generated by the enzymic activity of extracellular autotaxin (ATX), binds LPA receptors, resulting in an array of biol. actions on cell proliferation, migration, survival, differentiation, and motility, and therefore could mediate asthma pathogenesis.  Objectives: To define a role for the ATX-LPA pathway in human asthma pathogenesis and a murine model of allergic lung inflammation.  Methods: We investigated the profiles of LPA mol. species and the level of ATX exoenzyme in bronchoalveolar lavage fluids of human patients with asthma subjected to subsegmental bronchoprovocation with allergen.  We interrogated the role of the ATX-LPA pathway in allergic lung inflammation using a murine allergic asthma model in ATX-LPA pathway-specific genetically modified mice.  Measurements and Main Results: Subsegmental bronchoprovocation with allergen in patients with mild asthma resulted in a remarkable increase in bronchoalveolar lavage fluid levels of LPA enriched in polyunsatd. 22:5 and 22:6 fatty acids in assocn. with increased concns. of ATX protein.  Using a triple-allergen mouse asthma model, we showed that ATX-overexpressing transgenic mice had a more severe asthmatic phenotype, whereas blocking ATX activity and knockdown of the LPA2 receptor in mice produced a marked attenuation of Th2 cytokines and allergic lung inflammation.  Conclusions: The ATX-LPA pathway plays a crit. role in the pathogenesis of asthma.  These preclin. data indicate that targeting the ATX-LPA pathway could be an effective antiasthma treatment strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BrXkeNAJRrVg90H21EOLACvtfcHk0li-FjX_TEHtKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslymsLfF&md5=dbf28845b5268777693188e0e122f0e5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1164%2Frccm.201306-1014OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201306-1014OC%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DG.%2BY.%26aulast%3DLee%26aufirst%3DY.%2BG.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DNyenhuis%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DP.%26aulast%3DGorshkova%26aufirst%3DI.%2BA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DKarpurapu%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DRanjan%26aufirst%3DR.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DJaffe%26aufirst%3DH.%2BA.%26aulast%3DCorbridge%26aufirst%3DS.%2BJ.%26aulast%3DKelly%26aufirst%3DE.%2BA.%26aulast%3DJarjour%26aufirst%3DN.%2BN.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DKaffe%26aufirst%3DE.%26aulast%3DNinou%26aufirst%3DI.%26aulast%3DAidinis%26aufirst%3DV.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DSmyth%26aufirst%3DS.%2BS.%26aulast%3DAckerman%26aufirst%3DS.%2BJ.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DChristman%26aufirst%3DJ.%2BW.%26atitle%3DAutotaxin%2520production%2520of%2520lysophosphatidic%2520acid%2520mediates%2520allergic%2520asthmatic%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2013%26volume%3D188%26spage%3D928%26epage%3D940%26doi%3D10.1164%2Frccm.201306-1014OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) and its receptors: Role in airway inflammation and remodeling</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1831</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2012.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.bbalip.2012.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=22809994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=86-92&author=Y.+Zhaoauthor=V.+Natarajan&title=Lysophosphatidic+acid+%28LPA%29+and+its+receptors%3A+Role+in+airway+inflammation+and+remodeling&doi=10.1016%2Fj.bbalip.2012.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) and its receptors: Role in airway inflammation and remodeling</span></div><div class="casAuthors">Zhao, Yutong; Natarajan, Viswanathan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1831</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-92</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a simple bioactive phospholipid, is present in biol. fluids such as plasma and bronchoalveolar lavage (BAL).  It appears to have both pro- and anti-inflammatory roles in inflammatory lung diseases.  Exogenous LPA promotes inflammatory responses by regulating the expression of chemokines, cytokines, and cytokine receptors in lung epithelial cells.  In addn. to the modulation of inflammatory responses, LPA regulates cytoskeleton rearrangement and confers protection against lung injury by enhancing lung epithelial cell barrier integrity and remodeling.  The biol. effects of LPA are mediated through its cell surface G-protein coupled LPA1-7 receptors.  The roles of LPA receptors in lung fibrosis, asthma, and acute lung injury have been investigated using genetically engineered LPA receptor deficient mice and there appears to be a definitive role for endogenous LPA and its receptors in the pathogenesis of pulmonary inflammatory diseases.  This review summarizes recent reports on the role of LPA and its receptors in the regulation of lung epithelial inflammatory responses and remodeling.  This article is part of a Special Issue entitled: Advances in Lysophospholipid Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEic0M3fm3hbVg90H21EOLACvtfcHk0li-FjX_TEHtKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahtLvN&md5=ef51a05f3a4920b78597e8c2f1efa46c</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2012.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2012.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520and%2520its%2520receptors%253A%2520Role%2520in%2520airway%2520inflammation%2520and%2520remodeling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2013%26volume%3D1831%26spage%3D86%26epage%3D92%26doi%3D10.1016%2Fj.bbalip.2012.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hui, D. Y.</span><span> </span><span class="NLM_article-title">Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease</span> <span class="citation_source-journal">Curr. Opin. Lipidol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1097/MOL.0000000000000334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1097%2FMOL.0000000000000334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=27438680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVemtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=507-512&author=D.+Y.+Hui&title=Intestinal+phospholipid+and+lysophospholipid+metabolism+in+cardiometabolic+disease&doi=10.1097%2FMOL.0000000000000334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease</span></div><div class="casAuthors">Hui, David Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Lipidology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-512</span>CODEN:
                <span class="NLM_cas:coden">COPLEU</span>;
        ISSN:<span class="NLM_cas:issn">0957-9672</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Phospholipids are major constituents in the intestinal lumen after meal consumption.  This article highlights current literature suggesting the contributory role of intestinal phospholipid metab. toward cardiometabolic disease manifestation.  Recent findings: Group 1b phospholipase A2 (PLA2g1b) catalyzes phospholipid hydrolysis in the intestinal lumen.  The digestive product lysophospholipid, particularly lysophosphatidylcholine (LPC), has a direct role in mediating chylomicron assembly and secretion.  The LPC in the digestive tract is further catabolized into lysophosphatidic acid and choline via autotaxin-mediated and autotaxin-independent mechanisms.  The LPC and lysophosphatidic acid absorbed through the digestive tract and transported to the plasma directly promote systemic inflammation and cell dysfunction, leading to increased risk of cardiovascular disease and obesity/diabetes.  The choline moiety generated in the digestive tract can also be used by gut bacteria to generate trimethylamine, which is subsequently transported to the liver and oxidized into trimethylamine-N-oxide that also enhances atherosclerosis and cardiovascular abnormalities.  Summary: Products of phospholipid metab. in the intestine through PLA2g1b and autotaxin-mediated pathways directly contribute to cardiometabolic diseases through multiple mechanisms.  The implication of these studies is that therapeutic inhibition of PLA2g1b and autotaxin in the digestive tract may be a viable approach for cardiovascular and metabolic disease intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNnRXsdag26bVg90H21EOLACvtfcHk0lidEi1SRkYYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVemtbrK&md5=ea6703596f377164c18b771591124b0f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2FMOL.0000000000000334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOL.0000000000000334%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DD.%2BY.%26atitle%3DIntestinal%2520phospholipid%2520and%2520lysophospholipid%2520metabolism%2520in%2520cardiometabolic%2520disease%26jtitle%3DCurr.%2520Opin.%2520Lipidol.%26date%3D2016%26volume%3D27%26spage%3D507%26epage%3D512%26doi%3D10.1097%2FMOL.0000000000000334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span> </span><span class="NLM_article-title">Development of lysophosphatidic acid pathway modulators as therapies for fibrosis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span><span class="refDoi"> DOI: 10.4155/fmc.13.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.4155%2Ffmc.13.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=24175745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1935-1952&author=D.+C.+Buddauthor=Y.+Qian&title=Development+of+lysophosphatidic+acid+pathway+modulators+as+therapies+for+fibrosis&doi=10.4155%2Ffmc.13.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of lysophosphatidic acid pathway modulators as therapies for fibrosis</span></div><div class="casAuthors">Budd, David C.; Qian, Yimin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1935-1952</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a class of bioactive phospholipid that displays a wide range of cellular effects via LPA receptors, of which six have been identified (LPAR1-6).  In serum and plasma, LPA prodn. occurs mainly by the hydrolysis of lysophosphatidylcholine by the phospholipase D activity of autotaxin (ATX).  The involvement of the LPA pathway in driving chronic wound-healing conditions, such as idiopathic pulmonary fibrosis, has suggested targets in this pathway could provide potential therapeutic approaches.  Mice with LPAR1 knockout or tissue-specific ATX deletion have demonstrated reduced lung fibrosis following bleomycin challenge.  Therefore, strategies aimed at antagonizing LPA receptors or inhibiting ATX have gained considerable attention.  This Review will summarize the current status of identifying small-mol. modulators of the LPA pathway.  The therapeutic utility of LPA modulators for the treatment of fibrotic diseases will soon be revealed as clin. trials are already in progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Jpew1zYC8rVg90H21EOLACvtfcHk0lidEi1SRkYYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislynsg%253D%253D&md5=ee2db60359f2a0217de52a3bf115dd22</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.154%26sid%3Dliteratum%253Aachs%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DQian%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520lysophosphatidic%2520acid%2520pathway%2520modulators%2520as%2520therapies%2520for%2520fibrosis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1935%26epage%3D1952%26doi%3D10.4155%2Ffmc.13.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P.</span><span> </span><span class="NLM_article-title">Autotaxin-LPA receptor axis in the pathogenesis of lung diseases</span> <span class="citation_source-journal">Int. J. Clin. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">17117</span><span class="NLM_x">–</span> <span class="NLM_lpage">17122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=26770305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVKqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=17117-17122&author=X.+Chuauthor=X.+Weiauthor=S.+Luauthor=P.+He&title=Autotaxin-LPA+receptor+axis+in+the+pathogenesis+of+lung+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-LPA receptor axis in the pathogenesis of lung diseases</span></div><div class="casAuthors">Chu, Xiangpeng; Wei, Xiaojie; Lu, Shaolin; He, Peijian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">17117-17122</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a small lipid which mediates a variety of cellular functions via the activation of LPA receptors.  LPA is generated from lysophosphatidylcholine by the extracellular enzyme, autotaxin (ATX).  Elevated ATX expression, LPA prodn. and their signaling pathways have been reported in multiple pathol. conditions of lung tissue, including inflammation, fibrosis and cancer.  Emerging evidence has highlighted the importance of ATX and LPA receptors in the pathogenesis of lung diseases.  Here, we briefly review the current knowledge of different roles of the ATX-LPA receptor axis in lung diseases focusing on inflammation, fibrosis and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXIh6-lgHGkLVg90H21EOLACvtfcHk0lidEi1SRkYYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVKqs7w%253D&md5=c0bcf6499ae1e3732f507666988a9b48</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DP.%26atitle%3DAutotaxin-LPA%2520receptor%2520axis%2520in%2520the%2520pathogenesis%2520of%2520lung%2520diseases%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D17117%26epage%3D17122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Oikonomou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouratis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzouvelekis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valavanis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaras, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karameris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidinis, V.</span><span> </span><span class="NLM_article-title">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1165/rcmb.2012-0004OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1165%2Frcmb.2012-0004OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=22744859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=566-574&author=N.+Oikonomouauthor=M.+A.+Mouratisauthor=A.+Tzouvelekisauthor=E.+Kaffeauthor=C.+Valavanisauthor=G.+Vilarasauthor=A.+Karamerisauthor=G.+D.+Prestwichauthor=D.+Bourosauthor=V.+Aidinis&title=Pulmonary+autotaxin+expression+contributes+to+the+pathogenesis+of+pulmonary+fibrosis&doi=10.1165%2Frcmb.2012-0004OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span></div><div class="casAuthors">Oikonomou Nikos; Mouratis Marios-Angelos; Tzouvelekis Argyris; Kaffe Eleanna; Valavanis Christos; Vilaras George; Karameris Andreas; Prestwich Glenn D; Bouros Demosthenes; Aidinis Vassilis</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory cell and molecular biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">566-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic form of diffuse lung disease occurring mainly in older adults.  Increased lysophosphatidic acid (LPA) concentrations have been reported in the alveolar space of both idiopathic pulmonary fibrosis patients and a corresponding animal model, whereas the genetic deletion or pharmacological inhibition of LPA receptor 1 attenuated the development of the modeled disease, suggesting a direct involvement of LPA in disease pathogenesis.  In this report, increased concentrations of autotaxin (ATX; ENPP2), the enzyme largely responsible for extracellular LPA production, were detected in both murine and human fibrotic lungs.  The genetic deletion of ATX from bronchial epithelial cells or macrophages attenuated disease severity, establishing ATX as a novel player in IPF pathogenesis.  Furthermore, the pharmacological inhibition of ATX attenuated the development of the modeled disease, suggesting that ATX is a possible therapeutic target in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLNdXayAacMr5XHngOXiV_fW6udTcc2eZ0RhyvM6rtubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D&md5=f89e6297df4584c0b50c4ef5a33b0565</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0004OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0004OC%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomou%26aufirst%3DN.%26aulast%3DMouratis%26aufirst%3DM.%2BA.%26aulast%3DTzouvelekis%26aufirst%3DA.%26aulast%3DKaffe%26aufirst%3DE.%26aulast%3DValavanis%26aufirst%3DC.%26aulast%3DVilaras%26aufirst%3DG.%26aulast%3DKarameris%26aufirst%3DA.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DBouros%26aufirst%3DD.%26aulast%3DAidinis%26aufirst%3DV.%26atitle%3DPulmonary%2520autotaxin%2520expression%2520contributes%2520to%2520the%2520pathogenesis%2520of%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D566%26epage%3D574%26doi%3D10.1165%2Frcmb.2012-0004OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Funke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1165/rcmb.2010-0155OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1165%2Frcmb.2010-0155OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=22021336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=355-364&author=M.+Funkeauthor=Z.+Zhaoauthor=Y.+Xuauthor=J.+Chunauthor=A.+M.+Tager&title=The+lysophosphatidic+acid+receptor+LPA1+promotes+epithelial+cell+apoptosis+after+lung+injury&doi=10.1165%2Frcmb.2010-0155OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span></div><div class="casAuthors">Funke, Manuela; Zhao, Zhenwen; Xu, Yan; Chun, Jerold; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Increased epithelial cell apoptosis in response to lung injury has been implicated in the development of idiopathic pulmonary fibrosis (IPF), but the mol. pathways promoting epithelial cell apoptosis in this disease have yet to be fully identified.  Lysophosphatidic acid (LPA), which we have previously demonstrated to mediate bleomycin lung injury-induced fibroblast recruitment and vascular leak in mice and fibroblast recruitment in patients with IPF, is an important regulator of survival and apoptosis in many cell types.  We now show that LPA signaling through its receptor LPA1 promotes epithelial cell apoptosis induced by bleomycin injury.  The no. of apoptotic cells present in the alveolar and bronchial epithelia of LPA1-deficient mice was significantly reduced compared with wild-type mice at Day 3 after bleomycin challenge, as was lung caspase-3 activity.  Consistent with these in vivo results, we found that LPA signaling through LPA1 induced apoptosis in normal human bronchial epithelial cells in culture.  LPA-LPA1 signaling appeared to specifically mediate anoikis, the apoptosis of anchorage-dependent cells induced by their detachment.  Similarly, LPA neg. regulated attachment of R3/1 rat alveolar epithelial cell line cells.  In contrast, LPA signaling through LPA1 promoted the resistance of lung fibroblasts to apoptosis, which has also been implicated in IPF.  The ability of LPA-LPA1 signaling to promote epithelial cell apoptosis and fibroblast resistance to apoptosis may therefore contribute to the capacity of this signaling pathway to regulate the development of pulmonary fibrosis after lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_okuklehf2bVg90H21EOLACvtfcHk0liZtp7O5qeRmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D&md5=ae97ec6b86cb2006ed7c3ce6b7d35c0b</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2010-0155OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2010-0155OC%26sid%3Dliteratum%253Aachs%26aulast%3DFunke%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520promotes%2520epithelial%2520cell%2520apoptosis%2520after%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26spage%3D355%26epage%3D364%26doi%3D10.1165%2Frcmb.2010-0155OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCamera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Shah, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nm1685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+A.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak&doi=10.1038%2Fnm1685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0lhkuvv1PkRqFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D45%26epage%3D54%26doi%3D10.1038%2Fnm1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Xu, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violette, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAnulty, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, G.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span><span class="refDoi"> DOI: 10.2353/ajpath.2009.080160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.2353%2Fajpath.2009.080160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=19147812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2009&pages=1264-1279&author=M.+Y.+Xuauthor=J.+Porteauthor=A.+J.+Knoxauthor=P.+H.+Weinrebauthor=T.+M.+Maherauthor=S.+M.+Violetteauthor=R.+J.+McAnultyauthor=D.+Sheppardauthor=G.+Jenkins&title=Lysophosphatidic+acid+induces+%CE%B1v%CE%B26+integrin-mediated+TGF-%CE%B2+activation+via+the+LPA2+receptor+and+the+small+G+protein+G%CE%B1q&doi=10.2353%2Fajpath.2009.080160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq</span></div><div class="casAuthors">Xu, Ming Yan; Porte, Joanne; Knox, Alan J.; Weinreb, Paul H.; Maher, Toby M.; Violette, Shelia M.; McAnulty, Robin J.; Sheppard, Dean; Jenkins, Gisli</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1264-1279</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Activation of latent transforming growth factor β (TGF-β) by αvβ6 integrin is crit. in the pathogenesis of lung injury and fibrosis.  We have previously demonstrated that the stimulation of protease activated receptor 1 promotes αvβ6 integrin-mediated TGF-β activation via RhoA, which is known to modulate cell contraction.  However, whether other G protein-coupled receptors can also induce αvβ6 integrin-mediated TGF-β activation is unknown; in addn., the αvβ6 integrin signaling pathway has not yet been fully characterized.  In this study, we show that lysophosphatidic acid (LPA) induces αvβ6-mediated TGF-β activation in human epithelial cells via both RhoA and Rho kinase.  Furthermore, we demonstrate that LPA-induced αvβ6 integrin-mediated TGF-β activity is mediated via the LPA2 receptor, which signals via Gαq.  Finally, we show that the expression levels of both the LPA2 receptor and αvβ6 integrin are up-regulated and are spatially and temporally assocd. following bleomycin-induced lung injury.  Furthermore, both the LPA2 receptor and αvβ6 integrin are up-regulated in the overlying epithelial areas of fibrosis in patients with usual interstitial pneumonia.  These studies demonstrate that LPA induces αvβ6 integrin-mediated TGF-β activation in epithelial cells via LPA2, Gαq, RhoA, and Rho kinase, and that this pathway might be clin. relevant to the development of lung injury and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRLfe65xAfj7Vg90H21EOLACvtfcHk0lhkuvv1PkRqFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D&md5=0b9c319e5b3e4f6794333d2810edd958</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.080160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.080160%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%2BY.%26aulast%3DPorte%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DA.%2BJ.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DViolette%26aufirst%3DS.%2BM.%26aulast%3DMcAnulty%26aufirst%3DR.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DG.%26atitle%3DLysophosphatidic%2520acid%2520induces%2520%25CE%25B1v%25CE%25B26%2520integrin-mediated%2520TGF-%25CE%25B2%2520activation%2520via%2520the%2520LPA2%2520receptor%2520and%2520the%2520small%2520G%2520protein%2520G%25CE%25B1q%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D174%26spage%3D1264%26epage%3D1279%26doi%3D10.2353%2Fajpath.2009.080160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harijith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1165/rcmb.2013-0070OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1165%2Frcmb.2013-0070OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=23808384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyhu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=912-922&author=L.+S.+Huangauthor=P.+Fuauthor=P.+Patelauthor=A.+Harijithauthor=T.+Sunauthor=Y.+Zhaoauthor=J.+G.+Garciaauthor=J.+Chunauthor=V.+Natarajan&title=Lysophosphatidic+acid+receptor-2+deficiency+confers+protection+against+bleomycin-induced+lung+injury+and+fibrosis+in+mice&doi=10.1165%2Frcmb.2013-0070OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice</span></div><div class="casAuthors">Huang, Long Shuang; Fu, Panfeng; Patel, Priya; Harijith, Anantha; Sun, Tianjiao; Zhao, Yutong; Garcia, Joe G. N.; Chun, Jerold; Natarajan, Viswanathan</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">912-922</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis is a devastating disease characterized by alveolar epithelial cell injury, the accumulation of fibroblasts/myofibroblasts, and the deposition of extracellular matrix proteins.  Lysophosphatidic acid (LPA) signaling through its G protein-coupled receptors is crit. for its various biol. functions.  Recently, LPA and LPA receptor 1 were implicated in lung fibrogenesis.  However, the role of other LPA receptors in fibrosis remains unclear.  Here, we use a bleomycin-induced pulmonary fibrosis model to investigate the roles of LPA2 in pulmonary fibrogenesis.  In the present study, we found that LPA2 knockout (Lpar2-/-) mice were protected against bleomycin-induced lung injury, fibrosis, and mortality, compared with wild-type control mice.  Furthermore, LPA2 deficiency attenuated the bleomycin-induced expression of fibronectin (FN), α-smooth muscle actin (α-SMA), and collagen in lung tissue, as well as levels of IL-6, transforming growth factor-β (TGF-β), and total protein in bronchoalveolar lavage fluid.  In human lung fibroblasts, the knockdown of LPA2 attenuated the LPA-induced expression of TGF-β1 and the differentiation of lung fibroblasts to myofibroblasts, resulting in the decreased expression of FN, α-SMA, and collagen, as well as decreased activation of extracellular regulated kinase 1/2, Akt, Smad3, and p38 mitogen-activated protein kinase.  Moreover, the knockdown of LPA2 with small interfering RNA also mitigated the TGF-β1-induced differentiation of lung fibroblasts.  In addn., LPA2 deficiency significantly attenuated the bleomycin-induced apoptosis of alveolar and bronchial epithelial cells in the mouse lung.  Together, our data indicate that the knockdown of LPA2 attenuated bleomycin-induced lung injury and pulmonary fibrosis, and this may be related to an inhibition of the LPA-induced expression of TGF-β and the activation and differentiation of fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlKYtpTWIkfbVg90H21EOLACvtfcHk0ljB_uay-5_ppw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyhu7bN&md5=e15e9a67c81d49cb5874bc768a283111</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2013-0070OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2013-0070OC%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%2BS.%26aulast%3DFu%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DHarijith%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DLysophosphatidic%2520acid%2520receptor-2%2520deficiency%2520confers%2520protection%2520against%2520bleomycin-induced%2520lung%2520injury%2520and%2520fibrosis%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2013%26volume%3D49%26spage%3D912%26epage%3D922%26doi%3D10.1165%2Frcmb.2013-0070OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Desroy, N.; Heckmann, B.; Brys, R. C. X.; Joncour, A.; Peixoto, C.; Bock, X.</span><span> </span><span class="NLM_article-title">Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders</span>. PCT Int. Appl. WO2014/139882 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Desroy&author=B.+Heckmann&author=R.+C.+X.+Brys&author=A.+Joncour&author=C.+Peixoto&author=X.+Bock&title=Compounds+and+pharmaceutical+compositions+thereof+for+the+treatment+of+inflammatory+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DCompounds%2520and%2520pharmaceutical%2520compositions%2520thereof%2520for%2520the%2520treatment%2520of%2520inflammatory%2520disorders%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Desroy, N.; Joncour, A.; Bock, X.; Housseman, C.; Peixoto, C.; Bienvenu, N.; Labeguere, V.; Cherel, L.; Annoot, D.; Christophe, T.; Conrath, K.; Triballeau, N.; Mollat, P.; Wohlkonig, A.; Blanque, R.; Cottereaux, C.; Hrvacic, B.; Borgonovi, M.; Monjardet, A.; Van der Aar, E.; Brys, R.; Heckmann, B.</span><span> </span><span class="NLM_article-title">Discovery of GLPG1690: A first-in-class autotaxin inhibitor in clinical development for the treatment of idiopathic pulmonary fibrosis</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 251st National Meeting & Exposition of the American Chemical Society, San Diego, CA, U.S., March 13–17, 2016; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>; MEDI-254.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Desroy%2C+N.%3B+Joncour%2C+A.%3B+Bock%2C+X.%3B+Housseman%2C+C.%3B+Peixoto%2C+C.%3B+Bienvenu%2C+N.%3B+Labeguere%2C+V.%3B+Cherel%2C+L.%3B+Annoot%2C+D.%3B+Christophe%2C+T.%3B+Conrath%2C+K.%3B+Triballeau%2C+N.%3B+Mollat%2C+P.%3B+Wohlkonig%2C+A.%3B+Blanque%2C+R.%3B+Cottereaux%2C+C.%3B+Hrvacic%2C+B.%3B+Borgonovi%2C+M.%3B+Monjardet%2C+A.%3B+Van+der+Aar%2C+E.%3B+Brys%2C+R.%3B+Heckmann%2C+B.+Discovery+of+GLPG1690%3A+A+first-in-class+autotaxin+inhibitor+in+clinical+development+for+the+treatment+of+idiopathic+pulmonary+fibrosis.+Abstracts+of+Papers%2C+251st+National+Meeting+%26+Exposition+of+the+American+Chemical+Society%2C+San+Diego%2C+CA%2C+U.S.%2C+March+13%E2%80%9317%2C+2016%3B+American+Chemical+Society%3A+Washington%2C+DC%3B+MEDI-254."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520GLPG1690%253A%2520A%2520first-in-class%2520autotaxin%2520inhibitor%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Usui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komuro, S.</span><span> </span><span class="NLM_article-title">Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2383</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1124/dmd.109.028860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1124%2Fdmd.109.028860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=19720731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=2383-2392&author=T.+Usuiauthor=M.+Miseauthor=T.+Hashizumeauthor=M.+Yabukiauthor=S.+Komuro&title=Evaluation+of+the+potential+for+drug-induced+liver+injury+based+on+in+vitro+covalent+binding+to+human+liver+proteins&doi=10.1124%2Fdmd.109.028860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins</span></div><div class="casAuthors">Usui, Toru; Mise, Masashi; Hashizume, Takanori; Yabuki, Masashi; Komuro, Setsuko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2383-2392</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Prediction of idiosyncratic drug-induced liver injury (DILI) is difficult, and the underlying mechanisms are not fully understood.  However, many drugs causing DILI are considered to form reactive metabolites and covalently bind to cellular macromols. in the liver.  The objective of this study was to clarify whether the risk of idiosyncratic DILI can be estd. by comparing in vitro covalent binding (CB) levels among 12 pos. compds. (acetaminophen, alpidem, bromfenac, carbamazepine, diclofenac, flutamide, imipramine, nefazodone, tacrine, ticlopidine, tienilic acid, and troglitazone) for DILI and 12 neg. compds. (acetylsalicylic acid, caffeine, dexamethasone, losartan, ibuprofen, paroxetine, pioglitazone, rosiglitazone, sertraline, theophylline, venlafaxine, and zolpidem).  After incubation with human liver microsomes in the presence of NADPH, there was a large overlap in the distribution of CB amts. between the pos. and neg. groups.  On addn. of UDP-glucuronic acid (UDPGA) as a cofactor for glucuronidation, the CB levels of bromfenac and diclofenac were increased.  With addn. of nucleophilic glutathione (GSH), values for most compds. were decreased.  However, sepn. of the two groups on the basis of CB could not be improved by UDPGA or GSH.  Furthermore, CB with human hepatocytes also failed to discriminate pos. from neg. compds.  Therefore, the CB amt. alone is not sufficient for risk assessment of DILI.  In contrast, when the CB amt. was multiplied by the max. daily dose, which may reflect max. hepatic exposure, the two groups did become discriminated.  Taken together, our findings suggest that the combination of CB amt. and daily dose can est. the risk of idiosyncratic DILI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvQoojI97OgLVg90H21EOLACvtfcHk0ljB_uay-5_ppw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr7K&md5=19ffc916995d60f9cb0b6b3a2074a082</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.028860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.028860%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DMise%26aufirst%3DM.%26aulast%3DHashizume%26aufirst%3DT.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DKomuro%26aufirst%3DS.%26atitle%3DEvaluation%2520of%2520the%2520potential%2520for%2520drug-induced%2520liver%2520injury%2520based%2520on%2520in%2520vitro%2520covalent%2520binding%2520to%2520human%2520liver%2520proteins%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D2383%26epage%3D2392%26doi%3D10.1124%2Fdmd.109.028860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0liFURsctPYRJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moutou, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J.-J.</span><span> </span><span class="NLM_article-title">A two-steps benzotriazole-assisted synthesis of 3-amino-2-ethoxycarbonyl imidazo [1,2-a] pyridines and related compounds</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1787</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span><span class="refDoi"> DOI: 10.1016/0040-4039(96)00132-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2F0040-4039%2896%2900132-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=1787-1790&author=J.-L.+Moutouauthor=M.+Schmittauthor=V.+Collotauthor=J.-J.+Bourguignon&title=A+two-steps+benzotriazole-assisted+synthesis+of+3-amino-2-ethoxycarbonyl+imidazo+%5B1%2C2-a%5D+pyridines+and+related+compounds&doi=10.1016%2F0040-4039%2896%2900132-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2896%2900132-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252896%252900132-3%26sid%3Dliteratum%253Aachs%26aulast%3DMoutou%26aufirst%3DJ.-L.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DCollot%26aufirst%3DV.%26aulast%3DBourguignon%26aufirst%3DJ.-J.%26atitle%3DA%2520two-steps%2520benzotriazole-assisted%2520synthesis%2520of%25203-amino-2-ethoxycarbonyl%2520imidazo%2520%255B1%252C2-a%255D%2520pyridines%2520and%2520related%2520compounds%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D1787%26epage%3D1790%26doi%3D10.1016%2F0040-4039%2896%2900132-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Katritzky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urogdi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayence, A.</span><span> </span><span class="NLM_article-title">The chemistry of <i>N</i>-substituted benzotriazoles Part 23. Synthesis of tertiary α-amino esters</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">1989</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1055/s-1989-27244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1055%2Fs-1989-27244" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1989&publication_year=1989&pages=323-327&author=A.+R.+Katritzkyauthor=L.+Urogdiauthor=A.+Mayence&title=The+chemistry+of+N-substituted+benzotriazoles+Part+23.+Synthesis+of+tertiary+%CE%B1-amino+esters&doi=10.1055%2Fs-1989-27244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1055%2Fs-1989-27244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1989-27244%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DUrogdi%26aufirst%3DL.%26aulast%3DMayence%26aufirst%3DA.%26atitle%3DThe%2520chemistry%2520of%2520N-substituted%2520benzotriazoles%2520Part%252023.%2520Synthesis%2520of%2520tertiary%2520%25CE%25B1-amino%2520esters%26jtitle%3DSynthesis%26date%3D1989%26volume%3D1989%26spage%3D323%26epage%3D327%26doi%3D10.1055%2Fs-1989-27244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gonzalez Lio, L.; Camacho Gomez, J. A.</span><span> </span><span class="NLM_article-title">New compounds as adenosine A1 receptor antagonists</span>. PCT Int. Appl. WO2009044250 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Gonzalez+Lio&author=J.+A.+Camacho+Gomez&title=New+compounds+as+adenosine+A1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%2BLio%26aufirst%3DL.%26atitle%3DNew%2520compounds%2520as%2520adenosine%2520A1%2520receptor%2520antagonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">King, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryden, I.</span><span> </span><span class="NLM_article-title">The reaction of ketones with formamidine disulfide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1947</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1813</span><span class="NLM_x">–</span> <span class="NLM_lpage">1814</span><span class="refDoi"> DOI: 10.1021/ja01199a072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01199a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1947&pages=1813-1814&author=L.+C.+Kingauthor=I.+Ryden&title=The+reaction+of+ketones+with+formamidine+disulfide&doi=10.1021%2Fja01199a072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fja01199a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01199a072%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DL.%2BC.%26aulast%3DRyden%26aufirst%3DI.%26atitle%3DThe%2520reaction%2520of%2520ketones%2520with%2520formamidine%2520disulfide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1947%26volume%3D69%26spage%3D1813%26epage%3D1814%26doi%3D10.1021%2Fja01199a072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Insights into autotaxin: how to produce and present a lipid mediator</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1038/nrm3188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnrm3188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=21915140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=674-679&author=W.+H.+Moolenaarauthor=A.+Perrakis&title=Insights+into+autotaxin%3A+how+to+produce+and+present+a+lipid+mediator&doi=10.1038%2Fnrm3188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into autotaxin: how to produce and present a lipid mediator</span></div><div class="casAuthors">Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is a secreted phosphodiesterase that produces the lipid mediator lysophosphatidic acid (LPA).  LPA acts through specific guanine-nucleotide-binding protein (G protein)-coupled receptors to stimulate migration, proliferation, survival and other functions in many cell types.  ATX is important in vivo for processes as diverse as vasculogenesis, lymphocyte trafficking and tumor progression.  However, the inner workings of ATX have long been elusive, in terms of both its substrate specificity and how localized LPA signalling is achieved.  Structural studies have shown how ATX recognizes its substrates and may interact with the cell surface to promote specificity in LPA signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm3UHhjy0QP7Vg90H21EOLACvtfcHk0lhEmJKTXjDtfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ&md5=96ab96a9e7f6cd70f5dcc1be0363d298</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1038%2Fnrm3188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3188%26sid%3Dliteratum%253Aachs%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DInsights%2520into%2520autotaxin%253A%2520how%2520to%2520produce%2520and%2520present%2520a%2520lipid%2520mediator%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D674%26epage%3D679%26doi%3D10.1038%2Fnrm3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Crystal structure of autotaxin an insight into GPCR activation by lipid mediators</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/nsmb.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1038%2Fnsmb.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=21240269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=205-213&author=H.+Nishimasuauthor=S.+Okudairaauthor=K.+Hamaauthor=E.+Miharaauthor=N.+Dohmaeauthor=A.+Inoueauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+structure+of+autotaxin+an+insight+into+GPCR+activation+by+lipid+mediators&doi=10.1038%2Fnsmb.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span></div><div class="casAuthors">Nishimasu, Hiroshi; Okudaira, Shinichi; Hama, Kotaro; Mihara, Emiko; Dohmae, Naoshi; Inoue, Asuka; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as Enpp2) is a secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine to generate lysophosphatidic acid (LPA), a lipid mediator that activates G protein-coupled receptors to evoke various cellular responses.  Here, we report the crystal structures of mouse ATX alone and in complex with LPAs with different acyl-chain lengths and saturations.  These structures reveal that the multidomain architecture helps to maintain the structural rigidity of the lipid-binding pocket, which accommodates the resp. LPA mols. in distinct conformations.  They indicate that a loop region in the catalytic domain is a major determinant for the substrate specificity of the Enpp family enzymes.  Furthermore, along with biochem. and biol. data, these structures suggest that the produced LPAs are delivered from the active site to cognate G protein-coupled receptors through a hydrophobic channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9dHNmB6yTbVg90H21EOLACvtfcHk0lhEmJKTXjDtfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D&md5=f2f9ccaadf5c7de7bfd8431e5f954b2a</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1998%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520structure%2520of%2520autotaxin%2520an%2520insight%2520into%2520GPCR%2520activation%2520by%2520lipid%2520mediators%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D205%26epage%3D213%26doi%3D10.1038%2Fnsmb.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moeller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ask, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warburton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauldie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, M.</span><span> </span><span class="NLM_article-title">The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span><span class="refDoi"> DOI: 10.1016/j.biocel.2007.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2Fj.biocel.2007.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=17936056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVentrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=362-382&author=A.+Moellerauthor=K.+Askauthor=D.+Warburtonauthor=J.+Gauldieauthor=M.+Kolb&title=The+bleomycin+animal+model%3A+a+useful+tool+to+investigate+treatment+options+for+idiopathic+pulmonary+fibrosis%3F&doi=10.1016%2Fj.biocel.2007.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?</span></div><div class="casAuthors">Moeller, Antje; Ask, Kjetil; Warburton, David; Gauldie, Jack; Kolb, Martin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">362-382</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Different animal models of pulmonary fibrosis were developed to investigate potential therapies for idiopathic pulmonary fibrosis (IPF).  The most common is the bleomycin model in rodents (mouse, rat and hamster).  Over the years, numerous agents were shown to inhibit fibrosis in this model.  However, to date none of these compds. are used in the clin. management of IPF and none has shown a comparable antifibrotic effect in humans.  We performed a systematic review of publications on drug efficacy studies in the bleomycin model to evaluate the value of this model regarding transferability to clin. use.  Between 1980 and 2006 we identified 240 exptl. studies describing beneficial antifibrotic compds. in the bleomycin model. 222 of those used a preventive regimen (drug given ≤7 days after last bleomycin application), only 13 were therapeutic trials (>7 days after last bleomycin application).  In 5 studies we did not find enough details about the timing of drug application to allow inter-study comparison.  It is crit. to distinguish between drugs interfering with the inflammatory and early fibrogenic response from those preventing progression of fibrosis, the latter likely much more meaningful for clin. application.  All potential antifibrotic compds. should be evaluated in the phase of established fibrosis rather than in the early period of bleomycin-induced inflammation for assessment of its antifibrotic properties.  Further care should be taken in extrapolation of drugs successfully tested in the bleomycin model due to partial reversibility of bleomycin-induced fibrosis over time.  The use of alternative and more robust animal models, which better reflect human IPF, is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO707NgQcoCLVg90H21EOLACvtfcHk0lhEmJKTXjDtfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVentrg%253D&md5=2d9caf63cbe8d6092cdf4b011e46dfce</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2007.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2007.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DMoeller%26aufirst%3DA.%26aulast%3DAsk%26aufirst%3DK.%26aulast%3DWarburton%26aufirst%3DD.%26aulast%3DGauldie%26aufirst%3DJ.%26aulast%3DKolb%26aufirst%3DM.%26atitle%3DThe%2520bleomycin%2520animal%2520model%253A%2520a%2520useful%2520tool%2520to%2520investigate%2520treatment%2520options%2520for%2520idiopathic%2520pulmonary%2520fibrosis%253F%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2008%26volume%3D40%26spage%3D362%26epage%3D382%26doi%3D10.1016%2Fj.biocel.2007.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renteria, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravindran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogaboam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, C. S.</span><span> </span><span class="NLM_article-title">Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">e59348</span><span class="refDoi"> DOI: 10.1371/journal.pone.0059348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1371%2Fjournal.pone.0059348" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e59348&issue=4&author=R.+Pengauthor=S.+Sridharauthor=G.+Tyagiauthor=J.+E.+Phillipsauthor=R.+Garridoauthor=P.+Harrisauthor=L.+Burnsauthor=L.+Renteriaauthor=J.+Woodsauthor=L.+Chenauthor=J.+Allardauthor=P.+Ravindranauthor=H.+Bitterauthor=Z.+Liangauthor=C.+M.+Hogaboamauthor=C.+Kitsonauthor=D.+C.+Buddauthor=J.+S.+Fineauthor=C.+M.+Bauerauthor=C.+S.+Stevenson&title=Bleomycin+induces+molecular+changes+directly+relevant+to+idiopathic+pulmonary+fibrosis%3A+a+model+for+%22active%22+disease&doi=10.1371%2Fjournal.pone.0059348"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0059348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0059348%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DSridhar%26aufirst%3DS.%26aulast%3DTyagi%26aufirst%3DG.%26aulast%3DPhillips%26aufirst%3DJ.%2BE.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DBurns%26aufirst%3DL.%26aulast%3DRenteria%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAllard%26aufirst%3DJ.%26aulast%3DRavindran%26aufirst%3DP.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DHogaboam%26aufirst%3DC.%2BM.%26aulast%3DKitson%26aufirst%3DC.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DBauer%26aufirst%3DC.%2BM.%26aulast%3DStevenson%26aufirst%3DC.%2BS.%26atitle%3DBleomycin%2520induces%2520molecular%2520changes%2520directly%2520relevant%2520to%2520idiopathic%2520pulmonary%2520fibrosis%253A%2520a%2520model%2520for%2520%2522active%2522%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D4%26spage%3De59348%26doi%3D10.1371%2Fjournal.pone.0059348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Noble, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costabel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassberg, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardatzke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, T. E.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahn, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szwarcberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeyre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Bois, R. M.</span><span> </span><span class="NLM_article-title">CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1769</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60405-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1016%2FS0140-6736%2811%2960405-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=1760-1769&author=P.+W.+Nobleauthor=C.+Alberaauthor=W.+Z.+Bradfordauthor=U.+Costabelauthor=M.+K.+Glassbergauthor=D.+Kardatzkeauthor=T.+E.+Kingauthor=L.+Lancasterauthor=S.+A.+Sahnauthor=J.+Szwarcbergauthor=D.+Valeyreauthor=R.+M.+du+Bois&title=CAPACITY+Study+Group.+Pirfenidone+in+patients+with+idiopathic+pulmonary+fibrosis+%28CAPACITY%29%3A+two+randomised+trials&doi=10.1016%2FS0140-6736%2811%2960405-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960405-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960405-4%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DP.%2BW.%26aulast%3DAlbera%26aufirst%3DC.%26aulast%3DBradford%26aufirst%3DW.%2BZ.%26aulast%3DCostabel%26aufirst%3DU.%26aulast%3DGlassberg%26aufirst%3DM.%2BK.%26aulast%3DKardatzke%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DT.%2BE.%26aulast%3DLancaster%26aufirst%3DL.%26aulast%3DSahn%26aufirst%3DS.%2BA.%26aulast%3DSzwarcberg%26aufirst%3DJ.%26aulast%3DValeyre%26aufirst%3DD.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26atitle%3DCAPACITY%2520Study%2520Group.%2520Pirfenidone%2520in%2520patients%2520with%2520idiopathic%2520pulmonary%2520fibrosis%2520%2528CAPACITY%2529%253A%2520two%2520randomised%2520trials%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D1760%26epage%3D1769%26doi%3D10.1016%2FS0140-6736%2811%2960405-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ashcroft, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timbrell, V.</span><span> </span><span class="NLM_article-title">Simple method of estimating severity of pulmonary fibrosis on a numerical scale</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1136/jcp.41.4.467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1136%2Fjcp.41.4.467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=3366935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A280%3ADyaL1c3htlOltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1988&pages=467-470&author=T.+Ashcroftauthor=J.+M.+Simpsonauthor=V.+Timbrell&title=Simple+method+of+estimating+severity+of+pulmonary+fibrosis+on+a+numerical+scale&doi=10.1136%2Fjcp.41.4.467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Simple method of estimating severity of pulmonary fibrosis on a numerical scale</span></div><div class="casAuthors">Ashcroft T; Simpson J M; Timbrell V</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-70</span>
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">A continuous numerical scale for determining the degree of fibrosis in lung specimens was devised for correlation with other pulmonary variables such as lung function tests or mineral burden.  Grading was scored on a scale from 0 to 8, using the average of microscope field scores.  The system allows fibrosis to be measured in small samples of tissue (1 cm) which can provide a detailed description of the changes in a lung, currently not possible with most existing methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5mGFCkDKSIzUE-swuRqsHfW6udTcc2eZ9me7dLdU4u7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3htlOltg%253D%253D&md5=d1da07e3ba735d309aa78d3955474bfd</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1136%2Fjcp.41.4.467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.41.4.467%26sid%3Dliteratum%253Aachs%26aulast%3DAshcroft%26aufirst%3DT.%26aulast%3DSimpson%26aufirst%3DJ.%2BM.%26aulast%3DTimbrell%26aufirst%3DV.%26atitle%3DSimple%2520method%2520of%2520estimating%2520severity%2520of%2520pulmonary%2520fibrosis%2520on%2520a%2520numerical%2520scale%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1988%26volume%3D41%26spage%3D467%26epage%3D470%26doi%3D10.1136%2Fjcp.41.4.467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Matsuse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuhashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uejima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouchi, Y.</span><span> </span><span class="NLM_article-title">ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1183%2F09031936.99.13107199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10836326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlymsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=71-77&author=T.+Matsuseauthor=S.+Teramotoauthor=H.+Katayamaauthor=E.+Sudoauthor=H.+Ekimotoauthor=H.+Mitsuhashiauthor=Y.+Uejimaauthor=Y.+Fukuchiauthor=Y.+Ouchi&title=ICAM-1+mediates+lung+leukocyte+recruitment+but+not+pulmonary+fibrosis+in+a+murine+model+of+bleomycin-induced+lung+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury</span></div><div class="casAuthors">Matsuse, T.; Teramoto, S.; Katayama, H.; Sudo, E.; Ekimoto, H.; Mitsuhashi, H.; Uejima, Y.; Fukuchi, Y.; Ouchi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Bleomycin-induced lung injury has been extensively used as a model of interstitial pneumonia and pulmonary fibrosis.  Intercellular adhesion mol. (ICAM)-1 is a ligand for lymphocyte function-assocd. antigen (LFA)-1α and has been shown to be required for leukocyte migration into inflamed areas.  The purpose here was to investigate the role of the ICAM-1/LFA-1α pathway in a murine model of bleomycin-induced lung injury.  Animals received 75 mg/kg-1 bleomycin (BLM) i.v. followed by treatment with phosphate-buffered saline (BLM group), anti-ICAM-1 and LFA-1α monoclonal antibodies (mAb) (BLM+mAb group).  Inflammatory cell counts of bronchoalveolar lavage (BAL) fluid, hydroxyproline content, and histol. findings were compared between these groups.  In the BLM group, increases in total cell count, macrophage count, and neutrophil count of BAL fluid were obsd. on days 7 and 14.  In the BLM+mAb group, bleomycin-induced accumulation of neutrophils was reduced on days 7 and 14.  However, the administration of mAb to ICAM-1 and LFA-1α did not decrease the lung hydroxyproline content or the histopathol. fibrosis grading score, indicating that the antagonism of ICAM-1 and LFA-1α did not attenuate bleomycin-induced pulmonary fibrosis.  Apparently, the ICAM-1/LFA-1α pathway mediates the accumulation of inflammatory cells in the injured lung caused by bleomycin; however, other mechanisms are important for the subsequent development of pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp1vLl5CSzmLVg90H21EOLACvtfcHk0lgh5XEMyAHm8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlymsL4%253D&md5=eaae85d8e5354d6eb20c74c643481c91</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1183%2F09031936.99.13107199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.99.13107199%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuse%26aufirst%3DT.%26aulast%3DTeramoto%26aufirst%3DS.%26aulast%3DKatayama%26aufirst%3DH.%26aulast%3DSudo%26aufirst%3DE.%26aulast%3DEkimoto%26aufirst%3DH.%26aulast%3DMitsuhashi%26aufirst%3DH.%26aulast%3DUejima%26aufirst%3DY.%26aulast%3DFukuchi%26aufirst%3DY.%26aulast%3DOuchi%26aufirst%3DY.%26atitle%3DICAM-1%2520mediates%2520lung%2520leukocyte%2520recruitment%2520but%2520not%2520pulmonary%2520fibrosis%2520in%2520a%2520murine%2520model%2520of%2520bleomycin-induced%2520lung%2520injury%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1999%26volume%3D13%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><div class="note"><p class="first last">This result will be further discussed in a future pharmacology publication. It contradicts observations made with another autotaxin inhibitor in the following article:</p></div><span class="NLM_contrib-group">Black, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagares, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahluwalia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2450</span><span class="refDoi"> DOI: 10.1096/fj.201500197R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;key=10.1096%2Ffj.201500197R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=2435-2450&author=K.+E.+Blackauthor=E.+Berdyshevauthor=G.+Bainauthor=F.+V.+Castelinoauthor=B.+S.+Sheaauthor=C.+K.+Probstauthor=B.+A.+Fontaineauthor=I.+Bronovaauthor=L.+Gouletauthor=D.+Lagaresauthor=N.+Ahluwaliaauthor=R.+S.+Knipeauthor=V.+Natarajanauthor=A.+M.+Tager&title=Autotaxin+activity+increases+locally+following+lung+injury%2C+but+is+not+required+for+pulmonary+lysophosphatidic+acid+production+or+fibrosis&doi=10.1096%2Ffj.201500197R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1096%2Ffj.201500197R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201500197R%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DProbst%26aufirst%3DC.%2BK.%26aulast%3DFontaine%26aufirst%3DB.%2BA.%26aulast%3DBronova%26aufirst%3DI.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLagares%26aufirst%3DD.%26aulast%3DAhluwalia%26aufirst%3DN.%26aulast%3DKnipe%26aufirst%3DR.%2BS.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAutotaxin%2520activity%2520increases%2520locally%2520following%2520lung%2520injury%252C%2520but%2520is%2520not%2520required%2520for%2520pulmonary%2520lysophosphatidic%2520acid%2520production%2520or%2520fibrosis%26jtitle%3DFASEB%2520J.%26date%3D2016%26volume%3D30%26spage%3D2435%26epage%3D2450%26doi%3D10.1096%2Ffj.201500197R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MHP','PDB','5MHP'); return false;">PDB: 5MHP</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00032">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45874"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00032">10.1021/acs.jmedchem.7b00032</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Preparation and characterization for additional final compounds, <i>K</i><sub>i</sub> determination for compound <b>11</b>, and cocrystallization protocol (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_001.pdf">jm7b00032_si_001.pdf (506.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00032/suppl_file/jm7b00032_si_002.csv">jm7b00032_si_002.csv (1.76 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code of cocrystal structure of compound <b>11</b> with ATX is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MHP">5MHP</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00032%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-9%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00032" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679974e2bb26d1fb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
